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SUMMARY 
 
The Ca
2+
-ATPase of sarco(endo)plasmic reticulum (SERCA) is a protein of about 
110 kDa member of the P-type ATPases family. SERCA pumps utilize the energy 
derived from the hydrolysis of a molecule of ATP to transport two Ca
2+
 ions across the 
Sarcoplasmic Reticulum (SR) membrane to decrease the Ca
2+
 concentration in the 
cytosol. SERCA isoform 1a (SERCA1a) is the mainly expressed isoform in adult fast-
twitch muscle fibre and it is both structurally and functionally the best characterized 
member of the P-type ion translocating ATPases. 
An inherited muscle disorder defined as Bovine Congenital Pseudomyotonia 
(PMT) has been recently described in two important Italian cattle breeds Chianina and 
Romagnola (RMG) and, as a single case, in a Dutch improved Red&White (VRB) 
crossbred calf in the Netherlands. Clinically the disorder is characterized by an exercise-
induced muscle contraction not associated to electromyogram alterations. Basing on the 
clinical signs, the explanation proposed for the delayed relaxation of muscle was a 
prolonged elevation in Ca
2+
 ion cytoplasmic concentration. Because the structure 
primary involved in the re-uptake of the Ca
2+
 ion into the SR after muscle-contraction is 
the ATPase pump, the more likely aetiological hypothesis was an involvement of 
SERCA1a protein. Indeed, DNA sequencing of affected animals provided evidence of 
mutations in ATP2A1 gene coding for SERCA1. So far, different point mutations have 
been described in the different breeds that displayed the disease. 
Bovine PMT has been well characterized at both genetic and biochemical levels in 
Chianina breed. The main objective of this project is to complete the characterization of 
the disease by mean of analysing from a morphological, histochemical and biochemical 
point of view the other PMT-cases diagnosed in RMG and VRB breeds. The final aims 
are to increase the knowledge on morphological and biochemical effects of the disease 
on muscle tissue, to evaluate phenotypic variability of the disease and to identify 
possible adaptive/compensatory mechanisms that could drive the future research to 
develop new therapeutic approaches. The interest on bovine PMT arises from its 
similarities with a rare human inherited muscular dysfunction named Brody disease. 
Indeed, PMT-affected Chianina cattle has been accepted as an interesting and useful 
non-conventional animal model for the study of this human pathological condition. 
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The histopathological examinations on semimembranosus muscle biopsies from RMG 
and VRB affected animals did not show severe signs of muscle damage. Some pale 
degenerated fibres, filled or surrounded by macrophages, were identified within the 
tissue, although they were always accompanied by regenerative phenomena (small size 
fibres neonatal MHC-positive). Histochemical protocols (COX-SDH and PAS staining) 
did not reveal metabolic alterations or changes in glycogen distribution. 
Immunohistochemical investigations on SERCA1 expression showed that pathological 
cases had a decrease in immunoreactivity for SERCA1 antibody suggesting a lower 
presence of the protein. The latter finding was confirmed by biochemical analysis on 
microsomal fractions enriched in content of SR membranes. Immunoblotting proved 
that only SERCA1 protein had a reduction in quantity whereas nor junctional (RyR) nor 
non-junctional (SL and GP53) markers of SR showed any variance. The quantitative 
decrease was also associated with a lower activity of the protein demonstrated by 
Ca
2+
ATPase activity assay. Real Time RT-PCR assays demonstrated that mRNA for 
SERCA1 was normally expressed suggesting that the protein reduction was due to post-
transcriptional events. 
Interestingly, the sections of the affected VRB subject showed an increased and more 
homogeneous stain for COX and SDH suggesting an augmentation in mitochondria 
content. This finding was reinforced by immunohistochemical and immunoblot surveys 
using an antibody against a protein of the mitochondrial outer membrane (Tom20). 
Moreover, microsomal fractions from VRB animal showed an increase in plasma 
membrane Ca
2+
ATPase (PMCA) when compare with controls. 
Finally in RMG and VRB affected subjects some fibres were immunoreactive for 
SERCA1 and phospholamban (PLB, regulator protein of SERCA2) or SERCA isoforms 
1 and 2 suggesting an alteration in the classic mutually exclusive protein expression 
pattern (either SERCA1 or SERCA2 and PLB). 
The results of this research describe Bovine Congenital Pseudomyotonia in RGM 
and VRB as a muscular disease characterized by mild histopathological alterations and 
a sole decrease in SERCA1 content and activity, in full agreement with the studies on 
Chianina. All the analyses performed on VRB and RGM animals allow to obtain a 
complete picture of the PMT in these breeds and afford to define a general 
histopathological and biochemical case of PMT. In addition, for the first time 
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compensatory mechanisms were demonstrated providing histochemical and biochemical 
evidences to support mitochondria and PMCA involvement in the Ca
2+
 homeostasis 
during the pathological condition caused by PMT mutation. Finally, the first evidence 
of co-expression of SERCA1, SERCA2 and PLB in affected animals, was an intriguing 
collateral finding that suggests a great potential plasticity of cattle muscle resembling 
the human muscle once again. 
 
A side project was developed in collaboration with the group of Prof. R. Smith 
and Dr. J. Dudhia of the Clinical Sciences and Services Department of the Royal 
Veterinary College (London). Two different pilot studies were carry out on extracellular 
matrix response to tendon injury in equine. The first had as object of study the cartilage 
oligomeric matrix protein (COMP) recently proposed as useful biomarker of 
tendinopathy. The aim of this project was to assess the level of fragmentation (index of 
alteration but also re-modelling) of COMP in healthy tendon tissue collected in sites 
well-known to be more frequently involved in lesions (predisposed to injury). The 
tendons analysed were the superficial digital flexor (SDFT) and the deep digital flexor 
(DDFT). Immunoblotting and densitometric analysis of total protein extracts showed an 
higher COMP fragmentation level in healthy predisposed sites when compare with non-
predisposed sites. Moreover, for the first time the different patterns of COMP 
expression in SDFT and DDFT of young and old subjects were described. The second 
pilot study analysed the morphological aspect of tendon tissue affected by tear-type 
lesion. The objective was to evaluate the influence of the lesion on the tissue adjacent, 
far and remote to the injury site. The tendon was extremely altered close to the lesion 
while the other areas showed high cellularity and vascularity but normal matrix 
organization. Masson trichrome staining distinguished damaged tissue (blue) from 
healthy (red) running to become an intriguing tool for histological investigation. 
Immunohistochemistry showed an increased reactivity for COMP antibody in the areas 
more proximal to the tear reinforcing the studies that support a fundamental role of this 
protein in the matrix re-modelling. Increasing the knowledge of COMP distribution in 
SDFT and DDFT, and providing information of tendon response to tear lesion, these 
two pilot studies create a useful platform for future researches with possible clinical and 
therapeutic implication. 
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RIASSUNTO 
 
La Ca
2+
-ATPasi del reticolo sarco(endo)plasmatico (SERCA) è una proteina di 
circa 110 kDa membro della famiglia delle P-type ATPasi. Le SERCA utilizzano 
l'energia ricavata dall’idrolisi di una molecola di ATP per trasportare due ioni Ca2+ 
attraverso la membrana del reticolo sarcoplasmatico (SR) e diminuire così la 
concentrazione di Ca
2+
 nel citosol. La SERCA1a è l'isoforma espressa prevalentemente 
dalle fibre muscolari fast nell’adulto ed è strutturalmente e funzionalmente la meglio 
caratterizzata tra tutte le ATPasi. 
Un disturbo muscolare ereditario definito come Pseudomiotonia Congenita 
Bovina (PMT) è stato recentemente descritto in due importanti razze bovine da carne 
italiane Chianina e Romagnola (RMG) e, come caso isolato, in un incrocio olandese 
(Dutch improved Red&White -VRB-). La malattia è caratterizzata clinicamente da una 
contrazione muscolare indotta da esercizio ma non associata ad alterazioni 
elettromiografiche. La causa attribuita al ritardato rilassamento muscolare è stata una 
prolungata permanenza del Ca
2+
 nel citoplasma. Poiché la struttura primariamente 
coinvolta nel re-uptake del Ca
2+
 all’interno del SR dopo la contrazione muscolare è la 
pompa ATPasi, è stato proposto un coinvolgimento della proteine SERCA1a. Il 
sequenziamento del DNA di animali affetti ha dimostrato la presenza di mutazioni nel 
gene ATP2A1 che codifica appunto la SERCA1. Ad oggi diverse mutazioni puntiformi 
sono state descritte nelle varie razze che manifestano la malattia. La PMT è stato 
caratterizzata a livello genetico e biochimico nella razza Chianina. 
L'obiettivo principale di questo progetto è quello di completare la caratterizzazione della 
malattia attraverso l’analisi morfologica, istochimica e biochimica dei casi di PMT 
descritti nelle razze RMG e VRB. Scopo ultimo è quello di aumentare le conoscenze 
sugli effetti morfologici e biochimici della malattia sul tessuto muscolare, valutare la 
variabilità fenotipica della malattia e individuare eventuali meccanismi di adattamento o 
compensatori che potrebbero suggerire nuovi approcci terapeutici alle ricerche future. 
L'interesse per la PMT deriva dalla sua stretta somiglianza con una rara disfunzione 
muscolare ereditaria dell’uomo chiamata malattia di Brody. Il bovino di razza Chianina 
affetto da PMT è stato di fatto accettato come un interessante e utile modello animale 
non convenzionale per lo studio di questa condizione patologica umana. 
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L’esame istopatologico delle biopsie muscolari ottenute dai soggetti RMG e VRB non 
hanno mostrato alterazioni particolarmente severe. Sono state individuate alcune fibre in 
degenerazione sempre accompagnate da fenomeni di rigenerazione (piccole fibre 
positive per la MHC neonatale). I protocolli istochimici (COX-SDH e PAS) non hanno 
evidenziato alterazioni metaboliche o cambiamenti nella distribuzione del glicogeno. 
Le indagini immunoistochimiche sull'espressione SERCA1 hanno mostrato una 
diminuita immunoreattività nei casi patologici suggerendo una minore presenza della 
proteina. Le analisi biochimiche effettuate sulle frazioni microsomiali hanno 
confermato la sola riduzione in contenuto di SERCA1, mentre né il RyR (marker del SR 
giunzionale) né SL e GP53 (marker del SR non-giunzionale) hanno mostrato alcuna 
variazione. Saggi di attività per la Ca
2+
 -ATPasi hanno associato una minore attività 
della proteina alla diminuzione quantitativa della stessa, mentre la Real Time RT-PCR 
ha dimostrato che l’mRNA della SERCA1 è espresso normalmente suggerendo che la 
riduzione della proteina avviene post-trascrizione. 
Un’interessante osservazione è stata che le sezioni del soggetto VRB mostravano una 
maggiore e più omogenea colorazione per COX e SDH suggerendo un aumento in 
contenuto di mitocondri. Quest'ultimo risultato è stato rafforzato da indagini di 
immunoistochimica e immunoblot utilizzando un anticorpo contro una proteina della 
membrana mitocondriale esterna (Tom20). Inoltre, frazioni microsomiali ottenute dal 
soggetto VRB hanno mostrato un aumento in contenuto della Ca
2+
-ATPasi della 
membrana plasmatica (PMCA). 
Infine, alcune fibre dei soggetti analizzati in questo studio hanno mostrato 
immunoreattività per SERCA1 e fosfolambano (PLB, proteina regolatrice della 
SERCA2) o per entrambe le isoforme 1 e 2 suggerendo un'alterazione nel classico 
pattern di espressione esclusivo delle tre proteine. 
I risultati di questa ricerca descrivono la Pseudomyotonia Congenita Bovina nei 
soggetti RGM e VRB come una malattia muscolare caratterizzata da alterazioni 
istopatologiche lievi e una diminuzione del contenuto e dell'attività della SERCA1, 
sovrapponibile al quadro descritto nella Chianina. Le analisi effettuate su VRB e RGM 
hanno permesso di ottenere un’immagine dettagliata della PMT in queste razze e, 
insieme ai dati sulla Chianina, ha permesso di definire un quadro istopatologico e 
biochimico generale della PMT. Inoltre, per la prima volta sono stati dimostrati 
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meccanismi compensatori fornendo prove istochimiche e biochimiche a sostegno di un 
coinvolgimento dei mitocondri e della PMCA nell’omeostasi del Ca2+ in situazioni 
patologiche come la PMT. Infine, il ritrovamento di fibre che co-esprimevano SERCA1, 
SERCA2 e PLB è stato un risultato collaterale interessante che suggerisce una elevata 
plasticità del muscolo bovino che lo avvicina ancora una volta al muscolo umano. 
 
Un progetto parallelo è stato sviluppato in collaborazione con il gruppo del Prof. R. 
Smith e del Dr. J. Dudhia del Clinical Sciences and Services Department of the Royal 
Veterinary College (London). Due diversi studi pilota sono stati effettuati per valutare la 
risposta della matrice extracellulare alla lesione tendinea nel cavallo. Il primo ha avuto 
come oggetto di studio la cartilage oligomeric matrix protein (COMP), recentemente 
proposta come biomarker di tendinopatia. Lo scopo di questo progetto è stato quello di 
valutare il livello di frammentazione (indice di alterazione, ma anche rimodellamento) 
di COMP nel tessuto tendineo sano raccolti in siti noti per essere più frequentemente 
coinvolti nelle lesioni (predisposti a lesione). I tendini analizzati sono stati il flessore 
digitale superficiale (SDFT) e il flessore digitale profondo (DDFT). L’immunoblot e 
l’analisi densitometrica di estratti totali di proteine hanno mostrato un più alto livello di 
frammentazione della COMP in siti sani ma predisposti a lesione quando confrontati 
con i siti non predisposti. Inoltre, per la prima volta sono stati descritti i diversi pattern 
di espressione della COMP in SDFT e DDFT di soggetti giovani e vecchi. Il secondo 
studio pilota ha analizzato l'aspetto morfologico del tessuto tendineo affetto da 
lacerazione (tear-type lesion). L'obiettivo è stato quello di valutare l'influenza della 
lesione sul tessuto adiacente, lontano e remoto al sito della lesione. Il tendine era 
estremamente alterato vicino alla lesione mentre nelle altre aree rimanevano un’alta 
cellularità e vascolarizzazione ma l’organizzazione della matrice migliorava  
notevolmente. La tricromica di Masson distingueva il tessuto danneggiato (blu) da 
quello sano (rosso) proponendosi come un interessante strumento nelle indagini 
istologiche. L'immunoistochimica ha mostrato un aumento della marcatura per COMP 
nelle aree più vicine allo strappo rafforzando gli studi che propongono questa proteina 
come fondamentale nel rimodellamento della matrice. Aumentando le conoscenze sulla 
distribuzione della COMP in SDFT e DDFT, e fornendo dati sulla risposta tissutale del 
tendine lacerato, questi due studi pilota hanno creato una piattaforma utile per le future 
ricerche con possibili implicazioni cliniche e terapeutiche. 
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1.INTRODUCTION 
 
 
 
1.1.Muscle anatomy and physiology 
Skeletal muscle tissue is the largest organ in the animals, representing up to 50% of 
body mass in some athletic species such as the dog and the horse (Gunn, 1989). 
Each muscle is composed of hundreds to hundreds of thousands of individual, 
elongated, multinucleated cells named fibres. Each fibre is constituted of many parallel 
myofibrils which consist of a repetitive series of an identical banded unit called 
sarcomere (Figure 1). 
A sarcomere is formed by overlapping arrays of thick filaments and thin filaments 
(constituted of the contractile proteins myosin and actin, respectively), which represent 
the contractile machinery (Brooks, 2003; Schiaffino and Reggiani, 2011). 
In mammals, the number of fibres in a muscle is determined at birth and it is barely 
modified during the life except in case of injury or disease. Whereas, the number of 
myofibrils and fibre diameter (CSA: cross-sectional area of muscle fibre) can radically 
change depending on external factors. For example, training exercise can induce 
hypertrophy while immobilization, inactivity, disease, or old age may lead to atrophy 
that means decrease in number of myofibres and volume of fibres (Brooks, 2003). 
 
Figure 1. Muscle structural organization. Modified from Benjamin Cummings Interactive 
Physiology Anatomy Review: Skeletal Muscle Tissue ( 2006). 
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Muscle myosin 
Myosin is an hexamer consisting of two heavy chains (MHC) and two pairs of light 
chains (MLC). The two heavy chains have the COOH-terminal ends that form a coiled 
spiral of two α-helices creating the body of the thick filaments. The other end of the 
heavy chains projects outward from the thick filament forming the cross-bridge portion 
of the molecule that connect the light chains with a non-covalently bound (Brooks, 
2003). The heavy chains are organized into three structurally and functionally different 
domains. The globular head domain (catalytic domain) contains both actin-binding site 
and ATP-binding site and is responsible for generating force, this is the most conserved 
region among the various myosins. The long α-helical neck domain lies adjacent to the 
head domain and extends toward the tail of the molecule. It appears to be stabilized by 
its interaction with the MLCs (essential or alkali MLC and regulatory or 
phosphorylatable MLC) that regulate the activity of the head domain. Between the head 
and neck domains a “converter domain” is described. The tail domain is the third and 
longer domain. It contains the binding sites that determine the specific activities of a 
particular myosin (Vale, 2000; Rüegg et al., 2002). The myosin tails create a packed 
filament through a process of self-assembly. The final product is the thick filament 
decorated with hundreds of myosin heads responsible for force generation and filaments 
sliding movement (Schiaffino and Reggiani, 2011). 
Heavy and Light myosin chains are present in multiple isoforms with a fibre type-
specific expression. For this reason MHC isoforms has been used as marker for the 
classification of fibre types. 
In brief, mammalian genomes contain 11 sarcomeric myosin heavy chain genes coding 
each one for a different MHC isoform (Berg et al., 2001). The isoforms expressed in 
cardiac muscle are MHC-α and MHC-β/slow or MHC-1 and they are coded by MYH6 
and MYH7. Three isoforms are coded by MYH2, MYH1, and MYH4 in adult skeletal 
muscle fibres and they are named MHC-2A, MHC-2X, and MHC-2B. Two more 
isoforms are expressed in embryonic and neonatal muscles (developmental isoforms): 
MHC-emb and MHC-neo, coded by MYH3 and MYH8. MHC-EO isoform is expressed 
exclusively in extraocular muscles (gene MYH13). Three additional MHC isoforms 
named MHC-slow tonic, MHC-15 and MHC-M (genes MYH7b, MYH15, and MYH16, 
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respectively) are expressed exclusively in some head and neck muscles (Schiaffino and 
Reggiani, 2011). 
 
Actin filaments 
Actin filaments constitute the thin filaments of sarcomere. They are helical polymers 
which have 13 actin molecules arranged on six left-handed turns. The actin monomer 
consists of two similar domains each of which contains a 5-stranded β-sheet and 
associated α-helices. One of the domains carries a sub-domain involved in actin-actin 
interactions while the other is involved in the formation of the nucleotide-binding 
pocket. Moreover, the thin filaments contain the regulatory proteins tropomyosin and 
troponin that are involved in the interaction between myosin and actin (Geeves and 
Holmes, 1999). The thin filament basic components are very similar in all muscle 
fibres. Actin is the main structural component of the thin filaments which form the trail 
along which myosin motors work. Two isoforms of actin can be expressed in 
mammalian skeletal muscle fibres: α-skeletal and α-cardiac isoforms, which differ by 
only four amino acids and are encoded by two different genes (Schiaffino and Reggiani, 
2011). 
 
Figure 2. Myosin-actin interaction. (a) Myosin molecule, (b) portion of a thick filament 
constituted by several myosin molecules, (c) portion of a thin filament constituted by actin 
molecule and its regulator proteins (troponin and tropomyosin), (d) organization of thick 
and thin filaments within a sarcomere. Modified from Benjamin Cummings Interactive 
Physiology Anatomy Review: Skeletal Muscle Tissue ( 2006). 
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The cross-bridge working stroke is produced by the angular swinging movement of the 
neck domain about a pivot point located in the converter domain. The neck domain 
appears to act as a lever arm that “amplifies” small, subnanometer movements 
associated with the closing and opening of the active site, ultimately producing a 
displacement at the end of the neck domain (Vale, 2000). With the catalytic domain 
rigidly attached to actin, the swinging lever arm drives the displacement of the thin 
filament relative to the thick filament to generate shortening of muscle fibres (Brooks, 
2003). Once the working stroke is completed, an attached myosin head ejects its ATP 
hydrolysis products, binds another ATP molecule, and detaches from the actin site. The 
bound ATP molecule then is split and the head returns to its original orientation. The 
head can repeat this cycle by attaching to a different actin monomer further along the 
thin filament (Julian et al., 1978). 
 
The rapidity of muscle fibre shortening depends on how rapidly the thick and thin 
filaments can slide past one another and this velocity of shortening is determined by 
ATPase activity. Myosin heavy-chain (MHC) isoform determines the enzyme activity 
(Brooks, 2003). 
Thus, the speed of shortening is determined by MHC isoform whereas the fatigue 
resistance depends on the fibre metabolism. 
 
The combination of different fibres in the same muscle confers the typical flexibility 
which allows the organ to be used for various tasks demanding different intensity 
activity levels (e.g. in maintaining posture is required a low-intensity but continuous 
activity, whereas in jumping is requested a strong maximal contraction). Moreover, the 
structural and functional properties of the fibres (fibre phenotype) are influenced by 
hormonal and neural stimuli which can determine and shift the fibre type profile. This 
property is defined muscle plasticity or malleability (Schiaffino and Reggiani, 2011). 
 
1.2.Types of fibres 
The traditional classification of fibre types based on myosin composition and metabolic 
profile has been integrated during the last 50 years due to the increased knowledge on 
muscle fibre diversity in terms of cell structure and function, from surface membrane 
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properties to calcium homeostasis. Schiaffino (2010) published a work that summarizes 
the evolution of the classification of fibre types since the first half of the 19th century 
till the current notion of muscle fibre types. In the paper he identifies three phases in the 
evolution of this notion (Schiaffino, 2010; Schiaffino and Reggiani, 2011). 
 
Phase I: two major types of skeletal muscles and corresponding fibre types are 
described as: i) slow red muscles, composed of fibres rich in myoglobin and 
mitochondria, characterized by an oxidative metabolism and involved in continuous, 
tonic activity; ii) fast white muscles, composed of fibres poor in myoglobin and 
mitochondria, relying more on glycolytic metabolism and involved in phasic activity 
(Needham, 1926). 
 
Phase II: analysis of motor units (Close, 1967), enzyme histochemistry with succinate 
dehydrogenase (SDH), myoglobin staining and electron microscopy (Schiaffino et al., 
1970) led to the view that skeletal muscles contain three major fibre types: the slow or 
type 1 fibres, the fast highly oxidative or type 2A fibres and the fast weakly oxidative or 
type 2B fibres. The introduction of novel histochemical staining procedures for the 
demonstration of ATPase activity creates the meeting point between the mechanical and 
the biochemical approach for fibre classification. Indeed, this procedure connects the 
actin-activated ATPase activity of myosin and the speed of muscle shortening (Barany, 
1967; Guth and Samaha, 1969; Brooke and Kaiser, 1970). These findings were 
integrated with studies on the physiological properties of the single fibres. Peter et al. 
(1972) found that both 2A and 2B fibres have high levels of glycolytic enzymes in spite 
of different oxidative enzyme content. The classification was then modified in slow 
oxidative (type 1), fast-twitch oxidative glycolytic (2A), and fast-twitch glycolytic 
fibres (2B) (Peter et al., 1972). 
 
Phase III: the discovery of a third fast fibre type with myosin heavy chain (MHC) 
composition different from 2A and 2B fibres leads to a further modification of the fibre 
types classification. Independent studies identified a type 2X or 2D MHC band distinct 
from the other MHC bands (Termin et al., 1989) and the novel fibre expressing this 
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MHC was called 2X (LaFramboise et al., 1990; De Nardi et al., 1993; Schiaffino and 
Reggiani, 2011). 
Type 2X fibres have twitch properties similar to 2A and 2B fibres. Their resistance to 
fatigue and their maximal velocity of shortening are intermediate between 2A and 2B 
(Bottinelli et al., 1991; Bottinelli, Betto, et al., 1994; Schiaffino and Reggiani, 2011). 
 
In addition to these findings, immunohistochemical and in situ hybridization analyses of 
muscle sections (Gorza, 1990; De Nardi et al., 1993) together with biochemical and 
physiological studies of single fibres (Bottinelli, Canepari, et al., 1994) demonstrated 
the existence of a spectrum of fibre types with pure or hybrid MHC composition. 
Even if not obligatory, a pattern of MHC gene expression has been described as it 
follows: 1 ↔ 1/2A ↔ 2A ↔ 2A/2X ↔ 2X ↔ 2X/2B ↔ 2B. Moreover, single fibre 
studies reported that fibres with apparently pure MYH composition may vary in terms 
of metabolic enzyme complement (Pette et al., 1999) suggesting a further degree of 
complexity in the fibre heterogeneity. 
The four major fibre types discussed above (type 1, 2A, 2X, 2B) are variously 
distributed in body muscles of mammals, including limb, trunk, and head muscles 
(Schiaffino and Reggiani, 2011). In addition, several studies demonstrated species-
specific MHC type expression. In particular, in humans, monkey, dog, sheep and llama 
only three fibre types and three MHC isoforms (slow, 2A and 2X) have been identified 
in skeletal muscles whereas 2B fibre type seems to be specific only for mouse, rabbit, 
rat and marsupials (Reggiani and Mascarello, 2004). Although in pig and bovine 
skeletal muscles, pure 2B fibres have been found only in specialised muscles such as 
extraocular muscles whereas hybrid fibres (2A/X and 2X/B) have been recognised in 
pig trunk and limb muscles (Maccatrozzo et al., 2004; Toniolo et al., 2004). In addition, 
an hybrid fibre type (2C) characterized by the co-expression of slow and α-cardiac 
MHC was identified in bovine masseter muscle (Maccatrozzo et al., 2004). 
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1.3.Calcium homeostasis and structures involved 
All muscles use Ca
2+
 ion as their main regulatory and signalling molecule. Indeed, the 
main functions of all muscle types have Ca
2+
 ion as second messenger (Gissel, 2005). 
At resting state, the concentration of free Ca
2+
 inside the muscle fibres ([Ca
2+
]c) is 
maintained at ~50 nM (Berchtold et al., 2000) whereas the concentration of Ca
2+
 in the 
extracellular fluid ([Ca
2+
]o) is around 1 mM. This enormous difference creates a strong 
chemical gradient for Ca
2+
 across the sarcolemma that overcomes the low permeability 
of the membrane and generates a continuous passive diffusion of the ion into the muscle 
fibre (Hidalgo et al., 1986). In addition, during a contraction-relaxation cycle there is an 
active flux of Ca
2+
 ions from and to the Sarcoplasmic Reticulum (SR) that causes 
relatively large changes in [Ca
2+
]c (up to 100-fold) although short in time and local in 
distribution (Gissel, 2005). 
To preserve the physiological functionalities, the muscle fibre must maintain and 
reinstate the [Ca
2+
]c at low levels and therefore it must actively remove from the cytosol 
the Ca
2+
 ions entered passively or actively (Michalak et al., 1984; Hidalgo et al., 1986; 
Carafoli, 1987). The skeletal muscle cell has several ways of clearing Ca
2+
 from the 
cytoplasm. The most important are the Ca
2+
-ATPases in the sarcoplasmic reticulum 
(SR) and in the sarcolemmal/T-tubular membranes, a secondary system of Ca
2+
 
transport is the Na
+
-Ca
2+
 exchanger and the mitochondrial Ca
2+ 
uniporter (MCU). 
(1) The Sarco(endo)plasmic Ca
2+
-ATPase (SERCA) is responsible for the re-uptake of 
Ca
2+
 into the SR. It is characterized by a high affinity for Ca
2+
 (Km
1
<0.5 µM) on the 
cytoplasmic side and a high capacity to transport the ions inside the SR [Salviati, 1984]. 
(2) The plasma membrane or sarcolemmal/T-tubular Ca
2+
-ATPases (PMCA) are active 
especially at resting state and export Ca
2+
 ions from the muscle cell cytosol to the 
extracellular fluids to regulate the [Ca
2+
]c. They have high-affinity for Ca
2+
 (Km=0.5 
µM) but a low-capacity of transporting ions (12-30 nmol/mg fibre protein/min in rabbit 
white muscle) (Michalak et al., 1984; Hidalgo et al., 1986; Monteith and Roufogalis, 
1995). 
(3) The Na
+
-Ca
2+
 exchanger plays a major role in Ca
2+
 regulation in cardiac muscle, 
whereas in skeletal muscle the capacity and quantitative importance of this transport 
                                                          
1
 The Michaelis-Menden constant (Km) is the substrate concentration at which the reaction rate 
is at half-maximum, and is an inverse measure of the substrate's affinity for the enzyme: as a 
small Km indicates high affinity, meaning that the rate will approach Vmax more quickly. 
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system is more controversial. It seems that Na
+
-Ca
2+
 exchanger activity in skeletal 
muscle is low during normal resting state but increases when [Ca
2+
]c exceeds 80 nM 
(Balnave and Allen, 1998). These observations suggest an important role of the Na
+
-
Ca
2+
 exchanger during fatiguing stimulation (Balnave and Allen, 1998) and in the long-
term regulation of Ca
2+
 concentration in the cytosol (Deval et al., 2002; Gissel, 2005). 
(4) The mitochondrial Ca
2+
 uniporter (MCU) of the inner membrane is the main 
structure primarily involved in mitochondrial Ca
2+
 uptake. It has a low Ca
2+
 affinity (Km 
between 10 and 100 µM) and consequently it seems involved especially when [Ca
2+
]c is 
extremely high (Gunter and Pfeiffer, 1990; Baughman et al., 2011; De Stefani et al., 
2011). 
 
Figure 3. Structures involved in Ca
2+
 homeostasis. (1) ryanodine receptor Ca2+ release 
channels (RyRs); (2) Sarco(endo)plasmic Ca
2+
-ATPase (SERCA); (3) plasma membrane 
or sarcolemmal/T-tubular Ca
2+
-ATPases (PMCA); (4) Na+-Ca2+ exchanger; (5) 
mitochondrial Ca
2+
 uniporter (MCU). Modified from Gissel, 2005. 
 
Considering the above, there are three different compartments where the Ca
2+
 free in the 
cytosol can be moved. The PMCA and the Na
+
-Ca
2+
exchanger pump the ions out of the 
muscle fibre in the extracellular fluid compartment. The SERCA uptakes the Ca
2+
 ions 
into the SR that is the most important storing compartment. The last compartment is 
constituted by the mitochondrial matrix where the ions are transported through the 
mitochondrial Ca
2+ 
uniporter (MCU) of the inner membrane. 
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The Sarcoplasmic Reticulum 
The sarcoplasmic reticulum (SR) is an intracellular membranous network found in 
muscle fibres (Figure 4). The release and re-uptake of Ca
2+
 ions by the SR essentially 
direct the entire process of contraction and relaxation of skeletal muscle, whereas the 
other structures seem to have a secondary role. Ca
2+
 ions can be released extremely 
rapidly into the cytosol of the fibre through the ryanodine receptor Ca
2+
 release channels 
(RyRs) that are primarily concentrated in the SR terminal cisternae (Franzini-Armstrong 
and Protasi, 1997). The Ca
2+
 ions are subsequently sequestered back into the SR by the 
activity of Sarco(endo)plasmic reticulum Ca
2+
-ATPase (SERCA) (Periasamy and 
Kalyanasundaram, 2007). There are different fibre type-specific isoforms of SERCA 
which influence the properties of the SR and consequently the dynamics of muscle 
contraction-relaxation cycle (Lyttons et al., 1992; Wu and Lytton, 1993; Talmadge et 
al., 2002; Murphy et al., 2009; Lamboley et al., 2013; Lamboley et al., 2014). 
The SR network can be divided in two parts called junctional and non-junctional SR 
different in structure and proteomic profile. The junctional portion consists of bulbous 
enlargements of the SR named “terminal cisternae” that are the part of the SR connected 
with the transverse tubules (T-tubules). A T-tubule is an invagination of the sarcolemma 
normally perpendicular to the fibre length and it locates at the junction between the A 
and I bands of the sarcomere. A single T-tubule, together with the adjacent pair of 
terminal cisternae, forms an arrangement called “triad” that is the key structure for the 
excitation-contraction (E-C) coupling. There are two triads per sarcomere (Peachey, 
1965). 
The junctional SR contains primarily the ryanodine sensitive Ca
2+
 channels or 
ryanodine receptor (RyR) involved in E-C coupling (Meissner, 1994; Franzini-
Armstrong, 1996) together with associated proteins such as triadin, junctin and 
calsequestrin (CS) (Brandt et al., 1993; Guo et al., 1996). The tetrameric form of RyR is 
called “feet” and it interacts with the dihydropyridine receptors (DHPRs) of the T-
tubules. RyR, DHPR and their associated proteins form an ordered array that assures the 
mechanical stability of the contacts between the sarcolemma and the SR and facilitates 
the spatial and temporal coordination of the events (Meissner, 1994; Meissner and Lu, 
1995; Franzini-Armstrong, 1996; Protasi et al., 1996; Protasi et al., 1998). The non-
junctional portion of SR consists of longitudinal tubules and cisternae, it corresponds to 
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the part of the sarcoplasmic network between two triads. The non-junctional SR 
contains the Ca
2+
-ATPases, most of the luminal protein components of SR, the enzymes 
of phospholipid and sterol biosynthesis, cytochromes and various transporters (Figure 
4). The cisternae near the junctional SR contain also CS (Franzini-Armstrong and 
Jorgensen, 1994). 
The SR is the major storage compartment of the muscle fibre and its large buffer 
capacity is due to the presence of the high capacity and low affinity Ca
2+
-binding 
protein calsequestrin (CS) which is able to bind 40-50 moles of Ca
2+
/mol (MacLennan 
and Wong, 1971; Berchtold et al., 2000; Beard et al., 2004; Murphy et al., 2009). Thus, 
the Ca
2+
 concentration within the SR is maintained high at resting state (11 and 21 mM 
for slow-twitch and fast-twitch fibres, respectively), in contrast with a low Ca
2+
 
concentration in the cytosol (1 mM). Differences in SR properties have been described 
between slow- and fast-twitch fibres. At resting, it has been shown that the SR of slow-
twitch fibres is saturated with Ca
2+
, whereas in fast-twitch fibres the SR is saturated for 
one-third suggesting a larger buffer capacity of the SR of the second fibre type (Fryer 
and Stephenson, 1996; Gissel, 2005). 
 
Figure 4. Sarcoplasmic Reticulum. Junctional and non-junctional portions are indicated. 
Modified from Benjamin Cummings Interactive Physiology Anatomy Review: Skeletal 
Muscle Tissue (2006). 
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The Mitochondria 
Since 1960s, it has been proposed that the mitochondria are capable of up-taking and 
storing Ca
2+
 (De Luca and Engstrom, 1961). William et al. demonstrated that under 
physiological conditions, the Ca
2+
 influx into mitochondria per litre of cytosol is small 
and thus the [Ca
2+
]c is not altered. Nevertheless, the study also demonstrated that under 
extreme conditions (e.g. significant lack of Ca
2+
 extrusion pathways), very large fluxes 
can occur and mitochondrial Ca
2+
 uptake is more likely to influence cytosolic Ca
2+
 
concentration, especially during rapid and large changes in [Ca
2+
]c (Williams et al., 
2013). 
Mitochondria possess an elaborated system for facilitating the transport of Ca
2+
 across 
their inner membrane. The low affinity mitochondrial Ca
2+
 uniporter (MCU) of the 
inner membrane and the mitochondrial Na
+
/Ca
2+
 exchanger (mNCX) are considered the 
main structures primarily involved in mitochondrial Ca
2+
 uptake and extrusion, 
respectively (Gunter and Pfeiffer, 1990; Palty et al., 2010; Baughman et al., 2011; De 
Stefani et al., 2011; Scorzeto et al., 2013). Scorzeto et al. indicated that mitochondrial 
Ca
2+
-uptake and release are fast enough to allow the rapid adjustment of metabolic 
activity to increased demand (during exercise). In their experiment, by using a CS-null 
muscle they observed an increase in mitochondria number and in the resting free [Ca
2+
] 
inside the mitochondria (Scorzeto et al., 2013). These alterations together with the 
increase in mitochondrial volume noted by Paolini et al. (Paolini et al., 2011) represent 
a compensatory response to a reduction of SR store functions. Moreover, Ca
2+
 uptake 
by the mitochondria is crucial in skeletal and cardiac dysfunction and in programmed 
cell death (Giacomello et al., 2007; Denton, 2009). 
Recent studies have proposed that the mitochondria are located close to Ca
2+
-release 
channels of the SR (RyR) (Hayashi et al., 2009; Patron et al., 2013; Williams et al., 
2013). This position exposes the mitochondria to the high localized increase of [Ca
2+
] 
when the ions are released for contraction event. The high local concentration activates 
the MCU that sequesters the ions into the mitochondrial matrix (Rizzuto et al., 1999; 
Scorzeto et al., 2013). Moreover, it has been observed that the mitochondrial Ca
2+
 
uptake starts a few milliseconds after the [Ca
2+
]c rises during both a single twitch and 
tetanic contraction (Rudolf et al., 2004). 
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Summarizing, it is apparent that the mitochondria may play an important role in the 
regulation of Ca
2+
 homeostasis in skeletal muscle both in physiologic and pathologic 
situations (Gissel, 2005; Scorzeto et al., 2013). 
 
The Sarco(endo)plasmic Ca
2+
-ATPases 
The Ca
2+
-ATPase of sarco(endo)plasmic reticulum (SERCA) is a protein of about 110 
kDa (MacLennan et al., 1985) member of the P-type ATPases family together with 
PMCA, Na
+
/K
+
ATPase, and H
+
,K
+
ATPase (Sweadner and Donnet, 2001). 
The distinctive feature of the P-type ATPases is the transfer of terminal phosphate from 
ATP to an aspartate residue in the catalytic domain during the reaction cycle. Therefore, 
the hydrolysis of ATP is coupled to the movement of ions across a biological 
membrane. In particular, SERCA pumps utilize the energy derived from the hydrolysis 
of a molecule of ATP to transport two Ca
2+
 ions across the membrane (Aravind et al., 
1998; Johnson and Lewis, 2001). 
In addition, two functionally homologous small proteins have been found to have 
regulatory activity on SERCAs: phospholamban (PLB, 52 amino acid residues) and 
sarcolipin (SLN, 31 amino acid residues). These two proteins regulate SERCAs through 
physical interactions by lowering their apparent Ca
2+
 affinity (Odermatt et al., 1998; 
Asahi et al., 2002). Different studies showed that PLB is expressed almost exclusively 
in cardiac, smooth and slow-twitch skeletal muscle suggesting a sole regulation of 
SERCA2a (Odermatt et al., 1997; Damiani et al., 2000). Regarding SLN, it was 
originally hypothesized that SLN would act as a counterpart of PLB by regulating 
SERCA1a in fast-twitch muscle (Odermatt et al., 1997) although recently it has been 
demonstrated that SLN can regulate both SERCA2a and SERCA1a in a variety of 
muscle tissues (Tupling et al., 2011). 
A recent study enlightened the pattern of PLB and SLN expression using single fibre 
Western blotting and immunohisto/fluorescence staining techniques. 
The most important findings regarded the co-expression patterns of SLN and PLB with 
SERCA and MHC isoforms in human vastus lateralis fibres. Fast-twitch fibres contain 
relatively high levels of SLN and SERCA1a proteins and relatively low levels of PLB 
protein, moreover the 14-18% of these fibres express, at relatively low levels, also 
SERCA2a protein. Conversely, slow-twitch fibres contain relatively high levels of PLB 
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and SERCA2a proteins and the 22% also relatively low levels of SLN and SERCA1a 
proteins. The main conclusion of the study was that SLN and PLB likely preferentially 
regulate SERCA1a, and SERCA2a, respectively. However, the co-immunoprecipitation 
patterns suggest that PLB likely also regulates SERCA1a and SLN may also regulate 
SERCA2a in human skeletal muscle. Moreover, the co-expression of PLB and SLN 
gives evidences of the super-inhibition as possible regulatory mechanism of [Ca
2+
]c in 
physiological situation (Fajardo et al., 2013). 
Three distinct genes encoding for SERCA have been identified in vertebrates. Thus, 
there are three mainly SERCA isoforms named 1, 2, and 3 (Periasamy and 
Kalyanasundaram, 2007). 
SERCA1 is principally expressed in fast-twitch skeletal muscle; it has been recognized 
an adult isoform named SERCA1a (994 aa) and a fetal isoform indicated as SERCA1b 
(1011 aa) (Brandl et al., 1987). 
SERCA2 has two main isoforms: SERCA2a (997 aa) is expressed predominantly in 
cardiac and slow-twitch skeletal muscle (MacLennan et al., 1985; Zarain-herzberg et al., 
1990), whereas SERCA2b (1042 aa) expressed at low levels in all tissues, in muscle and 
non-muscle cells (Gunteski-Hamblin et al., 1988; Lytton and Maclennan, 1988; de la 
Bastie et al., 1990). In addition, a third isoform, named SERCA2c (999 aa), has been 
recognized in cardiac muscle (Dally et al., 2006). 
SERCA3 is a minor form in muscle fibres although the isoforms 3a, 3b and 3c are 
highly expressed  in the hematopoietic cell lineages, platelets, epithelial cells, 
fibroblasts, and endothelial cells (Burk et al., 1989; Anger et al., 1993; Bobe et al., 
1994; Wuytack et al., 1994; Bobe et al., 2005). 
 
An excessive accumulation of free Ca
2+
 in the cytosol of muscle fibre results in a loss of 
the control on Ca
2+
 homeostasis. Whether this condition is not solved rapidly, by means 
of the activation of defensive and/or compensatory mechanisms, it leads to short- and 
long- term muscle damages. 
As mentioned earlier, Ca
2+
 ion is an important second messenger in skeletal muscle and 
thus, a wide range of processes can be activated by a variation of [Ca
2+
]c. Therefore, a 
tightly control [Ca
2+
]c is crucial to the muscle fibre. The main structures involved in this 
process are the SR together with SERCAs, PMCA, Na
+
/Ca
2+
 exchangers and 
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mitochondria. In addition, buffer Ca
2+
-binding proteins such as parvalbumin seem to 
have an important buffer effect in fast muscle fibres of lower vertebrates and small 
mammals although not in humans (Fohr et al., 1993; Gailly, 2002; Gissel, 2005). 
When a larger influx of Ca
2+
 ions will occur due to an increased permeability of the 
sarcolemma or when the Ca
2+
 permanence lasts long after the releasing from the storing 
compartments, the Ca
2+
 load on the fibre increases. The storage capacity of the SR and 
the mitochondria is large, therefore the increased [Ca
2+
]c can be handled and the 
excessive Ca
2+
 ions can be stored, whether there is a fibre type-specificity of this 
feature. However, if the increased influx of Ca
2+
 or the Ca
2+
 permanence in the cytosol 
persist, an excessive accumulation of free Ca
2+
 may result. Consequently, Ca
2+
-
activated neutral proteases (calpains) and phospholipases (PLA2) can be activated and 
reactive oxygen species (ROS) production increases. Moreover, mitochondria are 
activated increasing the Ca
2+
 up-taking. This last event can lead to activation of 
apoptotic processes (Gissel, 2005). 
 
1.4.SERCA1 architecture 
Sarco(endo)plasmic Reticulum Ca
2+
-ATPase isoform 1a (SERCA1a) is the mainly 
expressed isoform in adult fast-twitch muscle fibres. SERCA1a is both structurally and 
functionally the best characterized member of the P-type (or E1/E2- type) ion 
translocating ATPases. 
 
1.4.1.SERCA1a structure and functional conformations 
The three-dimensional structure of SERCA1a was solved by Toyoshima et al. (2000). 
SERCA1a consists of three cytoplasmic domains called A (actuator), N (nucleotide 
binding) and P (phosphorylation), and a domain M, which includes ten transmembrane 
helices (M1-M10) along with the short luminal loops (Figure 5). 
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Figure 5. Cartoon representing SERCA1a structure. The three cytoplasmic domains (A, N 
and P) and the 10 transmembrane helices (domain M) are indicated in the figure. 
Modified from MacLennan et al., 1997. 
 
The A-domain is connected to the M1–M3 helices with rather long linkers and works as 
the actuator of the transmembrane gating mechanism that regulates Ca
2+
 binding and 
release. It seems to play a key role in processing of aspartylphosphate (Ma et al., 2005; 
Anthonisen et al., 2006). 
The P-domain contains Asp351 which is the residue that is phosphorylated during the 
reaction cycle. The P-domain is wedge shaped and has a flat top surface to allow a large 
rotation of the A-domain on the top surface of the P-domain (Toyoshima et al., 2007). 
The Rossmann fold of the P-domain is particularly suited for this purpose. This wedge 
shape is the key in converting rotational movements of the A-domain to vertical ones of 
the transmembrane helices. The P-domain can be also bent in two approximately 
orthogonal directions by the phosphorylation and Mg
2+
-binding. Such flexibility is a key 
in realising different domain interfaces. The central β-sheet in the Rossmann fold 
consisting of two halves allows such bending and is also used as the secondary hinge in 
SERCA1a to allow an extra 30° not covered by the primary hinge between the N- and 
P- domains.  
The N-domain consists of a long insertion between two parts of the P-domain. It 
contains the nucleotide-binding site (Phe487 residue) and other residues (e.g. Arg560) 
that are critical for bridging ATP and the P-domain, although it exhibits no large 
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structural changes during the enzyme cycle (Toyoshima and Inesi, 2004; Toyoshima, 
2008). 
The M-domain consists of 10 transmembrane helices, some of them (M2-M5) have long 
cytoplasmic extensions, while others (M4, M5, M6 and M8) form the two Ca
2+
-binding 
sites. Helix M5 can be considered the spine of the molecule because it is 60 Å long and 
extends from the lumenal surface of the membrane to the end of the P-domain. M4 and 
M6 helices have proline residues in the middle and are partly unwound throughout the 
reaction cycle. All helices from M1 to M6 move considerably during the reaction cycle, 
whereas M7-M10 helices do not. Helix M7 makes a tight couple with M5 and allows 
the bending of M5 (Toyoshima and Mizutani, 2004). 
 
The SERCA1a protein has been extensively characterized in rabbit where 44 crystal 
structures have been proposed as possible representations of all the conformational 
states in the enzyme cycle (Toyoshima and Nomura, 2002; Xu et al., 2002; Sørensen et 
al., 2004; Toyoshima and Inesi, 2004; Obara et al., 2005; Jensen et al., 2006; Moncoq et 
al., 2007; Olesen et al., 2007; Takahashi et al., 2007; Laursen et al., 2009; Winther et 
al., 2010; Toyoshima et al., 2011). 
The ion translocating mechanism of the protein has been explained in terms of a cycle 
characterized by two major conformational states, called E1 and E2. Conformation E1 
is the form with the highest affinity for calcium, in this state SERCA1 binds Ca
2+
 from 
the cytoplasm. Conformation E2 has lower affinity for the ion, in this state SERCA1 
releases Ca
2+
 into the lumen of the SR (de Meis and Hasselbach, 1971; Moller et al., 
1996). The three cytoplasmic domains (A, P and N) are well separated in the E1 crystal 
structure although they form a compact headpiece in the other states. This drastic 
rearrangement follows the aspartate phosphorylation that is the key event to have Ca
2+
 
release into the lumen of the SR (Toyoshima and Mizutani, 2004; Toyoshima, 2008). 
More in detail, two other intermediate conformation states have been proposed as key 
steps in the transfer of bound Ca
2+
 from cytosol into SR. These intermediates are called 
E1P and E2P, where ‘P’ indicates that the enzyme is phosphorylated. The transfer takes 
place through the two phosphorylated intermediates in exchange of H
+
 from the SR 
lumen (Figure 6) (Hua et al., 2002; Toyoshima and Nomura, 2002; Ma et al., 2005; 
Toyoshima, 2009). 
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Figure 6. Conformational cycle of SERCA1a. Conformation E1 is the form with the 
highest affinity for calcium, E2 is the form with the lowest affinity. The others are the 
most important intermediate steps of the cycle that permits to bind Ca
2+
 from the 
cytoplasm and free it into the lumen of the SR. 
 
It is well established that SERCA1 has two high affinity transmembrane Ca
2+
-binding 
sites, called I and II, located close each other near the cytoplasmic surface (Inesi et al., 
1980). The binding of the two Ca
2+
 is sequential. The first ion is bound by site I that is 
surrounded by M5, M6 and M8 helices. The adjacent M4 helix is the key structure for 
coordination. When the first Ca
2+
 is bounded at site I, the event is mechanically 
transmitted to the site II that changes its conformation to receive a second Ca
2+
 ion. 
Consequently, there is an essential communication between the Ca
2+
-binding sites and 
the phosphorylation site. This is possible because the cytoplasmic end of M5 helix (site 
I) is integrated into the P-domain near the phosphorylation site. Moreover, M5 is 
hydrogen bounded to the M4 helix (site II) forming a short β-strand. These connections 
make possible a mechanical transmission of the conformational changes occurring in 
the sites permitting a coordinate communication (Toyoshima and Nomura, 2002; 
Toyoshima, 2009). 
 
1.4.2.Bovine SERCA1a  
The crystal structure of the Ca
2+
-bound conformational state (E1) of bovine SERCA 
includes residues from 1 to 993. A deletion in the bovine enzyme occurs in the position 
corresponding to rabbit position 504, this generates few disordered amino acids in the 
stretch 876-880. Consequently, the numbering system of the protein sequence is shifted 
by 1 compared with the rabbit (Sacchetto et al., 2012). 
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The amino acid deletion mentioned occurs in a loop connecting α-helices N8 and N9 in 
the N-domain with no functional effect. 
Twenty-two residues have been found different in bovine SERCA comparing with 
rabbit. Among these 22 substitutions, 12 are conservative (mainly Ser↔Thr or Leu, 
Ile↔Val) and 10 are non-conservative replacements. Eight of these are located in two 
areas of the C-terminal of the protein (M-domain) that protrudes in the lumen of the SR. 
The other two are located in helix M9 in position 937 (Cys→Gly) and 922 (Met→Val). 
Nevertheless, the last substitutions described appear to be irrelevant from the 
conformational point of view. At the contrary, six of the eight non-conservative 
substitutions (residues 863-881) seem to generate a conformational difference between 
bovine and rabbit enzyme (Sacchetto et al., 2012). The specific region involved is the 
long loop of M-domain that protrudes into the SR lumen and connects α-helices M7 and 
M8. It is interesting to note that also this region of the protein undergoes a 
conformational rearrangement during the cycle E1→E2 as consequence of the large 
movements of the cytoplasmic domains transmitted through the intermembrane helices. 
In fact, the movement of the helices M1 and M2 is transmitted to helix M3 causing a 
shift of the loop connecting helices M3-M4. Simultaneously, helices M7 and M8 
undergo a rearrangement that moves them closer to the M3-M4 loop forming a 
hydrogen bond between Glu877 and Ser287. The amino acidic sequence preceding and 
following Glu877 is involved in the non-conservative substitutions (Q874K, T876S, 
D878H, H879S, H881D). These changes could delay the transition from the E1 to the 
E2 conformation of the bovine enzyme explaining its reduced specific activity when 
compared with rabbit enzyme (Sacchetto et al., 2012). It is possible that the reported 
mutations are consequence of an evolutionary process directed by different 
physiological and behavioural requests that render the bovine enzyme less efficient than 
the rabbit counterpart. Whilst the binding sites for ions and for the nucleotide are very 
well conserved, and the calcium binding constant is almost the same for both enzymes 
(Sacchetto et al., 2012). 
 
1.4.3.SERCA1a mutants for the study of its domains functions 
Several studies have been accomplished in order to investigate the importance of this 
protein in muscle physiology, to understand the role of the different domains in the 
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functionality of the enzyme and to evaluate the effects of alterations in the different 
domains. Numerous SERCA1a mutants were built in vitro and in vivo substituting 
different amino acids in different sites in accordance with the role that the researchers 
had planned to highlight. 
 
Dahio and coworkers investigated the role of disulfide bond between Cys876 and 
Cys888 on the loop M7-M8. In all mutated SERCA1a they built, the disulfide bond was 
disrupted. As consequence, ATP hydrolyzing activity was maintained at high rates 
although none of the mutants could transport Ca
2+
 at a detectable rate (Daiho et al., 
2001). 
Clausen and co-authors studied different Ca
2+
-ATPase constructs involving the N-
domain with mutations of ATP-binding residues. This domain plays a major role in the 
conversion from E1 to E2 and interfaces with the other cytoplasmic domains (A and P).  
The substitutions of amino acids Thr441, Glu442, Lys515, Arg560 and Leu562 
introduced in the experiments by Clausen et al., seem crucial primarily to ATP binding 
step of the enzyme cycle, although also subsequent catalytic steps were affected. In 
particular, Thr441Ala substitution reduced to 50% both Ca
2+
 transport capacity and 
ATPase activity comparing with wild type (WT) control levels. Arg560Val substitution 
displayed approximately 60% of the WT Ca
2+
 transport capacity and only 30% of WT 
ATPase activity. Interestingly, the Cys561Ala substitution, adjacent to Arg560, reduced 
Ca
2+
 transport rate to 80% of WT without affecting ATP binding affinity. Among all 
these observations, it seems that none of the examined residues were very important for 
the binding of modulatory nucleotide to the phosphoenzyme. On the other hand, all 
mutations but one slowed the transition from E1P to E2P conformation state decreasing 
the Ca
2+
 transport activity of the enzyme. On the contrary. the Arg→Val mutation in 
position 560 enhanced the rate of the Ca
2+
 translocate activity suggesting that Arg560 
plays a critical role in optimizing the rate of E1P→E2P conformational transition. 
(Clausen et al., 2003). Similar inhibiting effect on E1P→E2P transition has been 
described in presence of point mutations located in the cytoplasmic domains A and P 
and in the segment connecting M4 with domain P (Vilsen et al., 1989; Clarke et al., 
1990a; Clarke et al., 1990b; Vilsen et al., 1991; Clausen et al., 2003). With the use of 
Circular Dichroism (CD) spectroscopy and 
15
N-
1
H heteronuclear single quantum 
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coherence (HSQC) spectra, Myint et al. (2011) demonstrated that little structural 
perturbation is present in the mutant proteins confirming the hypothesis already 
proposed by Clausen et al. (2003). The results confirmed that these mutants lead to 
local conformational changes at the binding sites without abolishing completely the 
catalytic activity (Myint et al., 2011). 
The research group of Pan (2003) generated SERCA1-null mice (SERCA1-/-) in order 
to study the central role of this enzyme and the effects of its completed absence. 
SERCA-/- mice were born with normal body weight and normal gross morphology 
although they developed cyanosis and gasping respiration and died shortly after birth. 
The SERCA-/- mouse model of this study has highlighted the importance of 
maintaining the Ca
2+
 homeostasis for a correct muscle functionality. Moreover, this 
study underlines the key role of Ca
2+
 ion as starting message to several mechanisms that 
lead to pathological changes in the tissues (Pan et al., 2003). High levels of cytosolic 
free Ca
2+
 stimulate glucose transport into skeletal muscle (Youn et al., 1991) where 
glycogenolysis is inhibited and pyruvate dehydrogenase is stimulated. In addition free 
Ca
2+
 activates mitochondrial function (McCormack et al., 1990), Ca
2+
-dependent 
proteases (Armstrong et al., 1991) and lysosomal proteases (Schwartz and Bird, 1977). 
All these responses are activated both in physiological (after exercise) and pathological 
(trauma, disease) situation and generate structural and morphological degradation of the 
muscular tissue. 
At this point, it can be noted that, depending on amino acid mutated and the domain 
involved, some mutations at SERCA1 sequences lead to a decrease in both protein 
quantity and activity whereas other mutation can affected the sole pump activity. 
 
Naturally occurring mutations in ATP2A1 gene have been described in human medicine 
and referred as cause of a rare inherited myopathy named Brody disease (Brody, 1969; 
Odermatt et al., 1996). Genetic heterogeneity has been reported in human patients, both 
in mutation type and in inheritance patterns (A Odermatt et al., 2000; Vattemi et al., 
2010; Voermans et al., 2012). 
Recently, an inherited condition affecting the skeletal muscles has been described in 
bovine species and the genetic analyses identified a mutation in ATP2A1 gene. The 
disease was named Bovine Congenital Psudomyotonia (Testoni et al., 2008).  
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1.5.Bovine Congenital Pseudomyotonia 
 
1.5.1.History and epidemiology  
Bovine Congenital Pseudomyotonia (PMT) is a recessively inherited disease described 
for the first time by Prof. Testoni in Italian Chianina cattle breed (Testoni et al., 2008). 
Clinically, the disorder is characterized by muscle contracture that prevents animals 
from performing muscular activities but a simple walk at a slow pace. The underlying 
cause of this pathological condition is a mutation of the ATP2A1 gene, encoding the 
fast-twitch Sarco(endo)plasmic Ca
2+
-ATPase (SERCA1) of the skeletal muscle 
(Drögemüller et al., 2008). Interestingly, in the same years a similar clinical 
manifestation has been described in Belgian Blue cattle and named Congenital 
Muscular Dystonia type I (CMD1). Its causative mutation interests ATP2A1 gene and 
leads to an amino acid substitution in the SERCA1 pump. Affected calves show 
impaired swallowing, fatigue after brief exercise or stimulation associated with muscle 
myotonia. The contraction results in limbs stiffness and lose of balance. Moreover, 
CMD1 calves usually have altered growth parameters and die within a few weeks as a 
result of respiratory complications (Charlier et al., 2008). 
Few years later, Grünberg and colleagues reported a single case of muscular disorder in 
a Dutch improved Red&White crossbred calf (Verbeterd Roodbont, VRB). Clinical and 
biochemical similarities suggested that the calf was a PMT case although genetic 
analysis indicated a mutation in ATP2A1 gene identical to the one of CMD1 affected 
calves. To solve this incongruence, it has been proposed that PMT and CMD1 refer to 
the same congenital condition (mutation of ATP2A1 gene) with a different phenotype 
expression (Grünberg et al., 2010). 
In addition, my group reported recently the typical symptoms of Congenital PMT in 
four Italian Romagnola cattle breed, another beef breed similar to Chianina. Genetic 
analysis was performed and the result was the identification of two mutations, one novel 
and one previously described in Chianina cattle breed. One of the affected calves was 
homozygous for the novel mutation of ATP2A1 gene while the others were 
heterozygous for both mutations. This condition is called “compound heterozygous 
mutation” and it has been described in bovine species for the first time by my group of 
research (Murgiano et al., 2012). These Romagnola affected subjects and the Dutch 
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improved Red&White crossbred case were the object of study in my PhD research 
project. 
The increased frequency of Congenital Pseudomyotonia diagnosis in bovine population 
may highlight the importance of a correct breeding programs in those animal 
populations characterized by a stringent selection for high specialization and low 
genetic variability due to a small effective/reproductive population (Charlier et al., 
2008). The University of Berne developed a DNA-based test for the detection of PMT 
carriers. Since 2008 this test has been used by the Italian Chianina Breeders’ 
Association (ANABIC) in order to identify, within all the top sires indexed in the 
annual catalogues, the ones that are carriers of the PMT causative mutation. Moreover, 
also the new young bulls selected for performance test have been tested for the mutation 
and the carriers excluded from the breeding program. An epidemiologic study has been 
recently performed to estimate the frequency of the recessive allele (A) causative of 
PMT in the Italian Chianina cattle breed. Because analyse the entire population of 
Chianina finds critical logistic and economic difficulties it has been decided to evaluate 
the carrier prevalence within top sires and selected bull calves. The results showed a 
frequency of 6.8% of the mutant ATP2A1 allele within the top sires tested (9 animals on 
66 -13.6%- were heterozygous carriers of the PMT mutation), and a frequency of 6.7% 
among the young bulls (56 animals on 417 -13.4%- tested were heterozygous PMT-
carriers)
2
 (Murgiano et al., 2013). This high frequency of mutant allele in the population 
might be correlated with the presence of quantitative trait loci (QTL) for beef traits in 
the same region. In other words, it could be possible that selection of high performance 
traits implicates a transmission of other characters (positive or negative) due to co-
segregation mechanism. This hypothesis is supported by a work on Angus cattle breed 
in which two QTL influencing carcass traits were mapped to the ATP2A1 gene region 
(McClure et al., 2010; Murgiano et al., 2013). 
Because most of the top sires carry important characters for high performances, the 
current strategy of the ANABIC is to exclude new bulls PMT carriers from the breeding 
                                                          
2
 The allele frequency was estimated using the Hardy-Weinberg equation: p
2
 + 2pq + q
2
 =1, 
where p is the frequency of the wild-type allele (G) and q is the frequency of the mutant allele 
(A). PMT allele frequency (q) was calculated as follows: q =1 - [2(GG) + (AG)]/2n, where n = 
total number of animals tested, GG = number of PMT non-carrier cattle, and AG = number of 
PMT carriers. 
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programme but only to identify the carriers within the actual sires without disabling 
them from further mating. This means that the PMT carrier prevalence is predicted to be 
<0.1% only at the seventh generation (Thompson et al., 2006). 
 
1.5.2.Features of Congenital Pseudomyotonia 
The clinical approach, the histopathological and biochemical investigations used on the 
first cases of PMT in Italian Chianina breed have been standardized later in the 
approach to other cases in other breed. In the following paragraphs I will sum up the 
clinical features and the main histopathological and biochemical findings published on 
Chianina cattle breed. 
 
Clinical aspects of PMT in Chianina cattle breed 
Bovine Congenital Pseudomyotonia (PMT) is an impairment of muscle relaxation 
induced by exercise that prevents animals from performing rapid movements. 
The medical case was initially defined in Italian Chianina cattle in 2008. The main 
characteristic was a prolonged muscular contracture that particularly interests the hind 
limbs skeletal muscles (Figure 7). When the animal was stimulated to move faster than 
a simple slow-pace walk, the muscles froze-up temporarily leading to a stiff and 
uncoordinated gate. Whether the animal was obliged to continue the movement, the 
contracture prevented it to keep the balance and consequently it fell to the ground. 
 
 
Figure 7. Image sequence of a muscle stiffness attack in two Chianina subjects (a and b). 
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The animal did not lose consciousness although it lied on the ground in a tetanic-like 
spasm till the contraction disappeared (within 20-30 seconds) and the animal regained 
the ability to normally move. The cramp attack was also provoked by walk on irregular 
ground, when animal dismounted from a track or if it was obliged to a sudden change of 
walk direction or speed. Moreover, strong external stimuli could frighten the animal and 
provoke the contraction attack. On the contrary, prolonged walk (at least 30 minutes) at 
low and regular pace did not provoke any cramp or sign of fatigue (Testoni et al., 2008). 
Another clinical sign associated with the skeletal muscle contracture was the protrusion 
of the third eyelid caused by the prolonged contraction of the retractor bulbi muscle. 
This aspect was also described in animals farmed in tie-stall housing in response of 
external stimuli (sounds or physical interaction) although no generalized muscle 
contractions were displayed (Testoni et al., 2008). 
Routine hematology tests revealed no alterations in the values of the affected animals 
although biochemistry analysis showed a slight increase in levels of muscle-specific 
enzymes: creatine-kinase (CK: 8,000 iu/l, reference number <200 iu/l), lactate-
dehydrogenase (LDH: 4000 iu/l, <1500 iu/l) and aspartate-aminotransferase (AST: 300 
iu/l, <150 iu/l). L-lactate showed physiological values at rest (<2mmoli/l) but these 
levels increased immediately after the exercise-stimulated cramp attack (8 mmoli/l) 
(Testoni et al., 2008). Standard needle electromyography revealed no altered 
myoelectrical activities: spontaneous insertion and voluntary electrical activities were 
normal in all skeletal muscles observed, in addition no myotonic discharges were 
recorded after the exercise and the following contracture display. The latter feature led 
to adopt the term of “psudomyotonia”, in contrast to true myotonia, to describe the 
pathology in the cattle (Testoni et al., 2008). 
 
Histopathological findings of PMT in Chianina cattle 
Semimembranosus muscle biopsy sections obtained from Chianina cattle PMT subjects 
were analysed. Routinely morphological and histochemical stainings were performed on 
samples collected from animals kept at rest, moved at a slow pace or after an fast-
movement exercise test protocol (Sacchetto et al., 2009). 
Gomori trichrome morphological staining showed normal fibre diameter, and no 
evidence of muscle damage when animal was at rest or moved at slow walk were 
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analysed, while dark giant fibres with large areas of degeneration were observed in the 
subjects that performed exercise protocol before biopsy. Anti-neonatal MHC 
immunostaining labelled small or medium size fibres around the degeneration areas 
suggesting a regenerative activity driven by local satellite cells. Histochemical stainings 
such as periodic acid-Schiff (PAS), cytochrome oxidase (COX) and succinic 
dehydrogenase (SDH) did not show morphological alterations and displayed a normal 
fibre type distribution in all samples. As general observation there was a subject-
dependent variation in the severity of damages and in the grade of regenerative response 
(Testoni et al., 2008; Sacchetto et al., 2009). 
Furthermore, monoclonal antibody against SERCA1 isoform was used to analyse fibre 
type distribution. In semimembranosus biopsies, most of the fibres were labelled 
representing type 2 fibre (fast-twitch), in agreement with the well-establish definition of 
semimembranosus as representative fast-twitch skeletal muscle. The small number of 
fibres that was unstained with anti-SERCA1, were positive to anti-SERCA2, and 
antiSERCA2-regulatory protein phospholamban (PLB), both markers of type 1 fibres 
(slow-twitch). This mutually exclusive protein expression, either SERCA1 or SERCA2 
and PLB, was maintained in fibre of both pathological and control animals. 
Interestingly, comparing with normal, PMT-affected muscle sections revealed a 
reduction, from mild to severe, of immunoreactivity to SERCA1 suggesting a decrease 
in SERCA1 content (Sacchetto et al., 2009). 
 
Biochemical characteristics of PMT Chianina cattle 
Basing on the histological findings on SERCA1 distribution, biochemical analysis has 
been performed in order to obtain a protein profile of the disease. 
Sarco(endo)plasmic Reticulum (SR) fractions were prepared from pathological and 
control muscle biopsies and probed with specific antibodies after electrophoresis and 
blotting. The antibodies used were against protein markers of junctional and non-
junctional SR membranes. There were no differences between pathological and control 
sample in the expression of FKBP12 (junctional) or sarcalumenin and 53-kDa 
glycoprotein (non-junctional), although SERCA1 content showed a decrease in 
labelling of PMT-affected samples. In a case of Chianina cattle breed, a protein band of 
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about 55 kDa corresponding to the slow/cardiac Calsequestrin (CS) isoform was 
detected suggesting a regenerative process (Sacchetto et al., 2009). 
In addition, real-time PCR experiments were performed to investigate whether the 
reduced levels of SERCA1 might be due to a reduced ATP2A1 transcriptional activity. 
The analysis showed comparable mRNA expression levels in all pathological and 
control samples suggesting that the reduction might be due to post-transcriptional 
mechanisms (Sacchetto et al., 2009). 
The Ca
2+
-ATPase activity assay was another interesting analysis that has been 
performed in order to shed light on the functional characteristics of mutated SERCA1. 
The assay has been achieved on microsomal fractions enriched of SR membranes 
(Sacchetto et al., 2009). All the tests showed a lower pump activity of affected-subject 
samples when compared with control-animal samples, although the Ca
2+
-dependence of 
pump activity resulted similar between pathological and healthy fractions. In other 
words, the functional assay indicated a reduction in the activity of SERCA1 in the fast-
twitch skeletal muscle but not in the functionality of the enzyme. In conclusion, it has 
been displayed that the reduction in SERCA1 protein density in immunoblotting 
consistently correlated with the decrease in Ca
2+
-ATPase activity. Moreover, this is also 
correlated with the reduced labelling in immuno-fluorescence histology (Sacchetto et 
al., 2009). Altogether, the data reported defined PMT mutation of Chianina as an 
alteration that leads to a decrease in quantity of SERCA1 protein that likely maintains 
its proper functionality. 
 
After a few years from the first diagnosis of PMT, a 5-month old Dutch improved 
Red&White calf with a clinical history highly similar to PMT Chianina cases was 
presented to the Clinic of the Department of Farm Animal Health at Utrecht University. 
The research were immediately directed to assess the presence of the congenital 
alteration. Indeed, a DNA test was performed and a mutation in ATP2A1 gene, different 
from Chianina mutation, was identified. In order to evaluate whether the functionality 
of mutant SERCA1 was maintained as in Chianina, Ca
2+
-ATPase activity assay was 
performed on the new case and a decrease in activity was reported (Grünberg et al., 
2010). Therefore, despite the different genetic background, the Dutch improved 
Red&White case was incredibly similar to Chianina affected animal. 
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Genetics of Bovine Congenital Pseudomyotonia 
As mentioned before, Congenital PMT is caused by a genetic mutation in ATP2A1 gene 
coding for SERCA1. So far, different point mutations have been described in the 
different breeds that displayed the disease (Figure 8). 
 
Figure 8. Cartoon model of bovine SERCA1 protein and its mutations reported so far in 
PMT animals. (1) mutation Arg164His identified in Chianina breed; (2) mutation 
Arg559Cys reported in CMD1-affected Blue Belgian calves and in the Dutch improved 
Red&White PMT case; (3) the double point mutation Gly211Val, Gly286Val reported in 
homozygosis or coumpound heterozygosis with Arg164His in Romagnola breed. Modified 
from Murgiano et al., 2012. 
 
The affected Chianina cattle carried homozygous a single base transition within exon 6 
(c.491G>A), the missense mutation leads to an amino acid exchange in position 164 
(Arg164His). In detail, the arginine in position 164 is substituted by an histidine within 
a highly conserved domain of SERCA1 affecting the actuator domain (domain A) and 
consequently the Ca
2+
 and ATP binding phases of the pump (Drögemüller et al., 2008). 
The DNA sequencing carried on the Belgian Blue calves affected by CMD1 and the 
Dutch improved Red&White crossbred calf PMT-affected revealed a single base 
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transition within exon 14 (c.1675 C>T) of ATP2A1 gene. The alteration leads to a 
substitution in position 559 in the amino acidic sequence of SERCA1. The arginine in 
position 559 is substituted by a cystein (Arg559Cys) generating an alteration in the 
conformation of the nucleotide-binding domain (domain N) of the Ca
2+
-ATPase pump 
(Charlier et al., 2008; Grünberg et al., 2010). 
In Romagnola cattle breed, a case was homozygous for two single nucleotide variations 
in ATP2A1 exon 8 (c.[632 G>T; 857 G>T]) leading to the substitution of the two 
glycines in position 211 and 286 with two valines (Gly211Val, Gly288Val) in the 
protein sequence. The first substitution altered the domain A while the second one (286) 
affected a sarcoplasmic loop of the transmembrane domain (domain M). The other cases 
in Romagnola cattle breed were heterozygous for this double mutation at the exon 8 
and, in addition, they were heterozygous for missense point mutation in exon 6 (c.491 
G>A), the same variation identified in Chianina cattle breed. The Romagnola calves 
carrying all the three single substitutions were the first reported cases of compound 
heterozygosis for different mutations in a single gene in the bovine species (Murgiano et 
al., 2012). 
 
Overall, it can be noticed how Pseudomyotonia is characterized by substantial genetic 
heterogeneity. The phenotypical expression of the disease is influenced by the carried 
mutation although some other genetic/breed characteristics should be considered for the 
final manifestation of the pathology, especially in terms of severity. This last proposed 
hypothesis may explain why the same mutation, Arg559Cys, caused impaired 
swallowing, abnormal growth and early death in Belgian Blue calves but neither 
respiratory implication, nor growth alteration were described in the Dutch improved 
Red&White case (Grünberg et al., 2010). At the same way, it is interesting to notice 
how different mutations in the same gene may generate severe and lethal changes (in 
Belgian Blue) or no deleterious symptoms allowing the animal to survive (in Chianina) 
and, from an economical point of view, to reach an age and a satisfying weight for 
slaughterhouse (Testoni et al., 2008; Sacchetto et al., 2009). 
Finally, an intriguing result of the studies on Bovine PMT is that the observed 
phenotypes in affected cattle and the particular genetic heterogeneity make this disease 
a perfect model for a rare human genetic disorder named Brody disease (Brody, 1969; 
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Drögemüller et al., 2008). This pathological condition of skeletal muscle is caused by 
various mutations in the human ATP2A1 gene which produce alterations in the 
SERCA1. The symptoms of bovine disease closely resembled the symptoms of human. 
Indeed, Brody disease is characterized by painless muscle contracture and exercise-
induced impairment of muscle relaxation due to a defect of calcium re-uptake 
(Odermatt et al., 1996; Odermatt et al., 1997; Alex Odermatt et al., 2000). Moreover, 
Brody disease is genetically heterogeneous showing recessively or dominantly inherited 
forms, different mutations or no mutations in ATP2A1 in patients displaying the typical 
symptoms of the muscular disease (Pan et al., 2003; Vattemi et al., 2010; Voermans et 
al., 2012). Consequently, the PMT affected cattle might be a very helpful and useful 
model to deepen the pathogenesis of the disease and the role of SERCA1. Indeed, 
bovine model allows to study naturally occurring mutation in a large animal which 
displays muscular morphology and biomechanics more similar to human than a 
traditional small mammal model (Drögemüller et al., 2008). A very intriguing 
application of bovine model might be the possible use as new target for therapeutic 
interventions such as injections of recombinant SERCA1 protein or inhibitors of the 
protein quality control systems (Drögemüller et al., 2008; Bianchini et al., 2014). 
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1.6.Objectives 
 
The main objective of my PhD project was to complete the characterization of Bovine 
Congenital Pseudomyotonia by mean of analysing Italian Romagnola cattle breed cases 
and deepening the Dutch improved Red&White crossbred case from a morphological, 
histochemical and biochemical point of view. The bases of my research were the studies 
on Italian Chianina cattle breed (Testoni et al., 2008; Sacchetto et al., 2009; Murgiano et 
al., 2012) that since the first diagnosis of PMT enlightened the genetic cause, the 
pathogenic mechanisms and the main clinical, histopathological and biochemical 
appearance of PMT. Since Chianina PMT cattle was proposed as animal model for the 
study of human Brody disease, the report of novel ATP2A1 gene mutations in different 
breeds reinforced the definition of PMT as the truly counterpart of the human muscular 
dysfunction. Consequently, the interest on this disease and its effects on the muscle 
tissue increased and the research progressed to understand whether the different genetic 
background lead to a similar phenotype. 
Therefore, the main goal of my study was to integrate the data on Chianina cattle with 
the analysis of other PMT-affected animals in order to increase the knowledge on 
morphological and biochemical effects of the disease on the muscle tissue, to evaluate 
the phenotypic variability of the disease and to identify possible adaptive/compensatory 
mechanisms (Hypothesis 1). Moreover, comparative histological and biochemical 
analyses between Dutch improved Red&White and Italian Piedmontese cattle purebred 
subjects were performed in order to evaluate genetic influences or compensatory 
mechanisms that lead to the particular phenotype of Dutch improved Red&White case 
(Hypothesis 2). 
 
Hypothesis 
1 
Bovine Congenital Pseudomyotonia (PMT) in Italian Romagnola cattle breed 
shows the same features described in Italian Chianina cattle breed: i) 
degeneration of fibres always associated with regenerative phenomena; ii) no 
variation in fibre type distribution, fibre dimension or metabolic alteration; 
iii) exclusive decrease in SERCA1a quantity and activity. 
2 
The increase of mitochondria number in the fibres of the affected Dutch 
improved Red&White crossbred calf is a compensatory response of the 
muscular cells to the prolonged Ca2+ permanence in the cytoplasm. 
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2.MATERIALS AND METHODS 
 
 
 
2.1.Animals recruitment 
The animal used in this study were: a 5-month old female Dutch improved Red&White 
crossbred affected calf and two healthy control animals of same phenotype, gender and 
age; four Italian Romagnola cattle purebred affected calves (two males and two females, 
2- or 3-month old) and three healthy control of the same breed. Figure 9 synthesizes 
graphically the genealogical tree of Dutch improved Red&White and Romagnola 
affected animals showing how the mutate alleles spread in heterozygosis through the 
generations till they cause clinical manifestation in homozygosis or in compound 
heterozygosis. 
 
Figure 9. (a) Part of pedigree of the PMT-affected Dutch improved Red&White calf, the 
half-filled symbol represents the Arg559Cys mutant allele that was present in homozygosis 
(filled symbol) in PMT case and in heterozygosis in the dam. The genotype of the sire of 
PMT case was unknown (VRB=Verbeterd Roodbont or Dutch improved Red&White; 
PIM=Piedmontese). (b) Part of pedigree of the PMT cases in Italian Romagnola cattle 
breed (RMG), the red halves symbols represent the double point mutation Gly211Val, 
Gly286Val that was reported in homozygosis in one subject (red filled circle). The light 
blue halves symbols represent the Arg164His mutant allele reported also in Chianina. 
Three PMT-cases of Romagnola were compound heterozygous for this two mutations (half 
red and half light blue symbols). Image modified from (a) Grünberg et al., 2010; (b) 
Murgiano et al., 2012. 
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Additionally, three Italian Piedmontese purebred subjects were included in the study for 
a comparative evaluation. Two of these animals showed double-muscled phenotype, 
between class S and E according to S.E.U.R.O.P.
3
 assessment grid of the EU carcass 
classification system (European Community, 1991; European Community, 2006). One 
was a 16-month old male, the other was a 22-month old female. The third animal was a 
female 27-month old with no extreme development of the muscles in the regions of the 
proximal fore and hind quarters like in the other two. This latter animal was indicated as 
non-hypertrophic, a condition that characterizes less than 4% of the population in 
Piedmonte Region in Italy (Miretti et al., 2013). 
Biopsies of semimembranosus muscle, a representative fast-twitch muscle, were 
obtained under epidural anesthesia from Romagnola and the Dutch improved 
Red&White crossbred subjects (Grünberg et al., 2010; Murgiano et al., 2012). 
Piedmontese samples were collected from the animals immediately after they were 
slaughtered at “Manzo Carni S.n.c.” slaughterhouse in Rocca Dè Baldi (Cuneo-Italy). 
Piedmontese breed was chosen because the Dutch improved Red&White crossbred 
affected calf was an offspring of a purebred Dutch improved Red&White sire and a 
crossbred (Piedmontese × Dutch improved Red&White) dam. Given that the affected 
Dutch improved Red&White displayed some intriguing morphological alterations when 
compared with the healthy controls, a complementary comparison with purebred 
Piedmontese could enlighten whether the reported changes were consequent to disease 
or phenotypic characters introduced by Piedmontese genetic line. Basing on various 
studies present in literature (Wegner et al., 2000; Wang et al., 2009), I speculated 
whether Piedmontese genetic line might confer phenotypic characters which could 
improve symptomatic outcomes in the affected crossbred animal. 
 
2.2.Preparation of the samples 
All muscle biopsies were frozen in cold isopentane and mounted upright for a cross-
sectional cut on cork-disc with OCT (Optimal Cutting Temperature compound). 
Transverse sections (8µm) were cut in a cryostat. The obtained series of sections were 
used to perform histological, histochemical and immunohistochemical staining 
                                                          
3
 S.E.U.R.O.P., EU carcass classification system: S = super; E = excellent; U = abundant; R = 
good; O = fair; P = poor. 
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protocols. Moreover, part of the biopsies were frozen and stored at -80°C for further 
procedure of total protein and microsomal fraction extractions. 
 
2.3.Histology, Histochemistry and Immunoistochemistry 
Hematoxylin and eosin staining protocol (H&E) was accomplished for a general 
morphological analysis. Comparative α-napthyl acetate protocol for esterase staining 
was performed to underline the presence of macrophages inside and around the fibres 
degenerated or in degeneration (Miller et al., 1984). 
Histochemical stains for cytochrome oxidase (COX) and succinic dehydrogenase (SDH) 
were performed to evaluate mitochondria distribution and possible metabolic 
alterations. Periodic acid shiff (PAS) stain was used to evaluate the glycogen content 
and its distribution in relation to the SR. 
In order to characterize fibre types, myofibrillar ATPase (m-ATPase) stain was 
performed as previously described (Latorre et al., 1993). M-ATPase staining followed 
either alkaline pre-incubation at pH 10.2, 10.3 and 10.4 (sodium barbital 0.075M, 
sodium acetate 0.07M, calcium cloride 0.1M) or acid pre-incubation at pH 4.4, 4.5 and 
4.6 (sodium acetate 0.2M). For the classification of fibres, we referred to the work of 
Maccatrozzo et al. (2004). In all slides, it was easily possible to distinguish type 1 from 
type 2 fibres. At pH 4.6 and 10.2, it was possible to separate type 2A fibres and 2X 
fibres (conventional 2B fibres). Some 2C fibres were also identified. All the histological 
and histochemical protocols are synthetically described in Table 1 along with the 
general immunostaining procedure used for the immunohistochemical analysis. 
The primary antibodies used were: 
_polyclonal anti neonatal (α) myosin heavy chain isoform (αMHC dilution 1:5000, 
Sigma St. Louis MO); 
_monoclonal antibody against sarco(endo)plasmic reticulum calcium ATPase 1a 
(SERCA 1a, dilution 1:500, Biomol Plymouth Meeting PA); 
_monoclonal antibody against sarco(endo)plasmic reticulum calcium ATPase 2 
(SERCA 2, dilution 1:200, Biomol Plymouth Meeting); 
_monoclonal antibody anti-phospholamban (PLB, dilution 1:200, Affinity BioReagents, 
Golden CO); 
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_monoclonal antibody against myosin heavy chain isoform I (MHCI dilution 1:200, 
Sigma); 
_polyclonal antibody anti-mitochondrial preprotein traslocases of the outer membrane 
20 (Tom20, dilution 1:100, Santa Cruz biotechnology, Texas US). 
Immunostained slides were then incubated either with secondary antibody conjugated 
with TRITC (Dako, Milano, Italy) and visualized with Laica TCS-SP2 confocal laser 
scanning microscope, or with secondary antibody conjugated with biotin (Sigma) and 
the reaction was visualized with Olympus Vanox AH-3 bright field microscope after 
Envision Method (Vector, Burlingame US). 
 
 
Staining Procedure 
H&E 
1.Rinse in deionized water; 2.Stain 1x12min in haematoxylin, rinse 1x3min in 
deionized water, rinse 1x5min in running tap water, dip few seconds in HCl-
ethanol (1/70), rinse 1x3min in deionized water; 3.Stain 1x40 seconds in eosin, 
dehydrate in alcohol 2x95%>2x100% (3min each), 3x5min in xylene; 4.Mount 
slides and dry ON in the hood. 
Esterase 
1.Stain 1x5min in Staining Solution (prepared fresh: 5mg α-naphtyl acetate, 
0.75 ml acetone, mix, add 12.5ml 0.2M sodium phosphate, mix, add azotized 
pararosaniline -0.4ml 4% pararosaniline HCl and 4ml 4% sodium nitrite); 
2.Rinse for several minutes in running tap water; 3.Dehydrate in alcohol 
1x50%>1x70%>2x95%>2x100% (5min each), and 3x5min in xylene; 4.Mount 
slides and dry ON in the hood. 
COX 
1.Stain 1x30min at RT in Incubating Solution (prepared fresh: 750mg sucrose in 
7.5ml deionized water, add 2.5ml 0.2M phosphate buffer pH7.6, add 5mg DAB, 
10mg cytochrome C, 20µg catalase); 2.Rinse 2x5min in deionized water; 
3.Dehydrate in alcohol 1x50%>1x70%>2x95%>2x100% (3min each), 3x5min 
in xylene; 4.Mount slides and dry ON in the hood.  
SDH 
1.Stain 1x30min at 37°C in Incubating Solution (prepared fresh: in 10ml 0.2M 
phosphate buffer pH7.6 dissolve 270mg sodium succinate and 10mg NBT-nitro 
blue tetrazolium-); 2.Rinse 2x5min in deionized water; 3.Rinse in 30%-60%-
90% acetone/water solution in increasing and decreasing concentration (3min 
each; 4.Rinse several times in deionized water; 5.Mount slides with aqueous 
mounting media and dry ON in the hood. 
PAS 
1.Incubate 1x15min in Carnoy’ fixative (60% ethanol, 30% chloroform, 10% 
acetic acid); 2.Rinse 3x3min in deionized water; 3.Incubate 5min in 0.5% 
periodic acid solution; 4.Rinse 3x3min in deionized water; 5.Incubate 15min 
with Shiff reagent; 6.Rinse 1x5min in tap water and 1x5min in deionized water; 
7.Stain 1min in haematoxylin; 8.Rinse 1x5min in tap water and 1x5min in 
deionized water; 9.Dehydrate in alcohol 1x50%>1x70%>2x95%>2x100% 
(3min each), 3x5min in xylene; 10.Mount slides and dry ON in the hood. 
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m-ATPase 
1.Incubate 1x15min in alkalin pre-incubation  buffer or 1x5min in acid pre-
incubation buffer; 2.Rinse twice in deionized water; 3.Rinse twice in Wash 
Solution (0.075M Na-barbital, 0.07M Na-acetate, 0.1M Ca-chloride, pH9.45); 
4.Incubate 30min (after alkaline pre-incubation) or 60min (after acid pre-
incubation) in ATP-incubation Solution (1mg/ml ATP in Wash Solution); 5.Rinse 
3x30seconds in Ca-chloride; 6.Incubate 1x3min in Co-chloride and rinse in 
deionized water; 7.Incubate 1min in Ammonium sulfid and wash in deionized 
water; 8.Dehydrate in alcohol 2x95%>2x100% (3min each), 3x5min in xylene; 
9.Mount slides and dry ON in the hood. 
HIC 
1.[For Tom20 Ab, permeabilization step 15min in 0.15%Triton in PBS]; 2.Block 
1x60min in 1%BSA-PBS; 3.Incubate primary antibody 60-90min; 4.Wash 
3x5min in PBS; 5.Incubate 60min with secondary antibody; 6.Wash 3x5min in 
PBS;  
-If biotin-conjugated (diluted 1:200): 7.Incubate 60min with ABCkit (Avidin-
Biotin Complex, Vector); 8.Wash 1x5min in PBS; 9.Stain with DAB (3, 
3’diaminobenzidine, Vector) from 45seconds till 1min and 45seconds 
depending on the signal; 10.Rinse in deionized water, dehydrate in alcohol 
2x95%>2x100% (3min each), 3x5min in xylene, mount slides and dry ON in the 
hood. 
-If TRITC-conjugated (diluted 1:100): 7.Mount slides with special mounting 
media (Vectrasin) and fix the coverslip with polish, store in dark. 
Table 1. Synthetic explanation of the staining protocols used in this project. 
 
Additionally, measurements of fibre areas were recorded using software Adobe 
Photoshop CS4 on COX stained slides images (magnification 10X) of Dutch improved 
Red&White and Piedmontese subjects. Fibres were chosen randomly among 20 images 
per sample and a total of 200 light labelled fibres and 200 dark labelled fibres per 
animal were measured. The fibres were then grouped in classes of dimension to build a 
distribution curve using Microsoft Excel 2010 software (Microsoft corporation). 
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2.4.Biochemical analysis 
2.4.1.Microsomal fractions preparative procedures 
For Romagnola and Dutch improved Red&White crossbred subjects, a crude 
microsomal fraction enriched in content of SR membranes was isolated using 
differential centrifugation method previously described (Sacchetto et al., 2005; 
Sacchetto et al., 2009). Briefly, tissue samples were homogenized in 10 mM/L HEPES, 
pH 7.4, 20 mM/L KCl containing 1 μg/ml leupeptin and 100 μM/L 
phenylmethylsulfonyl fluoride. The first centrifugation at 650×g for 10 minutes at 4°C 
removed the myofibrils (sedimented). Afterwards, ultracentrifugation at 120,000×g for 
90 minutes at 4°C was performed on the previous supernatant. The obtained pellet 
consisted in the crude SR fraction. These membrane fractions were resuspended in 0.3 
M/L sucrose, 5 mM/L imidazole, pH 7.4, containing 1 μg/ml leupeptin and 100 μM/L 
phenylmethylsulfonyl fluoride and stored at -80°C. Protein concentration was 
determined by the method of Lowry et al. (1951) using bovine serum albumin as 
standard. 
 
2.4.2.ATPase biochemical assay 
ATPase activity of the microsomal fractions (20 µg/ml) was measured by 
spectrophotometric determination of NADH oxidation coupled to an ATP regenerating 
system, as previously described (Sacchetto et al., 2009). The assay was performed at 
37
o
C in the presence of 2 µg/ml A23187 Ca
2+
-ionophore at pCa5. 
 
2.4.3.Total homogenates preparative procedures 
Roughly 100 mg of the biopsies from Dutch improved Red&White crossbred and 
Piedmontese subjects were used to prepare total muscle homogenates that were used in 
electrophoresis and immunoblotting as explained further below. 
The biopsy was first wetted with 5 µl of leupeptin (1µg/ml) and phenylmethylsulfonyl 
fluoride (100 µM/L) and then minced into small pieces with scissors. Finally, the 
minced muscle was collected in a 5 ml tissue grinder vessel (Potter). After 600 µl of 
Lysis buffer (62.5 mM Tris/HCl, pH 6.8, 10% glycerol, 2% SDS containing 1µg/ml 
leupeptin and 100 µM/L phenylmethylsulfonyl fluoride) were added, the sample was 
homogenized up and down until the tissue appeared completely homogenized. The 
     Pseudomyotonia - Materials and Methods 
 38 
liquid part was removed with a glass pipet and placed in a clean 1.5 ml test tube 
(eppendorf). Using other 400 µl of Lysis Buffer, the sample was homogenized a second 
time, the liquid part was removed and placed in the test tube. The homogenates were 
then centrifuged 10,000 rpm for 10 minutes and the supernatant was carefully removed, 
placed in a clean 1.5 ml test tube and stored at -80°C. Protein concentration was 
determined by the method of Lowry et al. (1951) using bovine serum albumin as 
standard. 
 
2.4.3.Gel Electrophoresis and Immunoblotting 
Equal quantities of crude sarcoplasmic reticulum microsomal fractions were separated 
by 5-10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) as previously 
described (R Sacchetto et al., 2012). On the other hand, total proteins fractions were 
separated by 10-15% SDS-PAGE. Slab gels were either stained with EZblue Gel 
Staining Reagent or cationic dye Stains-All (Sacchetto et al., 2009), or proteins were 
electroblotted to Protran Nitrocellulose transfer membrane (Schleicher&Schuell 
Bioscience GmbH Whatman Group, Dassel Germany) for subsequent immunoblotting 
survay. 
Immunoblotting was performed using the following primary antibodies: 
_monoclonal antibody against sarco(endo)plasmic reticulum calcium ATPase 1a 
(SERCA 1a, dilution 1:500, Biomol Plymouth Meeting PA); 
_monoclonal antibody against sarco(endo)plasmic reticulum calcium ATPase 2 
(SERCA 2, dilution 1:200, Biomol Plymouth Meeting); 
_monoclonal antybody anti-ryanodin receptor (RyR, dilution 1:5000, Thermo 
scientific); 
_monoclonal antibody anti-sarcalumenin and glycoprotein53 splice variant (GP53, 
dilution 1:4000, Affinity Bioreagents, Golden CO); 
_monoclonal antibody anti-plasma membrane calcium ATPase (PMCA, dilution 
1:2500, Thermo Fisher scientific); 
_polyclonal antibody anti-mitochondrial preprotein traslocases 20 of the outer 
membrane (Tom20, dilution 1:1000, Santa Cruz biotechnology). 
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The transfer membrane was incubated with secondary antibody alkalin phosphatase-
conjugated (Sigma) and premixed BCIP/NBT solution (Sigma-Aldrich) was used to 
visualize the reaction. 
 
2.5.RNA preparation and Quantitative Real-Time PCR 
SERCA1 mRNA levels were quantified by real-time PCR (RT PCR). The procedures to 
extract RNA, to synthetize cDNA and to perform RT PCR were the same described in 
Sacchetto et al. (2009). Briefly, total RNA was isolated from semimembranosus 
muscles using TRIzol reagent (Invitrogen, Milano, Italy). Two micrograms of total 
RNA from each sample were subjected to random hexamer primed first-strand cDNA 
synthesis in a volume of 20 μl using Superscript II reverse transcriptase (Invitrogen), 
according to manufacturer’s instructions. Real-time PCR was performed by the SYBR 
Green method with an Applied Biosystems 7,500 Fast Real Time PCR System (Patruno 
et al., 2008). Real-time PCR amplification was performed in a total volume of 20 μl. 
Reaction conditions were as follows: 2 minutes at 50°C, 10 seconds at 95°C, and 40 
cycles of 15s at 95°C, 1 minute at 60°C. Oligonucleotide primers used were: 
SERCA1 
             5′-GCACTCCAAGACCACAGAAGA-3′ (sense); 
             5′-GAGAAGGATCCGCACCAG-3′ (antisense);  
glyceraldehydes-3-phosphate dehydrogenase 
             5′-GGTCACCAGGG CTGCTTTTA-3′ (sense),  
             5′- GAAGATGGTGATGGCCTTTCC-3′ (antisense). 
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3.RESULTS 
 
 
 
3.1.Clinical features of Congenital Pseudomyotonia in Romagnola and Dutch improved 
Red&White affected animals 
The first approach to the animals manifesting signs of neuromuscular dysfunction was a 
deep clinical examination that put in differential diagnosis several possible disease, 
PMT included. 
The Romagnola animals analysed in this study were four young calves that, at clinical 
examination, were bright, alert and in good body condition. Since their birth, all were 
showing exercise-induced muscle contraction that prevented them from performing 
muscular activities of greater intensity than a simple walk at a slow pace. When forced 
to move faster, the muscles ‘froze up’ temporarily, inducing rigidity and uncoordinated 
gait without signs of pain. When forced to continue the movement animals reach a 
stiffness condition so pronounced that made impossible any further action and they fell 
to the ground. After a few seconds, the muscles relaxed and the animals regained their 
ability to get up and move. At the same way, when the calves were startled by an 
operator that rapidly approached them or was making sudden noises and movements, a 
cramp attack showed up (Figure 10a and b). One of the calf had a character particularly 
active and curious, moving and scouting during the whole clinical evaluation. This 
subject was also characterized by an hyper-reactivity to the external stimulations 
showing stronger intensity in the attacks (Figure 10b). 
As already reported (Grünberg et al., 2010) the Dutch improved Red&White calf was 
bright, alert and responsive with normal mentation and behaviour. It was normally 
developed for its age with good body condition and, being the offspring of two doubled-
muscling cattle breeds (Dutch improved Red&White and Piedmontese), it had the 
characteristic muscle development. In contrast with Romagnola calves, this animal was 
moving slowly, making short strides and carrying the head low (dorsal line of the neck 
parallel to the ground). Pushing the calf from either side to induce a corrective 
movement to maintain equilibrium induced a generalized sudden muscle spasm of the 
whole body resulting in a saw-horse type position and a consequent loss of balance. The 
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calf flipped over with extended legs and remaining in lateral recumbency with stiffened 
limbs for 20 to 30 seconds (Figure 10c). The relaxation of the limb musculature 
occurred after this period of time allowing the animal to regain sternal recumbency first, 
and to get up later. During these episodes the animal remained bright and alert without 
losing consciousness. At the same way, forcing the calf to walk at a faster pace rapidly 
induced an increase in muscle tone of body and limbs leading to a bunny-hopping type 
gait, and as stiffness progressed, making further strides or even movements of head or 
neck impossible. Whether the animal was left at rest after this forced exercise, the 
muscle stiffness shortly resolved (Grünberg et al., 2010). 
 
 
 
Figure 10. Sequential images of a muscle stiffness attack in (a, b) two Romagnola calves 
and in (c) the Dutch improved Red&White calf affected by PMT. 
 
In all the animals electromyography (EMG) investigation performed at rest on muscles 
of forelimb (paraspinalis of the thoracic region, deltoid muscles) as well as of hind limb 
(triceps surae and gluteobiceps muscles, quadriceps femoris muscles) showed no 
spontaneous activity. A part from the muscular symptoms no other clinical signs were 
reported. Consequently, the absence of myotonic discharges and the specific sequence 
of events in a cramp attack leaded the diagnosis to PMT. Indeed, the clinical symptoms 
reported in the Dutch improved Red&White case and in the four Romagnola affected 
calves, strongly resembled the Chianina cases of PMT (Testoni et al., 2008) even if the 
Dutch improved Red&White calf displayed more severe clinical appearance when 
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compared with the other PMT subjects. Indeed, the Dutch improved Red&White 
affected calf was unable to get up without assistance till three days of life and it always 
showed a certain level of muscle stiffness that obliged it to move slowly or limited some 
simple movements (e.g. lift the head, belt the neck). 
Regardless the different grade of severity, genetic analyses confirmed the clinical 
suspects of PMT locating novel point mutations in ATP2A1 gene, different from the one 
found in Chianina (Grünberg et al., 2010; Murgiano et al., 2012). 
 
3.2.Histopathological characterization of Congenital Pseuodomyotonia in Romagnola 
and Dutch improved Red&White calves 
Despite the different ATP2A1 gene mutation, the close clinical similarities between 
Chianina and Romagnola PMT subjects lead to speculate whether the two breeds share 
also the histopathological consequences of the genetic alteration. The histological, 
histochemical and immunohistochemical analyses performed on Romagnola animals 
aimed to collect information of the disease effects on muscle tissue in this breed. 
The Dutch improved Red&White affected subject had a particular genetic background 
being a crossbred of two different double-muscled breeds (Dutch improved Red&White 
and Piedmontese). Indeed, Dutch improved Red&White cattle is closely related with 
Belgian Blue cattle breed since it was used to increase the muscle development in a 
breed primarily characterized by dairy attitude (Dutch Red&White). The double-
muscling phenotype in Belgian Blue is caused by a deletion of eleven bases in the gene 
coding for Growth Differentiation Factor 8 (GDF8) or Myostatin that leads to a 
complete inactivation of the protein (Kambadur et al., 1997). This mutation was 
introduced in Dutch improved Red&White cattle breed to improve the beef production. 
At the same way, it could be possible that also the mutation in ATP2A1 gene, causing 
the substitution Arg559Cys in the SERCA1a, was accidentally introduced in Dutch 
improved Red&White genetic line in the inbreeding process. This last consideration 
may provide an explanation on the fact that the identical mutation at ATP2A1 gene was 
found in Belgian Blue calves affected by Congenital Muscular Dystonia 1 (CMD1) and 
in the Dutch improved Red&White crossbred calf affected by PMT. The other double-
muscled breed present in the genealogic tree of Dutch improved Red&White crossbred 
calf was the Piedmontese cattle breed, an Italian breed characterized by a missense 
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mutation in the gene coding for GDF8 that leads to a substitution of a cysteine by a 
tyrosine in protein sequence (Kambadur et al., 1997). As consequence of the mutation, 
GDF8 decreases its inhibiting activity and causes an increased muscle development. 
The Dutch improved Red&White calf represents a result of a combination of two 
mutations at GDF8 and this might influence the clinical and pathological outcome of 
SERCA1a mutation. Indeed, since the mutations in Belgian Blue CMD1-calves and in 
Dutch improved Red&White PMT-calf were the same, the severity of manifestation in 
the two breeds was different. A comparative study between Dutch improved 
Red&White and Piedmontese animals was performed in order to highlight common 
phenotypic characteristics that might improve the response to the disease in the Dutch 
improved Red&White subject. 
 
3.2.1.Morphological profile of Congenital Pseudomyotonia in Romagnola cattle breed 
and immunofluorescence analysis of SERCA1, SERCA2 and PLB expression in 
pathological muscle 
Biopsies of semimembranosus muscle were collected from affected and control animals 
kept at rest. No exercise protocols were performed before the sampling in order to avoid 
the influence of the physical activity (and of eventual muscle stiffness attack) in the 
histological appearance and obtain a picture of the disease in “normal” (non-stressed) 
condition. Indeed, in a previous study my group demonstrate an exercise-dependence in 
the severity of histopathological signs in muscle of Chianina PMT-affected animals 
(Sacchetto et al., 2009). The histopathological examination achieved on Romagnola 
animals used in this study revealed the presence of degenerated fibres in pathological 
subjects. The degree of alteration was generally mild with some fibres in degeneration 
followed by fibre regeneration and no other major morphological changes (e.g. central 
nuclei). Nevertheless, a Romagnola case appeared more severe than the other subjects 
displaying frequent degenerative fibres with enlarged and pale cytoplasm often 
surrounded or filled by mononuclear cells. The labelling for non-specific esterase 
suggested that these cells were macrophages (Figure 11a-d) (Cosford et al., 2008). This 
higher severity in histopathological signs might be relate to a major activity of the 
subject before the sampling procedure. The immunostaining of the serial section using 
anti-neonatal myosin heavy chain (αMHC) marked positively small-size fibres in the 
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proximity of degenerating/ed fibres and proved the presence of regenerative phenomena 
in all the affected animals analysed (Figure 11e-i). 
In addition, combined COX-SDH staining was performed to evaluated possible 
metabolic alterations. Sections from all Romagnola animals used in this project were 
analysed with this stain and no alterations were noticed (Figure 12a and b-da 
aggiungere). Also PAS stain revealed no changes in glycogen distribution displaying a 
typical honeycomb-like staining pattern and consequently indicating a normal 
association between glycogen and SR membranes (Figure 12c, d and e). 
Furthermore, in order to enlighten whether the mutation caused a decrease in SERCA1 
expression, sections of all Romagnola subjects were incubated with the corresponding 
antibody. Moreover, antibodies against SERCA1, SERCA2 and PLB were used on 
serial section to investigate the distribution pattern of the three proteins. 
Semimembranosus muscle is a predominantly fast-twitch muscle, consequently most of 
the fibres were immunostained for SERCA1 and few for SERCA2 and PLB. The 
evaluation of SERCA1 expression revealed a decrease in fibre immunoreactivity for 
SERCA1 in the affected animals compared with the healthy controls (Figure 13a, b). 
Moreover, immunofluorescence showed a mutually exclusive labelling for SERCA1 or 
SERCA2 along with PLB in all the sample. However, in pathological animals some 
fibres faintly labelled with SERCA1 were also faintly reactive for SERCA2, and some 
fibres were immunoreactive for both SERCA1 and PLB displaying a novel pattern of 
co-expression of the three proteins (Figure 14a-f). 
 
3.2.2.Morphological characterization of the Dutch improved Red&White PMT-affected 
subject and comparative analysis between Dutch improved Red&White calves and 
Piedmontese cattle 
The morphological analysis on Dutch improved Red&White crossbred case revealed to 
be a further support to the definition of a general PMT case. Indeed, the 
histopathological analyses described a picture similar to Chianina and Romagnola with 
some fibres in degeneration surrounded by macrophages and always accompanied with 
regenerative phenomena (Figure 11g-k). No metabolic alterations in terms of glycogen 
SR-association or oxidative enzymes distribution were reported. Although, an increased 
intensity for the oxidative enzymes staining was described in PMT case along with 
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hypertrophy of a particular fibre population (Dorotea et al., submitted for publication). 
These observations will be better described later in this paragraph. 
To complete the morphological investigation, serial sections of Dutch improved 
Red&White subjects were incubated with antibodies against SERCA1, SERCA2 and 
PLB in order to evaluate the expression levels and the distribution pattern of these 
proteins. As for Chianina and Romagnola, Dutch improved Red&White 
semimembranosus muscle sections showed almost complete immunostaining for 
SERCA1 and only few fibres positive for SERCA2 and PLB. In addition, the 
immunoreactivity for SERCA1 in the affected animals was relative minor when 
compared with the healthy controls (Figure 13c and d). Finally, also Dutch improved 
Red&White subjects displayed a classical mutually exclusive labelling for SERCA1 or 
SERCA2 along with PLB, although in pathological animals some fibres co-expressed 
the two isoforms or SERCA1 and PLB (Figure 14g-m). 
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Figure 11. Histological and immunohistochemical stainings on semimembranosus muscle 
cryosections from Romagnola (a-h) and Dutch improved Red&White (i-m) affected calves. 
Serial sections were stained with H&E (a, c, e, i, j) to identify areas of myonecrosis and 
phagocytosis, or with esterase reaction (b, d, k, l) to highlight the lysosomal activity within 
macrophages clearing necrotic debris. Arrows in (f, g, h, m) indicate small fibres positive 
for immunostained with antibodies to neonatal MHC isoform. Scale bars: 100 µm (a-d), 50 
µm (e-m). 
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Figure 12. Representative histochemical staining on semimembranosus muscle cryosections 
from Romagnola and Dutch improved Red&White healthy and affected calves. Combined 
COX-SDH staining shows no alteration in the distribution of mitochondria nor in healthy 
(a, f) nor in pathological (b, g) animals. PAS staining reveals a normal association of 
glycogen to SR membranes both in controls (c, h) and affected (d, i) subjects displaying the 
typical polygonal honeycomb-like staining pattern (e, j). Scale bar: 100 µm (a, b, h), 50 µm 
(c, d, f, g, i). 
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Figure 13. Confocal microscopy of semimembranosus muscle cryosections. (a) Control and 
(b) PMT affected Romagnola subjects; (c) healthy and (d) pathological Dutch improved 
Red&White animals. Transverse sections from were immunolabelled with monoclonal 
antibodies to SERCA1 and then incubated with TRITC-conjugated anti-mouse secondary 
antibodies. Control sections display a more intense immunoreactivity when compared to 
affected sections. Scale bars: 100 µm (a), 150 µm (b-d). 
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Figure14. Representative confocal microscopy of semimebranosus muscle cryosections 
from Romagnola (a-f) and Dutch improved Red&White (g-m) subjects. Serial sections 
were immunolabelled with monoclonal antibody against SERCA1 (a, b, g, j), SERCA2 (c, 
d, h, k) and PLB (e,f, i, l).The three proteins display a mutually exclusive pattern of 
expression although some fibres co-express the two SERCA isoforms or SERCA1 and 
PLB (b, d, f and j,k,l). Monoclonal antibody to MHC I (m).was used to identify fibres type 
1. Scale bar: 100 µm.  
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Moreover, cross sections of Dutch improved Red&White and Piedmontese subjects 
were stained for COX. Using the microscope images obtained from these slides, I 
measured the cross-section areas of a representative sample of the two fibre populations 
that this protocol easily differentiates: oxidative (dark labelled) and glycolytic (lightly 
or no labelled) fibres (Figure 15). Integrated fibre classifications described three types 
of fibre: large-size fast-twitch glycolytic fibres (type 2X), intermediate-size fast-twitch 
oxidative fibres (type 2A) and small-size slow-twitch oxidative fibres (type 1) 
(Schiaffino and Reggiani, 2011). 
As mentioned earlier, Piedmontese cattle breed is characterized by a great muscular 
mass development named double-muscling that is caused by a missense mutation in the 
gene coding for GDF8 (Kambadur et al., 1997). Generally, double-muscled animals 
have increased number and dimension of fast glycolytic fibre (conventional 2B or 2X 
type) that consequently are more frequent than slow fibre and have marked hypertrophy. 
In addition, different grades of hypertrophy and hyperplasia are described between and 
within double-muscled breeds (Wegner et al., 2000). The comparative analysis 
performed in this study showed that the largest glycolytic fibres were identified in 
Piedmontese subjects according to their pure double-muscled phenotype. The Dutch 
improved Red&White subjects had relatively smaller glycolytic fibre and, within them, 
the affected Dutch improved Red&White had the smallest. Interestingly, in all the 
healthy subjects, oxidative fibres are always smaller than the corresponding glycolytic 
fibres, on the contrary in the affected Dutch improved Red&White this proportion is 
inverted showing the oxidative fibres broadly larger than the glycolytic ones (Figure 
15d). 
Staining protocol for sole COX or SDH was used to evaluate the presence and 
distribution of mitochondria. In all the healthy animals used in the comparison study 
(Dutch improved Red&White and Piedmontese), COX and SDH stain showed a similar 
pattern with a restricted labelling to a specific population of fibres: oxidative (dark 
labelled) and glycolytic (lightly or non-labelled) fibres. Interestingly, the sections of the 
affected Dutch improved Red&White subject showed a more homogeneous stain for 
COX and SDH in all the fibres with no clear difference between the two population 
(Figure 16a, e and i). This increased staining level for oxidative enzymes might suggest 
a possible increase in mitochondria activity and/or number. To clarify this observation, 
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immunohistochemistry with an antibody against a structural protein of the 
mitochondrion (Tom20) was performed (Figure 16m-p). The stained sections of the 
healthy controls displayed an immunoreactivity mostly restricted to a population of 
fibres whereas in the affected Dutch improved Red&White subject the sections showed 
a diffuse immunofluorescence throughout all the fibres (Figure 16 q-v) supporting a 
possible increase in mitochondria presence. 
In addition, fibre type characterization was performed on sections of Dutch improved 
Red&White and Piedmontese using m-ATPase staining protocol. Comparing acid and 
alkaline pre-incubated serial sections, it was possible to unambiguously distinguish fibre 
type 1 (slow-oxidative), type 2A (fast-oxidative) and 2X (fast-glycolytic) in all the 
subjects (Figure 17). Few type 2C fibres (Maccatrozzo et al., 2004) were also identify 
(arrows in Figure 17g-i). 
A comparative analysis between serial slides stain with COX and m-ATPase allowed to 
combine the complementary information of these procedures. The comparison revealed 
that in healthy Dutch improved Red&White and in Piedmontese subjects the large-size 
fibres, light in COX stain, are type 2X fibres, the intermediate-size fibres, dark in COX 
stain, are type 2A fibres and the small, dark fibres are type 1 fibres (Figure 17a-i). 
Interestingly, in affected Dutch improved Red&White subject the fibres that displayed 
an increased labelling for COX resulted to be type 2X fibres (Figure 17j-l). Moreover, 
the large dark fibres of affected Dutch improved Red&White corresponded to type 2A 
fibres (Figure 17j-l). 
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Figure 15. Measurements of fibre cross-sectional areas in the comparative analysis 
between Piedmontese and Dutch improved Red&White subjects. (a) Distribution of areas 
in hypertrophic subjects (mean between the two animals). (b) Distribution of areas in non-
hypertrophic subject. (c) Distribution of areas in Dutch improved Red&White control 
subjects (mean between the two animals). (d) Distribution of areas in Dutch improved 
Red&White PMT-affected animal. The blue line represents oxidative fibre population, the 
red line glycolytic fibre population. Each graph is associated with a representative 10X 
microphotograph of COX-stained sections. Bar scale = 100 µm. 
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Figure 16. Histochemical stainings on semimembranosus muscle sections from Dutch 
improved Red&White PMT affected calf, from an healthy control and two Piedmontese 
healthy animals. Transverse sections from muscle biopsies were stained for mitochondrial 
specific reactions, succinic dehydrogenase (SDH) (a-d) and cytochrome oxidase (COX) (e-
h, i-l). Scale bar: 100 µm (a-h), 500 µm (i-l). The sections were also immunolabelled with 
polyclonal antibodies against Tom20. Sections were then incubated with antibodies 
conjugated with biotin and the reaction was revealed with the Envision method (m-p). 
Scale bar: 500 µm. (q-s) Healthy and (t-v) pathological Dutch improved Red&White serial 
section stained for SDH, COX and immunolabelled for Tom20. Scale bar: 50 µm. 
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Figure 17. Histochemical stainings on semimembranosus muscle from control Dutch 
improved Red&White (a-c), Piedmontese healthy animals (d-f, g-i) and affected Dutch 
improved Red&White calf (j-l). Transverse serial sections were stained for COX (a, d, g,j) 
and for mATPase at pH 4.6 (b, e, h, k) or pH 10.2 (c, f, i,l). In the figure the fibre types are 
indicated (1=type 1; 2A=type 2A; 2*=type 2X). The arrows in (g-i) indicate type 2C fibres. 
Scale bar: 100 µm. 
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3.3.Biochemical characterization of Congenital Pseuodomyotonia in Romagnola and 
Dutch improved Red&White calves 
In parallel with the histopathological investigation, biochemical characterization of the 
disease was performed in order to evaluate the effects of PMT on muscle proteomic 
profile in Romagnola cattle breed and in the Dutch improved Red&White crossbred 
case. 
 
3.3.1.Muscle proteomic profile of Congenital Pseudomyotonia in Romagnola and Dutch 
improved Red&White calves 
Crude microsomal fractions enriched in content of SR membranes were obtained 
through differential ultra-centrifugations from semimembranosus muscle biopsies of 
Romagnola and Dutch improved Red&White pathological and healthy subjects. The 
subfractions obtained by differential centrifugations of muscle homogenates prepared in 
a low-ionic strength medium (Sacchetto et al., 2005; Sacchetto et al., 2009) were a 
soluble surnatant (Sp), a myofibrillar pellet (MP) and total membranes (TM). In order to 
control the final content, all the fractions were saved during the separation procedure 
and store for further investigations. Indeed, all the fractions collected were loaded onto 
a gel and the protein profile were analysed after staining with EZblue Gel Staining 
Reagent or cationic dye Stains-All (Figure 18a and 19a). Results clearly confirmed that 
Sp fraction contained soluble proteins similarly in all the samples. The MP fraction 
showed a large band on top of the gel that corresponded to myosin filaments. This band 
was present in traces in the other fraction suggesting an efficient first purification step 
in the differential centrifugation process. Therefore, from the total muscle it was 
possible to obtain a fraction (TM) purified from the high content of contractile and 
soluble proteins. This fraction exclusively displayed a protein band of about 63 kDa 
corresponding to calsequestrin 1 (CS1), an established marker of junctional SR, that 
selectively stained blue with Stains-All (Figure 19a) (Sacchetto et al., 1999). Another 
intense protein band at about 110 kDa was present only in TM fractions, the 
immunoblot subsequently performed on these fractions revealed that this protein 
corresponded to SERCA1. In conclusion, these observations provided evidence that the 
TM fraction was constituted mostly of SR membranes and that was almost free of 
muscle structural proteins. 
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The sole TM microsomal fractions of all the animals analysed here were probed with 
specific antibodies against SERCA1a and SERCA2. In parallel, immunoblotting 
analyses were performed using antibodies against a representative protein of junctional 
SR (RyR) and a protein of non-junctional SR (SL and GP53) SR. The immunoblots 
showed a decrease in the amount of SERCA1 in Romagnola affected subjects (Figure 
18b) and in the Dutch improved Red&White case (Figure 19b). On the contrary, no 
differences were observed in content of junctional or non-junctional proteins suggesting 
that only SERCA1 protein was selectively affected by the mutation. In addition, 
SERCA2 did not show any notable variation in content excluding its involvement in a 
compensatory response to the decrease of SERCA1 neither in Romagnola nor in Dutch 
improved Red&White affected animals. 
The Dutch improved Red&White affected calf displayed a more severe clinical 
condition than Romagnola calves although not so severe to become life threatening as it 
was in Belgian Blue CMD1-affected calves. This intermediate situation prompted to 
focus the attention on possible compensatory mechanisms put to use by the Dutch 
improved Red&White PMT subject. Excluded the augmentation of SERCA2 
expression, TM fractions of Dutch improved Red&White animals were probed with an 
antibody against PMCA, another important ion pump involved in Ca
2+
 homeosatasis. 
The immunoblot displayed an increased PMCA band density in the affected samples 
when compared with the controls (Figure 20a) suggesting a compensatory increase of 
this membrane pump. Furthermore, in order to integrate and reinforce the histological 
findings, muscle total protein extracts obtained from Dutch improved Red&White 
subjects were used to evaluate mitochondria content using an antibody against a 
structural protein of the cellular organelle (Tom20). The immunoblots revealed that the 
samples from the PMT-affect Dutch improved Red&White showed a more intense band 
of Tom20 when compared to the healthy controls (Figure 20b). 
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Figure 18. Protein profile of muscle subfractions and immunodetection of SERCA1 and 
membrane protein markers in crude microsomal fractions from Romagnola controls and 
pathological animals. (a) Representative muscle subfractions from a Romagnola control 
sample: Sp=soluble surnatant, MP=myofibrillar pellet,TM=total membranes, CS1=cal-
sequestrina 1. (b) An equal quantity of protein from TM fractions from controls (CTRLs) 
and Romagnola PMT affected calves (PMT-RMG) was separated by SDS-PAGE and 
subjected to immunoblot analysis with antibodies specific to SERCA1, calcium release 
channel/ryanodine receptor (RyR1), sarcalumenin (SL) and 53 kDa glycoprotein (GP53) 
and SERCA2, as indicated. Only the pathological samples show lower intense bands 
selectively for SERCA1. 
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Figure 19. Protein profile of membrane isolated from control and pathological muscle and 
immunodetection of SERCA1 and membrane protein markers. (a) Crude microsomal 
fractions (50 µg/lane) from semimembranosus muscle obtained from controls (CTRLs) and 
PMT-affected Dutch improved Red&White calf (PMT-VRB), were resolved using 5–10% 
gradient gel and stained with Stains-All. This stain identify Ca
2+
 binding protein 
calsequestrin (CS1) as a dark blue band of about 63kDa in contrast with all the other 
proteins that stain purple. (b) An equal quantity of protein from crude microsomal 
fractions from controls (CTRLs) and PMT affected calf (PMT-VRB), was separated by 
SDS-PAGE and subjected to immunoblot analysis with antibodies specific to SERCA1, 
calcium release channel/ryanodine receptor (RyR1), sarcalumenin (SL) and 53 kDa 
glycoprotein (GP53) and SERCA2, as indicated. 
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Figure 20. Specific immunoblot analyses on crude microsomal fractions (a) and total 
protein extracts (b) from controls and PMT-affected Dutch improved Red&White calf. (a) 
Total membrane fractions from controls (CTRLs) and affected (PMT-VRB) calves were 
separated by SDS-PAGE and then probed with antibody against plasma membrane Ca
2+
-
ATPase. (b) Bundles of fibres from muscle biopsies from control and PMT-VRB subjects 
were homogenized and equal quantity of protein was separated by SDS-PAGE. 
Immunoblot analysis with antibodies specific to Tom20 shows a more intense band in the 
pathological sample. Lower panel in (b) is Ponceau Red staining of muscle total lysates, 
used as loading control. 
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3.3.2.Ca
2+
ATPase activity assay and SERCA1 mRNA expression in Romagnola and 
Dutch improved Red&White calves 
To complete the biochemical investigation, Ca
2+
ATPase activity assay was performed 
on SR microsomal fractions obtained from PMT-affected and control animals. In all the 
pathological cases the Ca
2+
 dependence of the SERCA pump activity was considerably 
lower in the SR membranes fractions from pathological muscle comparing to the ones 
from healthy controls. Figure 21 shows the results of the Ca
2+
ATase activity assay 
performed on samples of Dutch improved Red&White and Romagnola calves 
[Grunberg, 2010; Murgiano, 2012]. These results were in full agreement with the data 
recorded for Chianina affected animals (Sacchetto et al., 2009). Consequently, like in 
Chianina, also in Dutch improved Red&White and Romagnola cases, SERCA1a 
showed a lower activity that is correlated to a decrease in the content of the protein. 
Finally, in order to investigate the possibility that the reduced content of SERCA1 
displayed histologically and biochemically might be due to a reduced ATP2A1 
transcriptional activity, Real Time RT-PCR experiments were performed on Dutch 
improved Red&White and Romagnola subjects. The attention were focussed on the 
homozygous animals with the aim to enlighten whether the mutation (c.1675 C>T, 
Arg559Cys) of the Dutch improved Red&White and the double point mutation (c.[632 
G>T; 857 G>T], Gly211Val Gly286Val) of the Romagnola might affect the 
transcriptional activity of the gene. The analyses showed that SERCA1 mRNA 
expression levels in pathological samples were comparable to those of controls (Figure 
22). Also the Romagnola in compound heterozygosis displayed a normal mRNA 
expression confirming that the two mutation had effects on the protein but not on the 
mRNA levels in both homozygosis and heterozygosis. 
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Figure 21: Ca
2+
-ATPase activity in (a) control (CTRLs) and PMT affected Dutch 
improved Red&White calf (VRB) and (b) control (CTRL) and PMT cases of Romagnola 
breed (RMG). The Ca
2+
-ATPase activity was determined by a spectrophotometric enzyme-
coupled assay at optimum pCa (pCa 5) in the presence of ionophore A23187. Values were 
obtained from different preparations of microsomes obtained from the same muscle 
specimens. Data are expressed as percent of control value, considered 100%, and are the 
mean ± SD of several independent experiments. 
 
 
Figure 22: Expression levels of SERCA1 mRNA in a control (CTRL), a Romagnola case 
(RMG) and the PMT affected Dutch improved Red&White calf (VRB). SERCA1 mRNA 
levels were quantified by Real Time RT-PCR. Data are reported as the relative expression 
on control value. Data were obtained from different mRNA extractions from the same 
muscle specimens. 
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4.DISCUSSION and CONCLUSIONS 
 
 
 
The main goal of my PhD was to complete and deepen the knowledge on the 
histopathological and biochemical characteristics of Bovine Congenital Pseudo- 
myotonia (PMT). Chianina PMT-affected cattle has been proposed and accepted as 
truly counterpart of human Brody disease due to the strong similarities in clinical and 
histological manifestations along with the mutation at ATP2A1 gene encoding for 
SERCA1a. Brody disease is usually transmitted as an autosomal recessive trait but a 
few families line showed an autosomal dominant inheritance without mutation at 
ATP2A1 gene. Despite this latter situation, several different mutations (deletions and 
point mutation) in ATP2A1 have been described in human patients indicating the 
genetic heterogeneity of Brody disease (Vattemi et al., 2010; Voermans et al., 2012). 
Chianina cattle displayed only a single point mutation, therefore when a PMT case was 
diagnosed in a Dutch improved Red&White crossbred calf that carried another point 
mutation in ATP2A1 gene, the idea of bovine as animal model was reinforced. This 
definition was further supported by the diagnosis of PMT in Romagnola cattle with the 
location of a novel double mutation and a compound heterozygosis of this double 
mutation and the one described in Chianina. Consequently, PMT became an inherited 
muscular dysfunction characterized by genetic heterogeneity like Brody disease. This 
project started from this concept and developed a series of experiments to evaluate 
whether the different genetic background has similar phenotype and/or leads to various 
responses to the alteration. 
As previously mentioned, PMT cases have been diagnosed for the first time in Italian 
Chianina cattle breed that became the reference for all the following diagnoses. The 
starting point of my research was the morphological and biochemical profile of PMT-
affected Chianina subjects. Indeed, the first hypothesis I worked on prompted me to 
perform various analyses to verify whether PMT phenotype of Italian Romagnola cattle 
breed was the same described in Italian Chianina breed in spite of the different genetic 
background. 
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The clinical presentation of Romagnola calves was closely similar to Chianina affected 
animals. The animals were bright and alert, well-developed with no alteration in growth. 
The sole pathological symptom was the increased muscular tone exercise-induced, 
although the animal did not show any sign of pain during and after the attacks and did 
not lose consciousness. Altogether, these data suggests that, leaving the animal quite 
without forcing it to move fast, PMT affected subjects could have a life comparable 
with a normal animal. Consequently, PMT is not considered a life-threatening disease, 
therefore an attention in terms on management of PMT subjects could permit to reach a 
satisfying weight for slaughtering without particular difficulties. 
As a general consideration, the histopathological analyses performed on affected muscle 
found no dramatic alterations in fibres morphology. H&E staining showed some fibres 
degenerated or with degenerative changes in all the pathological samples, although 
these fibres were not extremely frequent and they were always accompanied with 
regenerative phenomenon. Interestingly, a Romagnola case showed a more severe 
histopathological picture characterized by frequent degenerated fibres and an 
acute/intense macrophages infiltration. All together these observations suggest that the 
muscular tissue is able to handle the mutation without suffering large damages or fibres 
loss, in addition the tissue maintains and actives the regenerative response. The 
difference in severity of histopathological alterations might depend on the animal 
condition when the biopsy was collected. Indeed, it could be possible that the 
Romagnola subject with more severe histopathological signs was subjected to the 
biopsy sampling after a cramp attack not observed by the operators or a particular 
intense activity independently performed by the animal. Furthermore, it should be noted 
that the Romagnola animals were all young calves basically more active (due to playing 
and scouting aptitudes) than an adult. Thus, these considerations could explain the 
alterations grading found in the samples analysed in this study, in agreement with the 
work by Sacchetto et al. (2009) in which the histopathological findings of Chianina 
affected animals undergone exercise protocols were more severe than affected subject 
maintained at rest (Sacchetto et al., 2009). Combined COX-SDH staining protocol 
displayed no alteration in oxidative metabolism showing an expression of both the 
oxidative enzymes in the same specific fibre population. At the same way, PAS stain 
did not show any alteration in glycogen content or distribution. In accordance with the 
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findings in Chianina cattle breed, the disease seems to do not cause any alteration in 
metabolism in Romagnola cases, indeed all fibres that expressed COX, expressed also 
SDH and the glycogen was normally associated to SR membranes. 
The biochemical analyses performed on Romagnola animals, both pathological and 
healthy, revealed that PMT-affected animals had lower Ca
2+
-ATPase activity than the 
controls and that this decrease was closely correlated to lower quantity of SERCA1 
demonstrated through immunoblotting and immunofluorescence. On the contrary, no 
alteration in ATP2A1 gene expression was reported. These data indicate that the protein 
is correctly encoded by the gene although, due to the substitution in the sequence, it 
might assume an incorrect folded conformation that makes SERCA1 mutant more 
susceptible to the protein quality control systems of the fibres, as for SERCA1 mutant in 
Chianina cattle (Bianchini et al., 2014). Consequently, because no gene over-expression 
is activated, the final result is a reduction in SERCA1 content in the fibres. Interestingly 
the other proteins included in the immunostaining assays did not show any alteration in 
expression. Indeed, nor proteins of junctional SR (RyR) nor proteins of non-junctional 
SR (SL-GP53) displayed decrease in quantity. It has been proposed that an ectopic 
expression of other SERCA isoforms could act as a compensatory mechanism 
(Odermatt et al., 2000) in affected fibres, although no differences were reported in 
SERCA2 expression between pathological and control samples of Romagnola. 
Altogether, Bovine Congenital Pseudomyotonia in Romagnola seems to show 
histopathological alteration strongly similar to Chianina affected animals. In addition, 
pathological Romagnola calves display the same biochemical characteristics described 
in Chianina with the sole decrease in SERCA1 content. 
All the analyses performed on Romagnola animals allowed to obtain a detailed picture 
of the PMT in these breed and proved the first working hypothesis of my PhD research 
project providing morphological and biochemical evidences along with the clinical 
picture of the general similarity between PMT phenotype in Chianina and the signs 
displayed by the Romagnola affected animals. Moreover, the clinical, histological and 
preliminary biochemical data referred to the Dutch improved Red&White case were 
confirmed and integrate with deep analyses here. Consequently, this study afforded to 
define a complete general histopathological and biochemical case of PMT which 
previously has been described referring to only one breed. 
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In addition, a reported collateral finding integrated and enriched the general picture of 
PMT. An intriguing observation was the evidence of co-expression patterns within 
SERCA1, SERCA2 and PLB in both Romagnola and Dutch improved Red&White 
affected animals. Indeed, pathological animals revealed some fibres expressing 
SERCA1 and SERCA2 and some fibres co-expressing SERCA1 and PLB. These kind 
of fibres were never described before nor in Chianina affected animals nor in healthy 
controls where the three proteins showed the typical mutually exclusive expression 
manner. Recently, co-expression pattern has been described in physiologically normal 
human fibres (Fajardo et al., 2013). The authors of this last work explained the co-
existence of both SERCA isoforms as a possible advantageous tool in human skeletal 
muscle to increase the versatility in Ca
2+
 homeostasis handling. Moreover, they 
suggested a possible, even if non preferential, regulation of SERCA1 by PLB. At the 
same way, the observations of SERCA isoforms co-expression in PMT affected muscle 
of this study might be explained as an attempt of the fibres to handle the Ca
2+
 overload. 
However, this event was described only in pathological situation prompting to consider 
it as a possible compensatory mechanism. Independent of the latter, bovine muscle 
showed evidence of a potential muscle plasticity like in human supporting, once again, 
its use as animal model. Despite the immunohistological data on SERCA2 expression 
together with SERCA1, there were no evidence of increased SERCA2 content from 
biochemical analysis. The immunoblotting assays showed no differences between 
affected and control SERCA2 bands although it should be noted that the number of 
“hybrid” fibres might be insufficient to alter the total content. Future studies that will 
evaluate the expression pattern of these proteins in single bovine fibres might enlighten 
the preliminary report of this research. 
 
The Dutch improved Red&White case displayed a histological and biochemical picture 
similar to Chianina and Romagnola. The morphological analysis described some fibres 
in degeneration surrounded by macrophages and always associated with regeneration 
phenomena, the immunofluorescence showed a general decrease in immunoreactivity 
for SERCA1 in the pathological section and highlighted the presence of some fibre that 
co-expressed the two SERCA isoforms or SERCA1 and PLB. The biochemical profile 
was characterized by a sole reduction of SERCA1 content confirming the 
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immunohistological data, whereas the other SR markers (RyR, SL-GP53) and SERCA 2 
did not display any variation. Moreover, a curious observation was reported in the 
pathological Dutch improved Red&White sections: COX and SDH staining displayed 
an increased intensity that involved especially type 2A fibres. One interpretation for this 
stronger intensity of labelling might be an increase in oxidative enzymes activity due to 
a variation in energy demand by the affected muscle. The use of the antibody Tom20 in 
the various immuno-surveys (IHC, fluorescence and blotting) confirmed an 
augmentation in mitochondria content when compare with both healthy Dutch improved 
Red&White controls and Piedmontese purebred subjects. These latter animals were 
chosen for a complementary analysis after the increase in oxidative staining was noted 
between the affected Dutch improved Red&White and the healthy controls. Basing on 
the collateral findings of Wang et al. (2009) that reported an increased expression of 
mitochondrial genes in Piedmontese crossbred offspring (Wang et al., 2009), the intent 
of this part of the research was to roll out whether the increase number of mitochondria 
was a compensatory mechanisms of the fibres rather than a result of the genetic 
background of the Dutch improved Red&White affected calf. The involvement of 
mitochondria in Ca
2+
 uptake was one of the first compensatory mechanisms proposed 
along with the ectopic expression of other SERCA isoforms, the Na
+
/Ca
2+
 exchangers 
and the plasma membrane Ca
2+
-ATPases (Carafoli, 1987; Odermatt et al., 2000). 
The comparative assessment performed between the Dutch improved Red&White and 
the Piedmontese subjects revealed that the increased labelling for oxidative enzymes or 
the reactivity in immunostaining were noticed only in the affected Dutch improved 
Red&White sections or in the total homogenates obtained from this subject. The 
absence of any alteration regarding mitochondria in the Piedmontese sections leads to 
exclude the possible influence of the pure Piedmontese genetic line on the particular 
phenotype of the affected Dutch improved Red&White. Consequently, the increase of 
mitochondria in the crossbred calf might be a compensatory mechanism put to use by 
the affected muscular fibres attempting to solve the Ca
2+
 overload. It is interesting to 
note that the fibres mainly involved in the adaptive changes were type 2 fibres (fast-
twitch, glycolytic) that were the population affected by the SERCA1 mutation. Among 
these, type 2A fibres seemed to respond with hypertrophy whereas type 2X fibres did 
not show volume changes but they responded with a clear increase in mitochondria 
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content. These findings point out the high plasticity potential of muscle tissue which is 
able to adapt and to shift its classical characteristics in order to respond to pathological 
situations. In this particular case, affected muscle of Dutch improved Red&White 
crossbred subject responded to the increase of free Ca
2+
 levels in the cytosol increasing 
the number of mitochondria in fast-twitch fibres population that was selectively affected 
by the mutation. Indeed, mutation in ATP2A1 gene leads to alteration in SERCA1a 
which is expressed primarily in fast-twitch fibres. Taken together, these observations 
might explain the entire picture in which affected muscle respond to the decrease of 
SERCA1a (in quantity and activity) through the activation of a compensatory 
mechanism that in this case involved the Ca
2+
 buffer capacity of mitochondria. The 
phenotypic effects of this adaptive change are the hypertrophy of type 2A (fast-
oxidative) fibres and the increased mitochondria content in type 2X (fast-glycolitic) 
fibres. Besides, another possible compensatory mechanism was described in Dutch 
improved Red&White affected calf. Immunoblot using antibody against PMCA 
displayed an increased presence of this sarcolemma ATPase pump suggesting that a 
further (or primary) response to the Ca
2+
 increase in the cytosol was put to use by the 
muscle fibre. 
The point mutation that underlied PMT in the Dutch improved Red&White crossbred 
calf was identified by my group in a previous case report (Grünberg et al., 2010). The 
transitional mutation in ATP2A1 gene leads to a substitution of an arginine with a 
cystein in position 559 of SERCA1a amino acids sequence. The mutation identified in 
the Dutch improved Red&White case was identical to a mutation reported in Belgian 
Blue cattle breed which was considered the aetiological cause of a disease named 
Congenital Muscular Distonia 1 (CMD1) (Charlier et al., 2008). After this case report, 
the two distinct pathological conditions were referred to the same congenital condition 
with a different phenotype expression. Indeed, CMD1-affected animals suffered from 
exercise-induced muscle spasms along with impaired swallowing, decreased growth 
rates and death within few weeks of age caused by respiratory insufficiency. The Dutch 
improved Red&White crossbred case showed no such severe symptoms resembling 
PMT clinical features in Chianina. It survived several months, growing normally with 
no changes in the clinical presentation. Its sudden death was attributed to a cervical 
trauma caused by longer and excessive muscle contraction (Grünberg et al., 2010). The 
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compensatory mechanisms described here might be the reason why the Dutch improved 
Red&White affected calf did not die after few weeks of ages like the Belgian Blue 
calves despite the same deleterious mutation. 
My research provided histochemical and biochemical evidences to support the 
hypothesis of the mitochondria involvement in the Ca
2+
 homeostasis (Yi et al., 2011) 
during the pathological condition caused by PMT mutation. In addition, also PMCA 
seems to be recruited in the attempt to decrease the lasting high [Ca
2+
]c (Odermatt et al., 
2000). The substantial difference between the two mechanism is that PMCA pumps the 
ions out of the fibre and thus the Ca
2+
 pool decreases with the consequent effects on the 
muscle functionality. At the contrary mitochondrial mechanism preserves the Ca
2+
 pool 
inside (even if not in the physiological compartment) the fibre with the possibility to 
release it later. Therefore, this latter response seems more effective in maintaining a 
functional muscle although the Ca
2+
 load in mitochondria could initiate other cellular 
mechanisms including apoptosis. 
Overall, the Dutch improved Red&White crossbred affected calf was the first case in 
which compensatory mechanisms has been described. Indeed, my project provided the 
objective evidences of the possible activation of two different although complementary 
adaptive response of the muscle tissue to the Ca
2+
 overload in the cytosol consequent to 
SERCA1 failure. Despite the fact that the pathological Dutch improved Red&White 
crossbred was a single isolated case in that breed line, it was an intriguing and clear 
example of possible compensatory reactions. Therefore the reported data contributed to 
enlighten the pathological response to PMT mutation and provided an approaching 
platform for further investigations. 
 
A further characteristic of PMT, described first in Chianina and confirmed here in 
Romagnola and Dutch improved Red&White, was that the SERCA1a mRNA levels 
were the same in healthy and pathological animals. This suggested that ATP2A1 gene 
did not alter its transcriptional activity and correctly encoded for SERCA1a. A recent 
study by my group (Bianchini et al., 2014) provided evidence that in Chianina cattle the 
Arg164His mutation in the amino acids sequence generates an alteration in the shape of 
the protein that is recognized incorrect by the protein quality control pathway named  
ubiquitin-proteosome system (UPS). This particular situation classify Chianina cattle 
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PMT in the group of Unfolded Protein Disease (UPDs). UPDs are characterized by a 
pathological condition caused by a mutation in a protein that is not folded correctly and 
consequently is more susceptible to the action of protein quality control systems. The 
mutated protein maintains the catalytic activity but the quality control systems reduce 
its half-life leading to a reduction in content that causes the pathological manifestations. 
This could be the case for Romagnola as well as Dutch improved Red&White PMT, in 
which mutations lead to a selective reduced expression of SERCA1 protein. 
Nevertheless, in Romagnola cattle breed the aminoacids substitutions occur in the A 
domain, at the N terminus of SERCA1 protein, a region described as critical for the 
correct folding and for maintenance of the three dimensional structure of SERCA1, but 
not for the catalytic activity (Daiho et al., 1999). By contrast, in Dutch improved 
Red&White PMT the mutation replaces the amino acid at position 559 (corresponding 
to R560 in rabbit SERCA1 isoform). Functional consequences of R560 mutations have 
been extensively studied by using heterologous cell expression systems. It has been 
reported that replacement of R560 with different amino acids affects the nucleotide 
binding and phosphoryl transfer, producing a strong inhibition of Ca
2+
-ATPase activity 
(Hua et al., 2002). In conclusion only Romagnola PMT could be ascribed to UPDs 
group. Further analyses of the Ca
2+
 dependence of the Ca
2+
 ATPase activity and/or of 
the ability of the mutant to counteract cytosolic Ca
2+
 transients, will clarify the 
functional properties of SERCA1 mutant expressed in Romagnola PMT affected 
muscles. The experiments performed by our group on heterologous HEK293 cellular 
model overexpressing the Arg164His mutant of SERCA1 and muscular explants from 
affected Chianina cattle using inhibitors of the UPS, demonstrated the rescue of mutated 
SERCA1 to SR membrane which can re-establish resting cytosolic Ca
2+
 concentration. 
The data suggested a therapeutic approach against PMT. It will be interesting to 
reproduce the experiments on heterologous system using the other mutation reported in 
Romagnola in order to deepened and integrated the first study on Chianina mutation. In 
particular it will be useful to evaluate the involvement of UPS or other protein quality 
control systems in the degradation of the other mutants of SERCA1a and the efficiency 
of the inhibitors to block the degradation process. A further step might be in vivo tests 
of the molecules to afford the therapeutic use in animal as well as in human. 
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Side project 
 
 
 
 
 
 
 
Extra Cellular Matrix responses to tendon injury: 
 
A.Biochemical analysis of cartilage oligomeric matrix (COMP) 
fragmentation levels in injury-predisposed sites 
  
B.Morphological analysis of deep digital flexor tendon (DDFT)  
with naturally occurring tear-type lesion 
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1.GENERAL INTRODUCTION 
 
 
 
1.1.Tendon anatomy: cell population and collagen organization 
Tendons are anatomic structures interposed between muscles and bones transmitting the 
force created in the muscle to bone, and, in this way, making joint movement possible. 
Basically, each muscle has two tendons, proximal and distal. The point of union with a 
muscle is called myotendinous junction (MTJ), and the point of union with a bone 
osteotendinous junction (OTJ) (Kannus, 2000). 
When healthy, tendons appear brilliant white and they consist of a dense fibrous 
extracellular matrix (ECM) with a high water content. This matrix is synthetized and 
maintained by a small population of tenoblasts and tenocytes (Sharma and Maffulli, 
2006; C T Thorpe et al., 2010). 
 
Cell population: The cellular elements of the tendon consist of tenoblasts and tenocytes 
for about 90–95% on the total cell population. The other 5-10% includes: i) 
chondrocytes located at the pressure and insertion sites, ii) synovial cells of the tendon 
sheath, and iii) vascular cells (endothelial and smooth muscle cells). Inflammatory cells, 
macrophages and myofibroblasts are observed within the tendon tissue in pathological 
conditions (Józsa and Kannus, 1997; Kannus, 2000). 
Tenoblasts and tenocytes are fibroblastic cells responsible for synthesis and turnover of 
the matrix. They are arranged in parallel rows between collagen fibril bundles within 
fascicles, where most lack direct contact with the vasculature located in the endotenon. 
The tenocytes extend long cytoplasmic processes within and between rows and are 
linked into complex three-dimensional networks by gap junctions and actin-associated 
adherens junctions that facilitate coordinated responses to mechanical loading. Gap 
junctional intercellular communication may also facilitate transfer of nutrients between 
cells within the avascular matrix (Patterson-Kane and Firth, 2009). 
In Veterinary medicine, an histological classification based on nuclear morphology do 
not describe tenoblasts in adult tissue although divides tenocytes in type 1, 2 or 3. Type 
1 tenocytes have long, thin spindle-shaped nuclei, and type 2 cells plump, cigar-shaped 
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nuclei. Type 3 cells are round with pale basophilic matrix immediately surrounding 
them (similar to chondrocytes) and are found in fibrocartilaginous regions of tendons 
(Smith and Webbon, 1996). Comparing the description above with the classification of 
tendon cells in human medicine, types 2 tenocytes are the ‘tenoblasts’ (Dowling et al., 
2000; Kannus, 2000). 
Type 2 cells (‘tenoblasts’) contain larger amounts of synthetic organelles suggesting an 
high metabolism which means high synthesis of extracellular matrix components. Type 
1 cells (‘tenocytes’) still have well-developed rough endoplasmic reticulum and Golgi 
apparatus, as well as an high quantity of free ribosomes, suggesting that tenocytes are 
metabolically active cells although not at the same level as the tenoblasts. Moreover, it 
is documented that an age-related increase in the proportion of type 1 on type 2 
tenocytes along with a reduction in total cellularity and levels of cellular activity 
(Kannus, 2000; Patterson-Kane and Firth, 2009). 
All the three main pathways of energy metabolism (aerobic Krebs’ cycle, anaerobic 
glycolysis, and pentose phosphate shunt) are used by tendon cell. In young tendon, all 
the three pathways of energy production are highly active while, with increasing age, 
there is a decrease in aerobic metabolism (Krebs’ cycle and the pentose phosphate 
shunt) and the anaerobic glycolysis becomes the main metabolic pathway for the 
tenocytes. In general, the synthetic activity is high during growth and diminishes with 
age. However, the activity pattern may change drastically in many pathological 
conditions (Kannus, 2000). 
 
The characteristic low metabolic rate of adult tendon tissue is well suited for the main 
purpose of the tendon. The low metabolic rate with well-developed anaerobic energy 
production is essential if the tendon is to carry loads and remain in tension for periods 
of time without the risk of ischemia and necrosis. The drawback of this low metabolic 
rate is the slow rate of recovery after activity and of healing after injury (Kannus, 2000). 
 
Collagen organization and tendon architecture: Tendons consist of collagen and elastin 
embedded in a proteoglycan-water matrix. Collagen is mostly type I collagen and it 
represents about 65–80% of the dry mass of the tendon, whereas elastin approximately 
the 1–2%. These elements are produced by tenoblasts and tenocytes (Kannus, 2000). 
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Collagen is arranged in hierarchical levels of increasing complexity (Figure 1), 
beginning with tropocollagen, a triple-helix polypeptide chain, which unites into fibrils; 
fibrils group in fibres or subfascicle (primary bundle); a group of primary bundles forms 
a fascicle (secondary bundle); a group of secondary bundles forms a tertiary bundle and 
these shape the tendon itself (Kannus, 2000; Sharma and Maffulli, 2006). 
In general, collagen fibres are mainly oriented longitudinally, although fibres also run 
transversely and horizontally, forming spirals and plaits. Under a polarized light 
microscope, four types of fibre crossing can be demonstrated simply crossing two 
fibres, crossing of two fibres with one straight-running fibre, a plait formation with 
three fibres, and up-tying of parallel running fibres with one fibre (Józsa et al., 1984; 
Kannus, 2000). In addition, all these fibres form spirals (Kastelic et al., 1978; Rowe, 
1985; Jozsa et al., 1991). 
 
Figure 1. Representation of hierarchical architecture of tendon. Image modified from 
original in Thorpe et al. (2010). 
 
Collagen bundles are divided by a series of sheaths: paratenon, epitenon and endotenon. 
The epitenon contains vascular, lymphatic, and nerve supply to the tendon. It is a fine, 
loose connective-tissue sheath that covers the whole tendon and extends deep within it 
between the tertiary bundles as the endotenon. The endotenon is a thin reticular network 
of connective tissue which originates from the epitenon and invests each tendon fibre. 
The paratenon sorrounds superficially the epitenon, and it consists of a loose areolar 
connective tissue with type I and III collagen fibrils, some elastic fibrils, and an inner 
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lining of synovial cells. In areas subjected to increased mechanical stress, synovial 
tendon sheaths are described. They consist of an outer fibrotic sheath, and an inner 
synovial sheath which invests the tendon body and functions as an ultrafiltration 
membrane to produce synovial fluid (conferring efficient lubrication) (Sharma and 
Maffulli, 2006). 
 
1.2.Tendon biomechanics 
The basic function of the tendon is to transmit the force created by the muscle to the 
bone, and, in this way, make joint movement possible. Moreover, the tendon provides 
skeletal support, increases the efficiency of locomotion by storing and releasing energy 
and withstand high-tensile forces(Kannus, 2000; Dahlgren, 2007). 
In the resting state, the collagen fibres and fibrils of a tendon show a wavy or crimping 
configuration which appears already under the light microscope as regular bands across 
the fibre surface. Crimping is, however, a rather varying, irregular phenomenon, the 
crimp angle varying between 0° and 60° (Józsa and Kannus, 1997). This may be due to 
varying contribution of the proteoglycan cross-linking to the crimp (Kannus, 2000). 
This configuration disappears if the tendon is stretched slightly corresponding to a 
straightening of the collagen fibres. When the tensile force is released, the tendon 
resumes its normal wavy appearance. 
Below about 4% elongation, the stress–strain curve of a tendon is reproducible by a 
sequence of stretches, but as soon as this limit is exceeded the wavy form will not 
reappear and subsequent deformations will not reproduce the original curve. If an acute 
stress causes an elongation of 8% or more, the tendon is likely to rupture (Figure 2) 
(Józsa and Kannus, 1997). 
Interestingly, in vivo measurement of equine SDFT strain at the gallop ranges from 
11.5% to 16.6%, which is in close agreement with measured in vitro ultimate strains of 
12–21% (Wilson et al., 2001; Dowling and Dart, 2005). Furthermore, during the 
movement, tendons are exposed not only to longitudinal (stretch) but also to transversal 
and rotational forces. In addition, they must be prepared to withstand direct contusions 
and pressures. The internal architecture of the tendon with the typical hierarchical 
organization of collagen fibres within the ECM forms a sort of buffer medium against 
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forces of various directions and prevent damages of the structure and disconnections 
between the components (Józsa and Kannus, 1997; Kannus, 2000). 
 
Figure 2. Simplified stress–strain curve for the SDFT (from Goodship et al., 1994). 1 = toe 
region; 2 = linear deformation; 3 = yield, elongation >4% (microscopic failure); 4 = 
rupture, elongation ≥ 8% (macroscopic failure). 
 
Experimental studies demonstrate how exercise and different training protocols can 
influence tendon composition and biomechanics. More in detail, training results in 
improved tensile strength, elastic stiffness, weight and cross-sectional area of tendons. 
These effects can be explained by an increase in tenocyte activity with new synthesis of 
collagen and ECM components such as proteoglycans and COMP (Cartilage 
Oligomeric Matrix Protein) (Smith et al., 2002). Oppositely, immobilization reduces the 
water and proteoglycan content of tendons, and increases the number of reducible 
collagen cross-links resulting in tendon atrophy (Dowling and Dart, 2005; Maganaris et 
al., 2006). 
Also age influences tendon biomechanical properties and functions. Indeed, adult 
tendon tissue loses the typical high metabolism of young tendon becoming a slow 
synthesis tissue. Adult tendon shows an aging-related decrease in cellularity, cell 
activity and matrix synthesis that lead to an increase tendon stiffness, disruption of 
matrix and loss of matrix components. Interestingly, studies on SDFT in the horse show 
how these modifications affect primarily only levels that would not endanger the 
functional competence of the tissue, even if excessive exercise could exacerbate those 
alterations and lead to a clinical manifestation (Smith et al., 2002; Dowling and Dart, 
2005; Sharma and Maffulli, 2006). 
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1.3.Extracellular Matrix (ECM) of tendon 
1.3.1.Composition and roles of tendon extracellular matrix 
The extracellular tendon matrix (ECM) is composed of the collagen fibres, elastic 
fibres, the anorganic components and the ground substance. 
 
Collagen and elastic fibres: As described in paragraph “1.1.”, collagen fibres are the 
65-80% of total dry mass of tendon while elastic fibres account only for approximately 
1-2%. Nevertheless, this elastic component may contribute to the recovery of the wavy 
configuration of the collagen fibres after stretch movement (Kannus, 2000). 
 
Anorganic components: Anorganic components represent less than 0.2% of the tendon 
dry mass. Calcium is found in the highest concentrations, between 0.05-0.1% in the 
insertion sites and between 0.001-0.01% in the tensional area of a normal tendon. In 
particular, pathological conditions (calcifying tendinopathy) calcium concentrations can 
increase a 10- to 20-fold. Magnesium, manganese, cadmium, cobalt, copper, zinc, 
nickel, lithium, lead, fluoride, phosphor, and silicon are other components detected in 
the tendon matrix although their role is not well known (Kannus, 2000). 
 
Ground substance: The tendinous ground substance consists of proteoglycans (PGs), 
glycosaminoglycans (GAGs), structural glycoproteins, and other small molecules. PGs 
and GAGs have considerable water-binding capacity which make the ground substance 
a perfect hydrophilic gel suited to improve the biomechanical tendon properties. 
Proteoglycans are large, negatively-charged hydrophilic molecules composed of a 
protein core in which one or more glycosaminoglycans are covalently attached. They 
are mostly entrapped within and between collagen fibrils and fibres forming a stiff net 
that provide to the structure a high capacity to resist compressive and tensile forces. 
Proteoglycans also facilitate rapid diffusion of water soluble molecules and migration of 
cells. GAG distribution is different in the different sites: it is approximately 0.2% of the 
dry mass in tensional zones while it is up to 3.5-5.0% in the insertion areas. Within 
GAGs, hyaluronic acid constitutes about 6% of the total. 
Glycoproteins are macromolecules that consist of a large protein fraction and a small 
glycidic component. Fibronectin, thrombospondins (1-5), tenascin-C, undulin and 
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laminin are the most common non-collagenous proteins identified in tendon tissue 
(Kannus, 2000). Studies on equine tendon have shown that the non-collagenous 
extracellular matrix is not homogeneous along the length of digital flexor tendons, 
reflecting the different biomechanical environments experienced in different regions of 
the tendon (Smith et al., 1997). 
Despite proteoglycans and glycoproteins are the most abundant non-collagenous 
proteins of tendon, their functions have not been fully determined. Due to their 
conformation and presence of side-chain, it has been proposed that proteoglycans 
regulate fibrillogenesis and organize the matrix. In addition, the stiff net that they form 
between the collagen fibrils increases the resistance to tensile loading and assists in the 
transfer of strain forces between the fibrils (Scott, 2003; Screen et al., 2005). 
The most abundant glycoprotein identified in physiologically normal tendon is 
thrombospondin-5, better known as Collagen Oligomeric Matrix Protein (COMP) 
(Smith et al., 2002; Thorpe et al., 2010). 
 
1.3.2.Collagen Oligomeric Matrix Protein (COMP) 
COMP is a 524 kDa acidic protein. It is constituted of five-armed protein joined by a 
central cylindrical structure which relate it to thrombospondins family (Figure 3). It has 
been found in many mechanically loaded tissues such as cartilage, tendon, ligament, 
meniscus, and intervertebral disc. 
 
Figure 3. Simplify cartoon of the COMP protein structure (Smith et al., 2002). 
 
The precise function is unknown, although it has been found that COMP is able to bind 
fibrillar collagen stabilizing the collagen fibre network. In addition, it may be involved 
in cell activity and interactions catalyzing fibrillogenesis and playing a key role in 
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assembly, organization and maintenance of the ECM (Smith and Webbon, 1996; Thorpe 
et al., 2010; Dakin et al., 2014; Smith et al., 2014). 
In human medicine, COMP synovial fluid concentrations have prognostic value in 
rheumatoid arthritis and osteoarthritis. The same was demonstrated in equine medicine 
where COMP were proposed as useful biomarkers of different tendon disease. 
Moreover, COMP fragmentation was analysed in detail to develop an assay specific to 
injury stage for tendon disease (Dakin et al., 2014; Smith et al., 2014). Proteomic 
analysis of tendon tissue provided interesting data on tendon protein profile in 
physiological and pathological situations considering also disease stage-factor and age-
factor influences. Dakin et al. (2014) identified a great number of proteins uniquely 
present in sub-acute stage disease. Within these, a novel COMP peptide was identified 
both in vivo and in vitro analysis and it was proposed as specific marker for injury 
stage. The authors speculated on the possibility to use this COMP fragment, along with 
the combination of other specific fragments, to develop a platform of antibodies to 
identify specific stage of tendon injury (Dakin et al., 2014). Peffers et al.(2014) 
compared the proteomic profiles of young and old horses demonstrating a quantitative 
decrease of several proteins that play a role in ECM organization in old animals. 
Moreover, they described an altered protein profile in injured tendon with an increase in 
proteins and greater degree of fragments (Peffers et al., 2014). Taken together, these last 
works increased the knowledge on the molecular aspects of tendon degeneration and the 
influence of factors such as disease and age on the functionality and healing process of 
the tissue. In addition, they identified specific products of protein fragmentation 
(peptides) that could be used as biomarkers of tendon injury. 
 
1.3.3.Turn-over of ECM 
In healthy tendon, the matrix is maintained and repaired by a small resident population 
of tenoblasts/tenocytes. These cells maintain a homeostatic balance between the 
breakdown of damaged ECM and the production of replacement proteins (Dahlgren, 
2007). In healthy connective tissue, the turnover for proteoglycans seems relatively 
rapid and varies between 2 and 10 days (Kannus, 2000). 
Tenocytes are able to remodel the matrix by synthesizing matrix molecules, including 
collagen and proteoglycans, and enzymes responsible for degradation, including matrix 
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metalloproteinases (MMPs). Specific MMPs are able to degrade different components 
of the matrix, but their activity is tightly regulated by a number of mechanisms. These 
include the presence of tissue inhibitors of metalloproteinases (TIMPs), whether the 
molecules are in their active form and their location within the matrix (Thorpe et al., 
2010; Castagna et al., 2013). 
Aging and excessive exercise, likewise stress deprivation (immobilization) affect the 
synthesis-degradation fine balance of ECM components. The effect of aging is 
primarily the decrease in cellularity which lead to a modification in cell-cell interaction 
and matrix production. These modifications, associating with overstimulation of the 
tissue, lead to cumulative microdamage within the tendon till a mechanical injury 
clinically apparent (Dahlgren, 2007). At the same way, lack of load input derived from 
physical immobilization or from damaged at the collagen network leads to 
overactivation of catabolic matrix proteases (MMPs) and increased apoptosis 
(programmed cell death) (Castagna et al., 2013). 
The remodelling rate of collagen is considered negligible due to its half-life of 198 
years (Thorpe et al., 2010), at the contrary the non-collagenous proteins of ECM appear 
to have a more rapid turn-over and therefore are likely the component more influenced 
by the alterations resulting from injury or aging (Smith et al., 2002; Jarvinen et al., 
2003). 
 
1.4.Tendon injury and healing 
Typical responses of tendons to repetitive excessive load are inflammation of tendon 
sheaths, tissue degeneration or a combination of both. Different source of stress induces 
different response which should lead to a repairing mechanism in order to avoid 
weakening or rupture of the tendinous structure. 
Hypoxia, ischaemic damage, oxidative stress (oxygen free radicals), hyperthermia, 
impaired apoptosis, inflammatory mediators, fluoroquinolones, and matrix 
metalloproteinase overactivation have been proposed as degenerative mechanisms in 
tendon (Goodship et al., 1994; Sharma and Maffulli, 2006). 
The aetiology of tendon injury is not completely understood, although it is clear the 
implication of degenerative mechanisms. Tendon degeneration may lead to changes in 
ECM composition and collagen network, alteration of cell-cell and cell-ECM 
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interaction. The final result is altered biomechanics with reduced tensile strength and a 
consequent predisposition to rupture (Kannus, 2000). Moreover, the damaged tendinous 
network is unable to properly transmit mechanical load information to resident 
tenocytes. This lack in loading input generates a series of cell responses that lead to 
overactivation of MMPs and increased apoptosis (Thorpe et al., 2010). 
 
Healing process: Tendon healing occurs in three overlapping stages: 1) acute 
inflammatory phase, 2) proliferation phase, 3) re-modelling phase. 
The healing process in tendon is slow according to the typical characteristics of the 
tissue (low cellularity, low blood supply). This make critical the choice of a correct 
rehabilitation protocol that should be thought to accommodate the healing delayed and 
to match the phase of process. 
1) The acute inflammatory phase begins immediately after injury and lasts 1 to 2 weeks. 
Heat, pain, and swelling are the characteristic clinically signs of this phase. In the first 
24 hours, monocytes and macrophages massively infiltrate the tissue and help to remove 
the damaged ECM via phagocytosis. Furthermore, they release vasoactive and 
chemotactic factors that stimulate cell (tenoblasts/tenocytes) proliferation, initiate 
angiogenesis, and recruit other inflammatory and non-inflammatory cells for the 
progression of healing process. In particular tenocytes gradually migrate to the site of 
injury and initiated  type III collagen synthesis (Sharma and Maffulli, 2006). 
2) Few days after injury, the proliferation phase begins and can last for several weeks to 
months. Vascular and cellular elements accumulate in the endotenon conferring the 
characteristic hypercellular aspect of the damaged region. This cell population has 
progenitor cells features: they are large, plump, with round to oval nuclei suggesting an 
high metabolism in preparation to increase collagen and other ECM components 
production. Collagen type III reaches its peak of synthesis in this stage of healing 
process providing a first, immature fibrous network in which other ECM elements are 
randomly scattered. This temporary structure can support tensile strength in the early 
stages of the healing process. The type III collagen fibrils are progressively replaced 
with larger and stronger collagen type I fibrils and new ECM is synthetized in the injury 
site (Sharma and Maffulli, 2006). 
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3) The re-modelling phase of tendon healing is the critical stage to regain the 
biomechanical properties of a functional tendon. Re-modelling begins approximately 6 
weeks after injury and can last for 6 to 12 months or longer. Tenocytes and collagen 
fibres become aligned in parallel fashion along lines of tension; synthesis of type I 
collagen increases and gradual change of fibrous tissue to scar-like tendon tissue occurs. 
This means that, despite the ongoing re-modelling, the healed tendon still lacks the 
biomechanical properties of the native tissue (Sharma and Maffulli, 2006). 
Re-modelling is also involved in the physiological response of tendon to particular 
prolonged stress (endurance training). The tissue is shaped to adapt the mechanical 
repetitive loads, and prevents the tendons from incurring injuries (Sharma and Maffulli, 
2006; Patruno and Martinello, 2014). 
Recent research on equine tendon has demonstrated how the early stage of tendon injury 
(inflammatory phase) is characterized by the presence of M1 polarised macrophages 
which elaborate pro-inflammatory mediators and stimulate all the cell-response 
described above. The same study described the presence of M2 polarised macrophages 
during the late proliferation and re-modelling phase (>3 months after injury). M2 
macrophages produce immunosuppressive cytokines and have clearly an anti-
inflammatory activity. Their predominant presence during the late stages of healing 
process may have the function to protect this susceptible region from repeated injury by 
dampening pro-inflammatory activities. An interesting therapeutic outcome from these 
findings suggests a more targeted approach to tendon injuries with a possible 
modulation of the inflammation according to the disease stage (Dakin et al., 2012; 
Dakin et al., 2014; Patruno and Martinello, 2014). 
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1.5.Frequent tendon injuries in horse 
All the epidemiology studies of tendon injuries in horse population have limited 
transferability to global scale due to national differences in horse demographics, racing 
and training practices, and different disciplines in which the animals are involved 
(Clegg, 2012). 
Nevertheless, tendon injury is considered one of the most common form of 
musculoskeletal injuries that occur to horses competing in all disciplines. In racehorses 
competing in UK National Hunt and flat races, 46% of total injuries diagnosed to the 
musculoskeletal system involved tendons or ligaments (Williams et al., 2001). Whereas, 
in horses used in hurdle and steeplechase races, tendon or ligament strain accounts for 
53% of musculoskeletal injuries (Pinchbeck et al., 2004). 
It is well documented that some tendons are more prone to injury than others, indeed 
specific strain-induced injuries are associated with specific tendons (Smith et al., 2002). 
Forelimb tendons are the most frequently injured tendons in horses (97-99%), with the 
superficial digital flexor tendon (SDFT) being injured in 75-93% of cases and the 
remaining injuries occurring to the suspensory ligament (SL) (Kasashima et al., 2004; 
Smith and Wright, 2006; Lam et al., 2007), while the deep digital flexor tendon (DDFT) 
and common digital extensor tendon (CDET) are considered rarely affected even if they 
have been increasingly diagnosed thanks to the advent of magnetic resonance imaging 
(Mair and Kinns, 2005; Murray et al., 2006; Thorpe et al., 2010; Cillán-García et al., 
2013) in cases of palmar foot pain. 
As general observation, it has been reported that in training horses tendon injury 
accounts for 43% of injuries that can occur. Within these, 33% of injuries involve the 
SDFT, 31% the SL and 17% the DDFT. Jumper horses have a high risk of injury to the 
forelimb SDFT and DDFT, whereas dressage horses have a high risk of injury to the 
hind limb SL (Thorpe et al., 2010). 
Moreover, the risk of tendon injury increases with increasing age (Ely et al., 2004; 
Kasashima et al., 2004; Perkins et al., 2005; Ely et al., 2009; Goodrich, 2011), and the 
healing process is slow and can be influenced by the management and training protocols 
applied on the horse after injury. This means that re-injury of the tendon could be a 
frequent result (up to 80%) of a wrong planning of the recovery and rehabilitation 
period (Dowling et al., 2000). In other words, micro-trauma and ageing may 
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synergistically predispose to severe tendon pathology in an adult horse (Beck et al., 
2011; Goodrich, 2011). Recent proteomic studies provided molecular evidences to 
characterize all these observations (Dakin et al., 2014; Peffers et al., 2014). 
 
1.6.Tendon anatomical overview 
The digital flexor tendon sheath (DFTS) surrounds the superficial (SDFT) and deep 
digital flexor tendon (DDFT) palmar or plantar to the fetlock joint. The DFTS begins 4 
to 7 cm proximal to the proximal sesamoid bones and extends distally to the middle 
third of the second phalanx. The DFTS is surrounded by the palmar/plantar annular 
ligament (PAL) and the proximal and distal digital annular ligament. 
Just proximal to the proximal sesamoid bones, the SDFT encircles the DDFT. This ring 
is called the manica flexoria. The distal aspect of the MF is located underneath the PAL. 
Proximal to the MF the DDFT is attached to the DFTS by a medial and lateral band, 
called the mesotendon. On the palmar aspect of the fetlock, the SDFT is also attached 
sagittally with a mesotendon to the DFTS (Dik et al., 1995; Wilderjans et al., 2003). 
 
Figure 4. The normal anatomy of equine distal limb. In the image are indicated the 
structures mainly involved in tendinopathies (modified from Smith et al., 2002). 
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The Superficial Digital Flexor Tendon (SDFT): 
The Superficial Digital Flexor Tendon arises from its muscle at the level of the carpus 
where it also combines with the proximal accessory ligament. The tendon passes 
distally on the caudal aspect of the limb, running through the carpal canal to the 
metacarpus. The SDFT runs together with the DDFT in a synovial structure named 
carpal sheath. Just proximal to the metacarpophalangeal joint, the SDFT forms a ring-
like structure called manica flexoria which wraps around the DDFT. From the distal 
metacarpus to the level of the middle phalanx, the SDFT and DDFT run together within 
another synovial structure named digital sheath. 
At the distal end of the proximal phalanx, the SDFT divides into two branches which 
insert on the lateral and medial eminences of the middle phalanx. A small amount of 
fibres insert on the lateral aspect of the proximal phalanx (Fails and Kainer, 2011). 
 
Lesions of SDFT range from minor partial unilateral to complete bilateral rupture. 
Lesions occur most frequently in the core of the mid-metacarpal (MidM) region, but can 
involve any site from the myotendinous junction to the branches of insertion (Patterson-
Kane and Firth, 2009). 
Strain maximal values have a site-specific range that is larger in metacarpal region of 
SDFT. In other words, different regions of the tendon have different biomechanics with 
different strain properties. Reported values for tendon strain at the walk range from 
2.2% to 4.6%, the strain increased significantly from 2.5% to 3.2% with a rider while no 
significant difference was recorded in SDFT maximal strains between different shoeing. 
At the trot gait values for strain ranged from 4.15% to 10.1% at maximal weight bearing 
(Riemersma et al., 1996). At the gallop, strain values are higher and range from 11.5% 
to 16.6%. In vitro experiments demonstrated that 12-21% is the ultimate strain value 
before rupture suggesting that, at this level of exercise the SDFT works close to its 
physiological limits with a relatively narrow safety margin (Crevier et al., 1996; 
Dowling and Dart, 2005). 
 
The Deep Digital Flexor Tendon (DDFT): 
The Deep Digital Flexor Tendon arises from the three bellies of the deep flexor muscle. 
The main part  origins from the humeral belly and it fuses with the other two parts 
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(ulnar and radial) to form a common tendon just proximal to the carpus on the caudal 
aspect of the limb. The single tendon passes distally together with the SDFT through the 
carpal canal. In the mid-metacarpal region the distal accessory ligament fuses with and 
reinforces the DDFT. At the metacarpophalangeal (MCP) joint, the DDFT passes 
through the manica flexoria becoming superficial and runs over the sesamoid groove. In 
the mid-region of the proximal phalanx, the DDFT runs between the branches of the 
SDFT and over the flexor cortex of the distal sesamoid (navicular) bone to insert on the 
flexor cortex of the distal phalanx. Three annular ligaments (palmar, proximal and 
distal) support both  the superficial and deep digital flexor tendons in their distal parts 
(Fails and Kainer, 2011). 
 
Injuries of the DDFT have been diagnosed alone or in conjunction with other injuries, 
such as lesions of the navicular bone (Dyson et al., 2003; Mair and Kinns, 2005). In a 
study by Dyson and Murray (2003), DDFT involvement  was reported in 83% of 
clinical examination for foot pain, while the DDFT was considered the primary cause of 
lameness in 43% of pathological animals in another study (Dyson et al., 2003; Cillán-
García et al., 2013). An important morphological characteristic of DDFT is its 
fibrocartilaginous distal dorsal layer located just proximally to the navicular bone 
(Blunden et al., 2006). This portion of the tendon is mostly avascular, blood supply 
derived from the palmar layers, the muscle and periosteal insertion and through vessels 
that run longitudinally in septal fascia within the digital flexor tendon sheath. These 
observations have suggested that vascular compromise or alteration may predispose 
DDFT to injury (Blunden et al., 2006; Blunden et al., 2009; Beck et al., 2011). 
DDFT lesions have been classified as: core lesions, parasagittal splits, dorsal border 
lesions and insertional lesions. i) Core lesions are characterised by damage to the central 
fibres of the tendon which can measure from 5 to 135 mm in length (Blunden et al., 
2006). ii) Parasagittal splits origin within the navicular bursal portion of the tendon and 
propagate along septal lines (Blunden et al., 2006). iii) Dorsal border lesions form in the 
navicular bursal portion of the tendon, often they curl up proximally in the recess of 
navicular bursa as strained fibres of the dorsal border of the tendon. iv) Insertional 
lesions are short core lesions or parasagittal splits less located close to the insertion of 
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the DDFT on the distal phalanx. They can occur alone or in association with other 
lesions in different portions of the DDFT (Blunden et al., 2009). 
 
Tendons in the equine forelimb act mainly to position the limb correctly during 
locomotion. Some tendons have an additional function, acting as springs to store and 
release energy as they are stretched and recoiled during the stance and swing phase of 
each stride and so decrease the energetic cost of locomotion (Alexander, 1991). The 
SDFT (and SL) is the main energy storing structures in the equine forelimb, whereas 
DDFT do not contribute significantly to energy storage although its primary function 
appears to be flexion of the distal phalangeal joint during late swing (Wilson et al., 
2001; Butcher et al., 2009). 
An interesting observation is that during high speed locomotion, the DDFT stores little 
energy, but acts to stabilize the MCP joint during hyperextension. DDF muscle is more 
susceptible to fatigue cause of its high percentage fast twitch fibres composition, this 
means that, if the exercise exceeds the limit of DDF muscle resistance, the MCP joint 
will lose stability and consequently, the SDFT will undergo higher strain increasing the 
risk of fibril micro-damage (Butcher et al., 2007; C T Thorpe et al., 2010). This last 
observation underlines the close relation between the SDFT and DDFT that is a result of 
the anatomical position but also from the functional interactions. 
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1.7.Objectives 
 
This side project arose from the collaboration between Professor Marco Patruno and the 
group of Professor Roger K. Smith and Doctor Jayesh Dudhia. 
Last year of my PhD, I had the opportunity to spend three months at the Department of 
Clinical Sciences and Services of The Royal Veterinary College (University of London) 
to work with Doctor Dudhia on the extracellular matrix of tendon. 
The main objective of the research was to investigate the expression and the 
fragmentation levels of cartilage oligomeric matrix protein (COMP) in equine tendon. 
The interest for this particular protein originated from recent findings that report COMP 
as the most abundant protein in normal ECM, second only to the collagen, that showed 
an increase expression in pathological situation. Moreover, specific disease stage was 
associated to a particular fragment of COMP. This product of COMP proteolysis was 
identified in vitro and in vivo by the group of Professor Smith (Dakin et al., 2014). 
Therefore, due to the possible implication in clinical practice, several studies has been 
planned to provide further information on COMP expression and cleavage products in 
normal and pathological tendon along with the possible influence of exercise and aging. 
The research project I developed with Doctor Dudhia analysed for the first time the 
levels of COMP100 fragment and whole COMP expression in injury-predisposed and 
non-predisposed sites of normal SDFT and normal DDFT in young and old horses. 
Moreover, I performed the same analysis on SDFT in presence of injury (Project A). 
An additional morphological study was performed on DDFT affected by naturally 
occurring tear lesion. I attempted to develop an analysis on three sites of the biopsy 
(adjacent, intermediate and remote from the injury) in order to collect data on the 
alterations and their grade of severity in DDFT (Project B). The main goal of this study 
was to deepen and reinforce the scarce information on equine injured DDFT. 
The next sections will describe the two projects that were developed in collaboration 
with the group of London. Each section will have a short introduction followed by the 
detailed experimental procedures, the attained results and the preliminary considerations 
which were formulated. However, these projects are interesting pilot studies and, 
increasing the small number of analyzed samples, it will be possible to obtain important 
data to better understand the regeneration process of tendon. 
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2.PROJECT “A” 
 
 
 
Preliminary study on COMP fragmentation level in injury-predisposed sites of 
Superficial Digital Flexor Tendon (SDFT) and Deep Digital Flexor Tendon 
(DDFT) in horse. 
 
 
 
2.1.INTRODUCTION____________________________________________________ 
 
 
 
The recent studies on tendon matrix composition and its alterations have shown a 
different proteomic profile between normal and pathological tissues and between young 
and old animals (Dakin et al., 2014; Peffers et al., 2014). A large number of proteins 
showed a variation in amount and/or in fragmentation level and cleavage site. Within 
these, COMP100 fragment seems to be disease-stage specific and has been proposed as 
useful bio-marker for possible clinical purposes (Lui et al., 2011; Dakin et al., 2014). 
Therefore, the main objective of this project was to evaluate the levels of COMP 
fragmentation (fragment COMP100) focusing on specific regions of normal SDFT and 
DDFT known to be predisposed to injury. 
In the following table, it is synthetized the working hypothesis for this project: 
Hypothesis  
1 Injury-predisposed sites of normal SDFT and DDFT have greater levels of 
COMP fragmentation when compared with non-predisposed sites. 
2 Tendon injury in predisposed regions of SDFT is associated with greater 
COMP fragmentation. 
3 
The difference in COMP levels between predisposed and non-predisposed 
sites is larger in young respect to old animals, although this difference is 
minor whether injured and normal SDFTs are compared. 
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2.2.EXPERIMENTAL PROCEDURES______________________________________ 
 
 
 
2.2.1.Tendon sampling and procurement 
The animals used in this study were four horses, euthanased for reasons other than 
tendon disease. These animals were two young Saudi horses (age: 2 and 3 years, 
respectively) and two old Thoroughbred horses (age: 8 and 12 years, respectively). 
Forelimb tendons (SDFT and DDFT) were immediately recovered post-mortem from 
the four animals (n=15; 7 SDFTs and 8 DDFTs, one SDFT was excluded for technical 
reason). Tendons which had no previous history or post-mortem evidence of tendon 
injury were considered normal (n=12; 4 SDFTs and 8 DDFTs). Tendons (SDFT) with 
previous history of diagnosed injury were included in the comparative study with the 
normal tendons, one was from a young animal the other two were from the two old 
horses1 (n=3 SDFTs). 
Superficial and deep digital flexor tendons were dissected free from cadaver limbs from 
the carpus to the point of insertion. The tendons were either stored entire at -80°C until 
further dissection procedures or divided fresh into 4 cm-thick sections. Each section has 
been indicated as a “level” and numbered from 1 to 7 from proximal to distal ends. Each 
level was subdivided in 1cm-thick slices (named a, b, c and d) that were stored at -80°C 
until further analysis. The sections selected for this study were the level 4, 
corresponding to the mid-metacarpal region (MidM, predominantly under tensional 
forces) and the level 7, corresponding to the metacarpo-phalangeal region (MCP, under 
both tensional and compressive forces). The slices “a” were chosen for the biochemical 
analysis performed in this project (Figure 5). 
 
                                                          
1 The two old animals have been already used in another study performed by the group of Professor Smith 
in which the injured tendon were treated with bone marrow-derived mesenchymal stem cells (BM MSCs) 
to evaluate their effect on the healing process (Smith et al., 2013). Therefore, despite the injured tendons 
result in fact also treated, we considered them not-normal and thus we used them for our comparative 
investigation. 
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Figure 5. Schematic representation of dissection procedures of the SDFTs and DDFTs to 
obtain the 1 cm-thick slices used in this study (modified from original scheme gently 
provided by Dr. Dudhia). 
 
For the first hypothesis (normal tendon study), level 4 (injury-predisposed) and level 7 
(non-predisposed) “a” slices of normal SDFTs from three left and one right forelimbs 
were used to analyse and compare COMP fragmentation levels (n=4). Since the DDFTs 
were not injured and considered normal in all subjects, DDFT injury-predisposed and 
non-predisposed levels (level 7 and level 4, respectively) of both forelimbs were used to 
analyse and compare the COMP fragmentation levels (n=8). 
For the second hypothesis (injured tendon study), level 4 (injury-predisposed) and level 
7 (non-predisposed) “a” slices of SDFTs from three injured right forelimbs were used to 
analyse and compare COMP fragmentation levels between injured and normal (n=3). 
For the third hypothesis (young VS old), predisposed and non-predisposed levels 
between young and old normal SDFTs (n=4) and between young and old normal 
DDFTs (n=8) were compared. In addition, the COMP fragmentation levels in injured 
SDFT of young (n=1) and old (n=2) animals comparing with the contralateral normal 
tendons were analysed. 
 
Finally, a descriptive analysis on the whole COMP expression levels in the SDFT and 
DDFT (n=15) collected for this study was performed, reporting the observations per 
single subject. 
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2.2.2.Sample preparation and protein extraction 
Each slice was grossly cut and immerged into liquid nitrogen. Afterwards, the frozen 
pieces were collected  and rapidly powdered using a dismembrator. 
For each sample, a 100 mg of powder was weighed and used for protein extraction with 
4M guanidine hydrochloride. The protocol performed was as follows: 
i) the sample was incubated with 1,500 µl of extraction buffer (4M Guanidine 
Hydrochloride, EDTA, protease inhibitors cocktail) at 4°C for 48 hours on 
rotating wheel; 
ii) centrifuge at 13,000 rpm for 15-20 minutes at 4°C, surnatant was collected 
and 900 µl of precipitation buffer (cold ethanol 100%) was added, 
incubation at -80°C for 20 hours follows; 
iii) centrifuge at 13,000 rpm for 15 minutes at 4°C, the pellet was washed and 
centrifuged with precipitation buffer at least 3 times; 
iv) the pellet was lyophilized on a 37°C plate for 1 hour, then re-suspended in 
250 µl of 0.5% SDS 50mM Tris buffer (pH 6.8). 
Protein concentrations of aliquots of soluble fraction were estimated by BCA Protein 
assay kit (Thermo Scientific). 
 
2.2.3.Electrophoresis and Immunoblotting 
Tendon soluble extracts (10 µg) were reduced by addition of 0.1 M DTT 
(Dithiothreitol) and heated to 95°C for 5 minutes prior to be loaded in 8-12% Expedeon 
RunBlue gel (Expedeon) for one dimensional sodium dodecyl sulphate polyacrylamide 
gel electrophoresis (SDS-PAGE). 
Electrophoresis was followed by transfer blot onto PVDF membrane (GE Healthcare, 
Hertfordshire, UK) for immunoblot analysis. Membranes were blocked overnight in 1X 
PBS 0.05% Tween20  buffer (Sigma-Aldrich) containing 10% powdered skimmed milk. 
After washing 5 minutes in 1X PBS 0.05% Tween20 buffer, membranes were incubated 
with the primary antibody diluted in the same buffer for 90 minutes. The primary 
antibodies used in this study were anti-COMP in rabbit (Smith, 1997) and anti-α-tubulin 
in mouse (Cell Signaling Tech) as house-keeping for normalization. Both primary 
antibodies were diluted 1:1,000 in 10X PBS 0.2% Tween20. Subsequently, membranes 
were washed for 2 hours changing the buffer every 15 minutes (washed 15 minutes 8 
     Tendon - Project “A” - Experimental Procedures 
 
 105 
times) and incubated with secondary antibody diluted 1:50,000 in 10X PBS 0.05% 
Tween20 buffer for 1 hour. The secondary antibodies were HRP-linked anti-rabbit in 
swine (Dako) and HRP-linked anti-mouse in donkey (Cell Signaling Tech), 
respectively. 
Antibody positive protein bands were visualized using Enhanced ChemiLuminescence 
(ECL) Select Western Blot Detection Reagent kit (GE Healtcare) by means through 
luminol-peroxide system. 
The images were collected in a dark chamber (G.Box, SYNGENE) using GeneSnap 
software and band densities analysis was performed with AlphaEASE FC software. 
 
The obtained density values for COMP100 fragment were divided to the values of 
COMP to obtain a proportion of fragmentation on the total COMP (COMP100/COMP) 
and acquire information on fragmentation levels in predisposed and non-predisposed 
sites of SDFT and DDFT. Moreover, the density values of COMP were divided to α-
tubulin values to normalize the results (COMP/tubulin) and extract information on 
COMP expression in the analysed regions. 
 
2.2.4.Statistical analysis 
Data were expressed as ratio COMP100/COMP in the analysis of COMP fragmentation 
levels and as ratio COMP/tubulin in the evaluation of COMP expression. 
Wilcoxon signed-rank test was performed to compare COMP fragmentation levels in L4 
and L7 in normal SDFT and DDFT, and in injured SDFT; moreover, the same test was 
carried out  to compare the levels of COMP expression between L4 and L7 in normal 
SDFT, in injured SDFT and in left and right DDFT. 
All the statistical analyses were undertaken using STATISTICA 10 (StatSoft, USA) and 
Microsoft Excel 2010 (Microsoft Corporation) software. Significance level was set at 
5% (p≤0.05). 
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2.3.RESULTS__________________________________________________________ 
 
 
 
The following section describes the results obtained from the analysis of the 
densitometry values. The rough optical density (OD) data of the COMP, the fragment 
COMP100 and the α-tubulin were organized in excel table for further elaborations. 
The comparison between the L4 and L7 of SDFT and DDFT were performed using the 
ratio values calculated dividing the OD data of COMP100 to the OD data of COMP 
(COMP100/COMP) and the ratio values calculated dividing COMP data to the OD data 
of α-tubulin (COMP/tubulin). 
Table 1 collects the ratio values (COMP100/COMP) obtained for all the samples 
analysed in this study for the comparison of COMP fragmentation levels. Table 2 
contains the COMP100/COMP values referred to the samples obtained from injured 
SDFTs. Table 3 shows the ratio values (COMP/tubulin) used in the evaluation of 
COMP expression in the sites of interest. 
 
 COMP100/COMP 
Animals 
Age 
(years) 
SDFT 
(n=4) 
DDFT 
(n=8) 
L4 L7 L4 L7 
Young 1 2 0.103 0.093 0.069 0.202 
Young 2 3 0.244 0.080 0.091 0.124 
Old 1 8 0.218 0.260 0.091 0.111 
Old 2 12 0.228 0.117 0.133 0.142 
mean  0.198±0.06 0.138±0.08 0.096±0.03 0.145±0.04 
 
Table 1. Values of COMP100/COMP ratio at L4 and L7 of normal SDFT and DDFT 
referred to each animal included in the study, and the mean values for the levels taken 
singularly. 
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 COMP100/COMP  
Animals 
Age 
(years) 
SDFT inj 
(n=3) 
  
L4 L7   
Young 1 2 0.165 0.050   
Old 1 8 0.185 0.076   
Old 2 12 0.064 0.103   
mean  0.138±0.06 0.076±0.03   
 
Table 2. Values of COMP100/COMP ratio at L4 and L7 of injured SDFT referred to each 
animal included in the comparison with the contralateral (normal) SDFT, and the mean 
values for the levels taken singularly. 
 
 COMP/tubulin 
Animals 
Age 
(years) 
SDFT DDFT 
left  right left  right 
L4 L7 L4 L7 L4 L7 L4 L7 
Young 1 2 3.769 2.434 6.005 3.796 10.80 9.832 11.97 5.560 
Young 2 3 9.842 4.490 / / 1.153 3.429 1.563 2.931 
Old 1 8 5.549 10.60 5.166 8.005 10.96 9.112 3.351 11.90 
Old 2 12 1.156 10.00 21.45 1.433 6.226 1.967 2.212 1.658 
 
Table 3. Values of COMP/tubulin ratio at L4 and L7 of SDFT and DDFT referred to each 
animal included in the study. 
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2.3.1.Comparison of COMP fragmentation levels between L4 (predisposed) and L7 
(non-predisposed) sites of normal SDFT 
In Figure 6, the COMP fragmentation levels in L4 versus L7 of normal SDFT are 
graphically reported coupling the values for each single horse (histogram A). 
In the histogram, young1 horse shows COMP fragmentation level in L4 barely larger 
than L7 whereas in young2 horse COMP fragmentation level is clearly larger in L4 
versus L7. Old2 horse shows the latter pattern (L4 clearly larger than L7), while in old1 
horse COMP fragmentation levels seem larger in L7 than L4. 
Nevertheless, whether the mean value of COMP100/COMP ratios are taken, the new 
graphical representation of fragmentation levels is shown in histogram B of Figure 6. 
When the individual-effect is deleted, COMP fragmentation levels in L4 is larger than 
L7. However, statistically there was no significant difference between L4 and L7 levels 
in normal SDFT (p = 0.27). 
 
    
Figure 6. Graphical representation of COMP fragmentation levels in the predisposed (L4) 
and non-predisposed (L7) sites of normal SDFT referred to each animal included in the 
analysis (A) and to mean values (B). 
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2.3.2.Comparison of COMP fragmentation levels between L7 (predisposed) and L4 
(non-predisposed) sites of normal DDFT 
Figure 7 shows graphically the COMP fragmentation values for DDFT at L4 and L7 in 
all animals (histogram A) and the mean values of the predisposed (L7) and non-
predisposed (L4) sites (histogram B). 
In both graphs, the levels of L7 are larger than the levels of L4. The difference is clearer 
in young1 horse respecting the other horses (young2, old1 and old2). The histogram B 
synthetizes the general pattern with L7 higher than L4, even though there was no 
statistical significance (p = 0.06). 
    
Figure 7. Graphical representation of COMP fragmentation levels in the predisposed (L7) 
and non-predisposed (L4) sites of normal DDFT referred to each animal included in the 
analysis (A) and to mean values (B). 
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2.3.3.Comparison of COMP fragmentation levels between L4 (predisposed) and L7 
(non-predisposed) sites of injured SDFT 
The COMP fragmentation levels of injured SDFT at L4 and L7 are graphically 
represented in the histogram A of Figure 8, whereas the corresponding normal SDFT 
are represented in histogram B. Although these two graphs show a variable pattern if the 
animal are considered singularly, the histogram with the media values (histogram C) 
displays L4 levels larger than L7 levels in both injured and normal samples. However, 
statistical analysis has found no statistically significance between L4 and L7 in injured 
SDFT (p = 0.28). 
In addition, the differences of the COMP fragmentation levels between L4 and L7 of 
injured SDFT and normal SDFT were calculated (mean differences = 0.061592 and 
0.026103, respectively). The histogram D of Figure 8 shows graphically that the 
difference of the injured samples was larger than the difference of normal SDFT. 
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Figure 8. Graphical representation of COMP fragmentation levels in the predisposed (L4) 
and non-predisposed (L7) sites of injured SDFT (A) and normal SDFT (B) referred to 
each animal included in the analysis. (C) graphical representation of mean values of both 
injured and normal L4 and L7. (D) differences between L4 and L7. 
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2.3.4.Comparison of COMP fragmentation levels at L4 and L7 between young and old 
animals 
Figure 9 shows the COMP fragmentation levels in L4 and L7 for young versus old 
horses in SDFT (histogram A) and in DDFT (histogram C), respectively. Grouping the 
animals in young and old revealed no differences in the pattern of COMP fragmentation 
levels: L4 has higher levels than L7 in SDFT and vice versa L7 has higher levels than 
L4 in DDFT. 
The differences of the COMP fragmentation levels between L4 and L7 for all the 
groups were calculated. The difference obtained for young animals was compared to the 
difference for the old subjects (mean differences of SDFT = 0.087038 and 0.034241, 
respectively; mean difference of DDFT = 0.082840 and 0.014995, respectively). 
Histograms B and D of Figure 9 show graphically that the difference of the young 
samples is larger than the difference of old samples in both SDFT (B) and DDFT (D). 
In addition, differences between L4 and L7 in young and old injured SDFT were 
calculated. Figure 10 shows graphically the results of the comparison of the differences 
(L4-L7) between non-injured (“normal”) and injured samples. It can be noted a slightly 
larger difference in presence of injury in young subjects (Figure10, histogram A), 
whereas there is no variation in the old animals (Figure 10, histogram B). 
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Figure 9. Graphical representation of COMP fragmentation levels in L4 and L7 sites of 
young versus old horses. (A) normal SDFT samples, (B) differences between L4 and L7 in 
young versus old SDFT samples. (C) normal DDFT samples, (D) differences between L4 
and L7 in young versus old DDFT samples. 
 
    
Figure 10. Graphical representation of differences between L4 and L7 in non-injured 
(normal) versus injured samples in young (A) and old (B) animals. 
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2.3.5.Evaluation of whole COMP expression in L4 and L7 sites of SDFT and DDFT 
Figure 11 shows the values of whole COMP expression in L4 and L7 sites of normal 
SDF and DDF tendons (COMP/tubulin). Only left DDFT values were chosen for the 
comparison whereas the right DDFT values were used in the comparison with injured 
SDFT values (Figure11). 
COMP expression levels were greater in SDFT L4 versus L7 in young animals while in 
old animals COMP was lower in SDFT L4 versus L7 (histogram A). Regarding the left 
DDFT, COMP expression was greater in L7 versus L4 only in young 2, while L4 has a 
larger level of COMP expression in the other subjects. 
The histograms of Figure 12 show the values of COMP expression in L4 and L7 sites of 
the injured SDFTs (A) and the right DDFTs (B), thus mean tendons from the same leg. 
The COMP expression levels were greater in SDFT L4 versus L7 in young1 and old2 
whereas in old1, L7 was greater than L4 in association with the presence of an injury in 
the site (histogram A). Regarding the right DDFTs, COMP expression was greater in L7 
versus L4 only in old1, while L4 had a larger level of COMP expression in the other 
two subjects, more clear in young1. 
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Figure 11. COMP expression in L4 and L7 sites of normal SDFT (A) and left DDFT (B). 
The COMP values were expressed as ratio to the α-tubulin values to normalize the results. 
 
      
Figure 12. COMP expression in L4 and L7 sites of injured SDFT (A) and right DDFT (B). 
The COMP values were expressed as ratio to the α-tubulin values to normalize the results.
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2.4.DISCUSSION_______________________________________________________ 
 
 
 
This project was focused on particular tendon regions well-known to be injury-
predisposed. Recent proteomic studies provide a wider protein profile considering the 
whole SDF tendon (Dakin et al., 2014; Peffers et al., 2014). The work presented here 
was a further preliminary novel investigation on COMP expression and fragmentation 
in predisposed sites of the SDFT and DDFT. 
 
In the normal tendons examined in this study, higher trends of COMP fragmentation in 
predisposed sites of SDFT and DDFT (L4 and L7, respectively) were observed. This 
supported and proved the first hypothesis showing that injury-predisposed site has 
greater levels of COMP fragmentation when compared with non-predisposed site. 
Level peaks were observed in L4 of young2 and L7 of old1 in normal SDFTs, while a 
peak was noted in L7 of young1 in DDFT. Probably, these observations were a 
consequence of an injury that was not diagnosed during the clinical evaluation or a 
macroscopic alteration not evident before the tissue collection. 
In the analysed injured SDFT, the observed trend was similar to the normal situation 
with larger level of fragmentation in predisposed sites. Interestingly, the gap between 
the predisposed (L4) and non-predisposed (L7) sites seemed larger in presence of lesion 
in the predisposed site. This proved the second hypothesis that supposed an association 
between presence of an injury and greater COMP fragmentation. 
In order to evaluate the possibility of an age influence on the observed trends of COMP 
fragmentation levels, a descriptive analysis was attempted on young animals separately 
from old animals. The most interesting observations were that young animals showed 
larger gap between the COMP levels of L4 and L7 in both normal SDFT and DDFT 
suggesting a greater fragmentation and consequently an higher re-modelling activity in 
young tissue in predisposed sites. In presence of injury, young or old did not show 
larger differences when compare to the corresponding non-injured tendon. However, 
young animals showed again a larger gap between L4 and L7 in comparison with the 
old animals. This observation disproved the third hypothesis in which a smaller gap 
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between the two sites was expected in young animals where the COMP fragmentation 
levels have been reported physiologically higher. 
 
The observations reported on the whole COMP expression level revealed a particular 
trend in which young animals showed more COMP at L4 and old animals at L7 in 
normal SDFT. In the homolateral DDFTs (left), COMP seemed to be more express in 
L4 in all samples except for young2. Therefore, COMP was more expressed in young 
animals in injury-predisposed site of SDFT suggesting a possible important role of this 
protein in the functionality of the tendon. Indeed, in the old animals COMP was 
relatively less expressed in L4. This may lead to a major risk of lesion in this site in 
accordance with the studies that reported a greater probability of injury in old animals 
and with the findings on the proteomic profile alterations with age (Clayton and Court-
Brown, 2008; Peffers et al., 2014). 
Interestingly, the peaks of COMP expression observed in injured SDFT showed a 
perfect match with the presence of lesion at the site with high levels. Therefore, young1 
with lesion at L4 had a peak of COMP expression at L4 site whereas old1 subject had 
the peak at L7 corresponding to the site of diagnosed injury and old 2 showed an 
extreme peak at L4 site where a severe lesion were diagnosed. An intriguing 
correspondence was found between the high COMP expression levels of SDFT and the 
high levels of DDFT.  
Taken all together, the last descriptive observations may suggest that the presence of a 
lesion stimulate an increase in COMP production and it is well established that non-
collagenous proteins content in the ECM shows a general augmentation. Moreover, the 
corresponding high levels of COMP in the same levels of injured SDFTs and normal 
DDFTs may be explained proposing a possible effect of the lesion not only on the 
tendon physically affected but also on the homolateral non-affected tendon. It will be 
interesting to deepen these observations with the aim of investigating the effect of 
altered biomechanisms and the compensatory response of the tendon tissue non directly 
affected by an injury. 
 
The small size sample was certainly a limit of this research, although the observations 
of this study were in agreement with the mentioned recent proteomic findings in which 
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a larger number of samples was used (Dakin et al., 2014; Peffers et al., 2014). In 
particular, this research provided the first evidence that COMP fragmentation is 
physiologically greater in predisposed sites of tendon both in SDFT and in DDFT (L4 
and L7, respectively) when compared with a non-injured site. This fact may indicate a 
more reactive tissue in sites that are more subjected to mechanical stress. Consequently, 
the tissue results to have higher adaptive characteristics maintaining a certain grade of 
re-modelling activity.  
The greater fragmentation levels in SDFT predisposed sites seemed further increased 
when a lesion was present in the site supporting that pathological situation causes a 
major activation of proteolytic enzymes (Dickinson et al., 2003; Hosaka et al., 2010) 
and a consequent increase of COMP fragments. Furthermore, the whole COMP 
expression was greater in predisposed sites with injury whereas in physiological 
situation showed an age-dependent trend. The considerations on the age effect on 
COMP fragmentation are limited cause of the small size sample although it is 
interesting to note the general lower differences in old animals that suggest less reactive 
tissue. 
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2.5.CONCLUSIONS and FUTURE PERSPECTIVES___________________________ 
 
 
 
Despite the fact that the small size sample of this study did not provide a statistical 
significance, the evidences reported on COMP fragmentation resulted interesting as 
platform for further and larger size investigations. 
This project was the first that focussed on specific injury-predisposed sites of SDFT and 
DDFT. The preliminary results obtained herein need to be reinforced and integrated 
increasing the size of the sample. However, these observations seem to be in accordance 
with the recent investigations and might be a starting point and an inspiration for future 
steps of research. Indeed, the data collected provided an intriguing view of COMP100 
fragment levels supporting the studies that suggesting COMP100 as bio-marker for 
tendinopathies. In addition, the evaluation of whole COMP expression and COMP 
fragmentation in SDFT and, for the first time, also in DDFT provided preliminary 
results that open new interesting possible physiological implication of COMP and 
clinical applications of the evaluation of COMP fragmentation level.  
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3.PROJECT “B” 
 
 
 
Morphological comparison between maximum injured site and remote site of 
DDFT naturally affected by tear-type injury. A pilot study. 
 
 
3.1.INTRODUCTION____________________________________________________ 
 
 
 
Magnetic resonance imaging (MRI) and Computer tomography (CT) diagnostic 
technologies facilitated the investigation of equine DDFT. Since the introduction of this 
procedures in the clinical practice, the interest in DDFT and in its alterations notably 
increased. The main motivation of this interest is correlated to the implication that 
DDFT lesions have on foot pain and SDFT injuries (Blunden et al., 2006; Butcher et al., 
2007). Moreover, equine DDFT shows structure and biomechanics similar to human 
rotator cuff, therefore it might be an interesting comparative model to study (Lui et al., 
2011). Several studies investigated the histopathological features of different type 
lesions in DDFT. However, the actual state of art is non-homogeneous and there are 
scarce information on the effects of tear-type injury within the equine DDFT. 
Therefore, the objective of this study was to further characterize the morphology of 
DDFT in presence of naturally occurring tear-type injury through the histopathological 
evaluation of the tendon tissue surrounding and far from the lesion. 
The following table synthetizes the working hypothesis of the project: 
Hypothesis  
1 
The tendon tissue near the lesion site is characterized by alteration of the 
cellularity, the matrix composition and vascularization. These alterations 
influence also the tissue far or remote from the tear site. 
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3.2.EXPERIMENTAL PROCEDURES______________________________________ 
 
 
 
3.2.1.Samples and preparation of the serial slides 
Two bioptic samples from two different DDFTs were used in this study and named 
CASE1 and CASE2. Both the biopsies contain the region of tear-type injury and tendon 
tissue without macroscopic evidences of alteration. Figure 13 shows the macroscopic 
sections of the original biopsies and indicates the two parts compared in this study: one 
containing the tissue surrounding the lesion (maximum injured site -In-) and the other 
containing the tissue distant from the injury site (remote site -Rm-). 
 
Figure 13. Transverse view of the whole biopsies of CASE1 (A) and CASE2 (B). “In” 
indicates the maximum injured site which contains the tear. “Rm” is the site distant from 
the injury or remote site and shows no macroscopic alterations. Scale bar = 1cm. 
 
Smaller pieces including In or Rm site were obtained from the whole biopsies. These 
small tissue samples went under softening process which consisted in placing the tissue 
in a solution made of 2 parts of 4% phenol (Sigma-Aldrich) and 1 part glycerol (VWR) 
for two weeks. The sample had been rinsed gently in running tap water and placed back 
into formalin before going under long dehydration process. Finally, the samples were 
embedded in wax in the desired orientation. Serial 7µm-thick sections were cut at the 
microtome, mounted on microscope slides and used for histological and 
immunohistochemical studies. 
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3.2.2.Histology and immunohistochemistry 
Morphological analysis has been displayed using histological techniques such as 
hematoxylin-eosin (H&E) staining and Masson trichrome staining. Moreover, 
immunohistochemical protocols were performed using antibodies against cartilage 
oligomeric matrix protein (COMP), collagene type I (Coll1) and collagene type III 
(Coll3). 
Table 4 reports the staining protocols used in this study. HIC protocol included always a 
negative control and it was the same for all three antibodies. The dilution is indicated in 
brackets in the first column. 
The sections series obtained for both cases were divided in three level groups according 
to their proximity to the injury. The “a” level contained the sections more adjacent to 
the lesion and corresponding to the maximum injured site. The slides with sections 
collected further in the “In” site were considered “b” level group and slides from the 
remote site corresponded to “c” level. 
Consequently, four slides per staining have been prepared for the following sample: 
i.Case1 maximum injured site (a); ii.Case1 intermediate site (b); iii.Case1 remote site 
(c); iv.Case2 maximum injured site; v.Case2 intermediate site (b); vi.Case2 remote site 
(c). 
Stained sections were imaged at the same magnification (20x) using D-Sight slide 
scanner and software (A.Menarini diagnostic, Firenze, Italy) to obtain from four to eight 
images. Each image was evaluated for cellularity, vascularity and extracellular matrix 
organization based on the system described in Table 4 [Movin, 1997; Smith, 2013]. 
Scores referring to each image were combined for each variable to give a general panel 
for each sample. 
In addition, stained sections were imaged at 0.5x, 10x and 20x magnification to analyse 
the general histopathological appearance and to evaluate the expression of matrix 
components. To obtain semi-quantitative data, stain intensity comparison between HIC 
sections (CASE1In versus CASE1Rm and CASE2In versus CASE2Rm) was displayed 
using ImageJ 1.47v software (Wayne Rasband, NIH, USA).  
     Tendon - Project “B” - Experimental Procedures 
 
 123 
Staining Protocol 
H&E 
1.Dewax in xylene (3x5min); 2.Rehydrate in alcohol 2x100%>1x95%> 
1x70% (5min each), rinse in deionized water; 3.Stain 1x12min in 
haematoxylin, rinse 1x3min in deionized water, rinse 1x5min in running 
tap water, dip few seconds in HCl-ethanol (1/70), rinse 1x3min in 
deionized water; 4.Stain 1x40 seconds Eosin, de- hydrate in alcohol 
2x95%>2x100% (3min each), 3x5min in xylene; 5.Mount slides and dry ON 
in the hood. 
Masson trichrome 
[HT15; Sigma, Milan 
Italia] 
1.Dewax in xylene (3x5min); 2.Rehydrate in alcohol 2x100%>1x95%> 
1x70% (5min each), rinse in deionized water; 3.Stain 1x15min in Bouin’s 
Solution at 56°C, cool slides in tap water and wash 1x5min in running tap 
water; 4.Stain 1x10min in haematoxylin, wash 1x5min in running tap 
water, rinse in deionized water; 5.Stain 1x5min in Biebrich Scarlet-Acid 
Fucshin, rinse in deionized water; 6.Place slides 1x5min in 
Phosphotungstic/phosphomolybdic Acid Solution, 1x5min in Aniline Blue 
Solution, 1x2min in 1% Acetic Acid; 7.Rinse in deionized water, de- hydrate 
in alcohol 2x95%>2x100% (3min each), 3x5min in xylene, mount slides 
and dry ON in the hood. 
HIC anti-COMP 
[ab74524; Abcam, 
polyclonal in rabbit, 
1:100] 
1.Dewax in xylene (3x5min); 2.Rehydrate in alcohol 2x100%>1x95%> 
1x70% (5min each), rinse in deionized water and in PBS; 3.Block 1x45min 
in 3%BSA-PBS; 4.Incubate primary antibody ON; 5.Wash 3x5min in PBS; 
6.Incubate 60min with secondary antibody conjugated with biotin (diluted 
1:200); 7.Wash 3x5min in PBS; 8.Incubate 60min with ABCkit (Avidin-
Biotin Complex, Vector); 9. Wash 1x5min in PBS; 10.Stain with DAB (3, 
3’diaminobenzidine, Vector) from 45seconds till 1min and 45seconds 
depending on the signal; 11.Rinse in deionized water, dehydrate in alcohol 
2x95%>2x100% (3min each), 3x5min in xylene, mount slides and dry ON in 
the hood. 
HIC anti-Coll1 
[C2456; Sigma, 
monoclonal in 
mouse, 1:500] 
HIC anti-Coll3 
[C7805; Sigma, 
monoclonal in 
mouse, 1:500] 
Table 4. Synthetic explanation of staining protocols used in Project B. 
[HIC = immunohistochemistry; ON = over-night; PBS = phosphate buffered saline; BSA = 
bovine serum albumin]. 
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Score type Appearance Description 
Cellularity   
0 normal 
Presence of flattened cells in linear pattern between 
fibres 
1 slightly abnormal Some rounded cells present, slight increase in cellularity 
2 abnormal 
Many rounded cells present, obvious increase in 
cellularity 
3 
markedly 
abnormal 
Mostly rounded cells present, much higher numbers 
Vascularity   
0 normal 
Presence of some vascular bundles parallel to collagen 
fibres 
1 slightly abnormal Slight increase in number of vascular bundles 
2 abnormal Increased number of vascular bundles 
3 
markedly 
abnormal 
Large increase in number of vascular bundles 
Organization   
0 normal Parallel collagen fibres of similar widths 
1 slightly abnormal Some loss of fibre organization, some loss of linearity 
2 abnormal Moderate loss of fibre organization, few linear regions 
3 
markedly 
abnormal 
Total loss of organization, no linear fibres 
Crimp   
0 normal Regular crimp angle and parallel spacing of fibres 
1 reduced Irregular crimp angle and spacing 
2 absent Poorly defined crimp angle or absent 
Table 5. Scoring system utilized in the assessment of cellularity, matrix organization and 
vascularity in the histological sections (modified from Smith et al., 2013).  
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3.3.RESULTS__________________________________________________________ 
 
 
 
3.3.1.Morphological analysis with scoring table 
Figure 14 summarizes graphically the results obtained from the scoring assessment 
performed on CASE1. The maximum injured site had highest scores at “a” level for all 
the parameters considered (cellularity, vascularity, organization and crimp) indicating 
severe situation in the tendon tissue immediately adjacent to the tear-type lesion. The 
“b” level of the injured site had lower organisational and crimp scores although high 
scores for cellularity and vascularity were observed when compared with the “a” level 
suggesting a tendon tissue still reactive but with a structural pattern closer to normal 
tissue. The remote site (“c” level) showed the lowest scores indicating normal situation. 
Figure 15 shows CASE1 representative micro-sections of the three levels which the 
scoring analysis was performed on. 
 
Figure 14. Scoring results for CASE1 collected at three levels: (a) maximum injured site, 
(b) intermediate site and (c) remote site. Scoring values referred to Table 5. 
 
Figure 15. Representative micro-sections of CASE1 analysed in the scoring assessment: (a) 
maximum injured site, (b) intermediate site and (c) remote site. Scale bar = 100µm. 
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The scoring analysis performed on CASE2 showed an extremely high organisational 
score and high values for cellularity and crimp at level “a” (maximum injured site). On 
the contrary, level “b” had score 0 for all the parameters considered indicating a normal 
situation in a region not far from the injury site but closer to the core of the tendon. The 
remote site had a slightly higher cellularity, organization and crimp scores compared to 
the intermediate site. Vascularity parameter maintained low scores in all levels 
indicating a poorly vessels presence throughout the whole tendon cross-section (Figure 
16). 
Examples of the histological appearance of the three levels are given in Figure 17. 
 
Figure 16. Scoring results for CASE2 collected at levels (a) maximum injured site, (b) 
intermediate site and (c) remote site. Scoring values referred to Table 5. 
 
Figure 17. Representative micro-sections of CASE2 analysed in the scoring assessment: (a) 
maximum injured site, (b) intermediate site and (c) remote site. Scale bar = 100µm. 
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3.3.2.Histopathological findings 
The images collected from the maximum injured site sections in both cases showed the 
typical features of pathologic tendon. H&E and Masson trichrome revealed increased 
vascular density, increased thickness of synovial lining with blood vessels infiltration 
and increased number of fibroblast-like cells with plump nuclei. Moreover, high level of 
disorganization in the extracellular matrix (ECM) with collagen fibrils fragmented and 
irregularly aligned, presence of fibrocartilagineous metaplasia and oedema within the 
ECM were observed (Figure 18). Interestingly, CASE1 showed dramatic 
hypervascularisation whereas CASE2 was characterized by poor vessels presence. At 
the same way, CASE2 showed extreme levels of matrix disorganization and 
degeneration whereas CASE1 had no degeneration areas and the matrix disorganization 
was consequent to higher vascular density. 
The Masson trichrome staining made an intriguing distinction between the maximum 
injured sites uniformly stained in blue and the remote sites that assumed also the red 
coloration (Figure 19). The Rm sections of CASE1 showed an irregular spotted red 
coloration probably due to artefacts. At the contrary, the Rm of CASE2 had a more 
homogeneous red stain, especially in the lower part of the section. The upper part 
stained in blue and showed microscopically damaged tissue. 
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Figure 18. Representative microscopic images from maximum injured site of the two 
cases. H&E: (a) hypervascularization; (b) and (c) cells with plump nuclei, ECM 
metaplasia and oedema. Masson trichrome: (d) cluster of vessels; (e) increased thickness 
and vessel infiltration in the synovial lining; (f) degenerated area, hypervascularization 
and increased cell number; (g) and (h) high level of matrix disorganization, crimp pattern 
is usually regular but the orientation of fibrils is irregular. Scale bar = 100µm (a,b,c,f,g), 
50µm (d,e,h). 
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Figure 19. Masson trichrome staining of CASE1 (left) and CASE2 (right). (a) and (b), 
maximum injured site sections appear completely blue; (c) and (d), the remote site sections 
stain with red colour, the areas that remain blue area associated to tissue damage or 
artefacts. Scale bar = 100µm. The images of whole sections are 0.5X magnification. 
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3.3.3.COMP and Collagens expression 
The subjective evaluation of IHC stain intensity was supported by the use of an imaging 
software with the aim of obtaining semi-quantitative measurements for a comparison. 
In CASE1, the immunostaining for all three antibodies used in this study showed a 
relative higher intensity in the maximum injured site sections than the corresponding 
remote site sections. In particular, COMP antibody seemed to localize diffusely in the 
matrix in both sites although in injured site the higher intensity suggested a possible 
increase in quantity. Type I and III collagens antibodies showed a labelling clearly 
diffuse in the matrix and in the nuclei in the “In” sections, whereas the labelling was 
primarily limited to the nuclei in the Rm sites. Only for type I collagen, there was a 
diffuse light staining in the matrix of this site. 
 
 
 
Figure 20. Representative IHC staining for Cartilage Oligomeric Matrix Protein (COMP), 
Collagen I (Coll1) and Collagen III (Coll3) in CASE1. The three images on the left were 
taken in the maximum injured site (In), the three on the right were sections from the 
remote site (Rm). The injured sections show a relative higher intensity of the labelling 
when compared to the corresponding remote sections. Scale bar = 50µm. 
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In CASE2, COMP antibody seemed to have a similar intensity between the two sites 
although the imaging software gave higher values for “In” site. Type I collagen 
antibody showed a light labelling diffuse in the matrix of “In” site whereas it localized 
primarily in the nuclei in the Rm sections. Type III collagen immunostaining showed a 
low intensity in both sites, nevertheless, it seemed to have a matrix diffusion in the 
injured section and a nuclear localization in the other sections. 
 
 
 
Figure 21. Representative IHC staining for Cartilage Oligomeric Matrix Protein (COMP), 
Collagen I (Coll1) and Collagen III (Coll3) in CASE2. The three images on the left were 
taken in the maximum injured site (In), the three on the right were sections from the 
remote site (Rm). Scale bar = 50µm. 
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3.4.DISCUSSION_______________________________________________________ 
 
 
 
This project provided interesting observations that enlightened the tendon tissue 
response to a tear-type injury. In accordance with the working hypothesis, the tissue 
near the lesion site (maximum injured site) showed alterations of cellularity, matrix 
composition and vascularization; also the region far or remote from the lesion site 
revealed some minor alterations suggesting a possible influence of the tear it-self. 
Moreover, a difference in severity of the alterations between the cases, and between the 
different regions of the same tendon was reported. 
 
CASE1 showed a clear grading from severe (in maximum injured site) to normal (in 
remote site), especially if cellularity and vascularization were considered. Matrix 
organization and crimp pattern were severely altered in the region near the lesion 
whereas they turn to normal appearance in the other regions suggesting that the tear 
influences dramatically the tissue adjacent to the lesion it-self. In addition, intermediate 
site showed increased cellularity and vascularity indicating that the tissue is still healing 
although characterized by a well-organized matrix. 
At the same way, in CASE2 the tissue was extremely altered in the maximum injured 
site although it obtained low scores (suggesting condition similar to normal) in the 
intermediate and remote sites of the biopsy. Curiously, some areas of the remote sites 
showed alterations in cellularity, matrix organization and crimps. These observations 
can be explained suggesting an accumulation of micro-damages that might precede a 
macroscopic lesion. The remote site in CASE2 may represent a site predisposed to 
evolve a further lesion. 
The histological observations collected the typical alterations were reported in other 
studies on DDFT (Józsa and Kannus, 1997; Blunden et al., 2006; Murray et al., 2006; 
Blunden et al., 2009; Crişan et al., 2013). Interestingly, CASE1 showed a greater level 
of vascularization in the injured site, on the contrary CASE2 had less vascular 
infiltration although it was characterize by a dramatic matrix disorganization. These 
different responses might be due to a different grade of lesion severity or they might be 
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a different stage of the same response influenced by the variable composition of DDFT. 
Some studies reported the influence of tear dimension in the tissue response (Matthews 
et al., 2006) and the variation in cellularity, vascularization and fibrotic tissue content in 
the different parts of DDFT (Blunden et al., 2006). These studies supported my 
interpretations of the morphological findings in this evaluation. 
Intriguing findings were observed with Masson trichrome stain. The injured tissue was 
completely blue whereas the tissue far from the lesion showed a red coloration. 
Recently, Martinello et al. (submitted for publication) proposed that Masson staining 
might be considered a precise and quick tool in discerning between healthy and injured 
tendons. Indeed, during healing process the tendon ECM is constantly under 
rearrangement and therefore the collagen and non-collagenous proteins turnover might 
influence the penetration of the stains used in the Masson trichrome procedure. My 
observation reinforced this study providing evidence of this theory applied on naturally 
occurring injury in equine tendon. 
The IHC analysis demonstrated an increased presence of COMP in CASE1 supporting 
the previous studies on SDFT and the proteomic analysis (Smith et al., 1997; Dakin et 
al., 2014). In CASE2, the difference between injured site and remote site was not 
evident, therefore, according to histological findings, my interpretation was that the 
remote site showed micro alteration preceding the injury. 
The collagens had a clear greater expression in the injured than the remote site of 
CASE1 suggesting a reactive tissue under re-modelling. On the contrary, in CASE2 
only collagen type I seemed more expressed. This observation might be interpreted as a 
tissue in a chronic stage of the disease. 
 
Taken all together, the data collected in this project have highlighted many aspects of 
the morphological alteration caused by a tear lesion within DDFT. It has been 
demonstrated a strict correlation between the proximity to the lesion site and the 
severity of alteration. In addition, it was noticed that cellularity and vascularity were 
higher than normal also in a location far (but not remote) from the lesion suggesting a 
reactive tissue area larger than the sole injured site. Possible pre-injury alterations were 
also noticed in a remote site in CASE2 giving histological evidences of the well 
establish theory of tendinopathy aetiopathogenesis. On the author’s knowledge, it was 
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the first time that COMP and collagens expression was evaluate in DDFT affected by 
tear lesion. It was interesting to report a pattern of expression in accordance with the 
healing process theory in which collagen III is produced in early stages of disease and 
later substituted by collagen I. Moreover, the helping role of COMP in ECM re-
organization was highlighted once again reporting an increase expression in reactive 
tissue. 
A limit of this study was that no detailed anamnestic information were available on the 
two analysed cases. However, the sectional shape of the biopsy might suggest the 
tendon region was involved by the tear. Thus, we supposed that CASE1 sample was a 
biopsy from metacarpo-phalangeal (MCP) region whereas CASE2 biopsy was probably 
from midmetacarpal (MidM) region. Both regions are known to be frequently involved 
in tendon injury, in particular the MCP region is indicated as an injury-predisposed site 
in DDFT. It is interesting to note that CASE1 showed, already macroscopically, a 
severe reaction to the lesion with a tissue reaction that microscopically displayed 
increased cellularity and vascularization, matrix disorganization and degeneration. Due 
to the particular stresses that the MCP region is subjected to (tensional and compressive 
forces), all the described alterations might be site-related pathological changes. MidM 
region is under predominantly tensional forces and in DDFT is not considered a 
predisposed site to injury. It is probable that the microscopic evidences of alterations in 
CASE2 were a consequence of the particular features of the site in terms of forces along 
with tissue constitution. 
It will be interesting to investigate and deepen the site-influence on the injury resolving 
process by tendon tissue. 
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3.5.CONCLUSIONS and FUTURE PERSPECTIVES______________ 
 
 
 
In conclusion, this project reported interesting observations on DDFT affected by tear 
type lesion. Even though the small number of samples did not permit to generalize the 
results obtained, they might be considered a well-structured platform for further 
investigations. 
The present data could be integrated by increasing the number of cases and adding other 
histological and immunohistochemical analysis. Antibodies against matrix metallo 
proteinases (MMP) and macrophages (esterase, CD172a) could be used to describe the 
degradation and inflammatory processes and antibodies against activated-Caspase 3 or 
Asp175 could be used to obtain some information about the apoptotic processes. 
Moreover, to assess the alteration in the vascularization of the injured areas, IHC using 
an antibody against Factor VII (Willebrands factor) could be performed. 
The observations reported on the different response of the tendon to the presence of 
injury suggest an important role played by vascularization in the process of healing. 
Therefore, an evaluation of re-modelling process in tendon tissue with more or less 
vascular support might be an interesting investigation to evaluate the importance of the 
tenogenic precursors contribution from the vascular system. 
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